<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>218 Medicine Ini-Cet 2021 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / PYQs / Medicine
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">28</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0xf5d6bd=_0x2d0e;(function(_0x138f01,_0x441b56){const _0x559fa6=_0x2d0e,_0x2a134c=_0x138f01();while(!![]){try{const _0x3a1f8c=-parseInt(_0x559fa6(0x37e))/0x1+-parseInt(_0x559fa6(0x2af))/0x2*(-parseInt(_0x559fa6(0x23d))/0x3)+-parseInt(_0x559fa6(0x1af))/0x4+parseInt(_0x559fa6(0x230))/0x5*(parseInt(_0x559fa6(0x353))/0x6)+-parseInt(_0x559fa6(0x2e2))/0x7*(parseInt(_0x559fa6(0x2b1))/0x8)+-parseInt(_0x559fa6(0x297))/0x9+parseInt(_0x559fa6(0x1df))/0xa;if(_0x3a1f8c===_0x441b56)break;else _0x2a134c['push'](_0x2a134c['shift']());}catch(_0x19cb22){_0x2a134c['push'](_0x2a134c['shift']());}}}(_0x5131,0xcabe2));const _0x38ed77=(function(){let _0x12a654=!![];return function(_0x2b7cb2,_0x362802){const _0x370c19=_0x12a654?function(){const _0xfaf6b1=_0x2d0e;if(_0x362802){const _0x1dd8d1=_0x362802[_0xfaf6b1(0x239)](_0x2b7cb2,arguments);return _0x362802=null,_0x1dd8d1;}}:function(){};return _0x12a654=![],_0x370c19;};}()),_0x2936c6=_0x38ed77(this,function(){const _0x5cceb8=_0x2d0e,_0x1d2100={'jHScr':_0x5cceb8(0x37b)};return _0x2936c6[_0x5cceb8(0x121)]()[_0x5cceb8(0x113)](_0x1d2100[_0x5cceb8(0x278)])[_0x5cceb8(0x121)]()[_0x5cceb8(0x299)](_0x2936c6)[_0x5cceb8(0x113)](_0x1d2100[_0x5cceb8(0x278)]);});_0x2936c6();const _0x154c9c=(function(){const _0x541b00=_0x2d0e,_0x507a39={'eCIHZ':function(_0x59b342,_0x11c3de){return _0x59b342===_0x11c3de;},'ejmNv':_0x541b00(0x281),'yNXPe':'EbhWB'};let _0x507c68=!![];return function(_0xe540eb,_0x480ce1){const _0x337425=_0x541b00;if(_0x507a39[_0x337425(0x207)](_0x507a39[_0x337425(0x157)],_0x507a39[_0x337425(0x2eb)])){if(_0x2b7729){const _0x4da5b1=_0x37cc82[_0x337425(0x239)](_0x56785a,arguments);return _0x4f1843=null,_0x4da5b1;}}else{const _0x3a9b13=_0x507c68?function(){const _0x323947=_0x337425;if(_0x480ce1){const _0x46c998=_0x480ce1[_0x323947(0x239)](_0xe540eb,arguments);return _0x480ce1=null,_0x46c998;}}:function(){};return _0x507c68=![],_0x3a9b13;}};}()),_0x474c72=_0x154c9c(this,function(){const _0x18679a=_0x2d0e,_0x16e67e={'RXyyC':_0x18679a(0x1b6),'wZGbB':'hidden','cgdvp':function(_0x13fe1f,_0x51470d){return _0x13fe1f===_0x51470d;},'pgRtr':'MZSBC','aKSns':_0x18679a(0x33e),'JLKJN':function(_0x500118,_0x3de593){return _0x500118(_0x3de593);},'lylzA':function(_0x1a255d,_0x3674b7){return _0x1a255d+_0x3674b7;},'LxYxF':function(_0x11236e,_0x6f9686){return _0x11236e+_0x6f9686;},'QnJQB':_0x18679a(0x2d1),'GwajK':'{}.constructor(\x22return\x20this\x22)(\x20)','ZmLEJ':_0x18679a(0x265),'WwXLn':function(_0x5d0bc2){return _0x5d0bc2();},'XuXaw':_0x18679a(0x1f0),'bwkzN':_0x18679a(0x126),'UKKpD':'info','iprwt':_0x18679a(0x20b),'kgdyd':_0x18679a(0x312),'yONdw':_0x18679a(0x397),'PNmxy':_0x18679a(0x346),'KcIuz':function(_0x212282,_0x17b3cf){return _0x212282<_0x17b3cf;},'VQvvh':function(_0x25ffdb,_0x17e8c6){return _0x25ffdb!==_0x17e8c6;},'tBwIy':_0x18679a(0x2d6)},_0x2a2360=function(){const _0x4ee141=_0x18679a;if(_0x16e67e[_0x4ee141(0x244)](_0x16e67e[_0x4ee141(0x318)],_0x16e67e[_0x4ee141(0x2b5)]))_0xc538c8[_0x4ee141(0x38e)](_0x16e67e[_0x4ee141(0x2aa)])[_0x4ee141(0x139)]['add'](_0x16e67e[_0x4ee141(0x145)]);else{let _0x1b98e3;try{_0x1b98e3=_0x16e67e['JLKJN'](Function,_0x16e67e['lylzA'](_0x16e67e[_0x4ee141(0x2a8)](_0x16e67e[_0x4ee141(0x2a5)],_0x16e67e[_0x4ee141(0x173)]),');'))();}catch(_0x529031){_0x1b98e3=window;}return _0x1b98e3;}},_0x405f31=_0x16e67e[_0x18679a(0x25b)](_0x2a2360),_0x405e0a=_0x405f31[_0x18679a(0x2c2)]=_0x405f31['console']||{},_0x4015b1=[_0x16e67e[_0x18679a(0x33c)],_0x16e67e[_0x18679a(0x269)],_0x16e67e[_0x18679a(0x22c)],_0x16e67e[_0x18679a(0x26d)],_0x16e67e[_0x18679a(0x286)],_0x16e67e[_0x18679a(0x377)],_0x16e67e[_0x18679a(0x206)]];for(let _0x479b94=0x0;_0x16e67e[_0x18679a(0x1bc)](_0x479b94,_0x4015b1[_0x18679a(0x236)]);_0x479b94++){if(_0x16e67e[_0x18679a(0x38d)](_0x16e67e[_0x18679a(0x2ba)],_0x16e67e[_0x18679a(0x2ba)]))_0x529b7++,_0x592f03[_0x18679a(0x137)]=_0x16e67e[_0x18679a(0x15a)];else{const _0x55b7a9=_0x154c9c[_0x18679a(0x299)][_0x18679a(0x112)][_0x18679a(0x237)](_0x154c9c),_0x49aa60=_0x4015b1[_0x479b94],_0x255358=_0x405e0a[_0x49aa60]||_0x55b7a9;_0x55b7a9[_0x18679a(0x1b3)]=_0x154c9c[_0x18679a(0x237)](_0x154c9c),_0x55b7a9['toString']=_0x255358[_0x18679a(0x121)][_0x18679a(0x237)](_0x255358),_0x405e0a[_0x49aa60]=_0x55b7a9;}}});_0x474c72();let questionsData=[{'text':_0xf5d6bd(0x395),'choices':[{'id':0x1,'text':_0xf5d6bd(0x22a)},{'id':0x2,'text':_0xf5d6bd(0x373)},{'id':0x3,'text':_0xf5d6bd(0x305)},{'id':0x4,'text':'Candida\x20krusei\x20-\x20Fluconazole'}],'correct_choice_id':0x4,'solution':_0xf5d6bd(0x2b9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x323),'choices':[{'id':0x1,'text':'MS'},{'id':0x2,'text':_0xf5d6bd(0x12e)},{'id':0x3,'text':_0xf5d6bd(0x31c)},{'id':0x4,'text':_0xf5d6bd(0x252)}],'correct_choice_id':0x2,'solution':'<p><strong>Multiple\x20sclerosis\x20(MS)</strong>&nbsp;is\x20an\x20autoimmune\x20<strong>demyelinating</strong>&nbsp;and\x20inflammatory\x20disease\x20of\x20the\x20CNS\x20characterized\x20by\x20gliosis\x20and\x20neuronal\x20loss.\x20It\x20is\x20caused\x20by\x20an&nbsp;<strong>autoimmune\x20response</strong>&nbsp;directed\x20against\x20components\x20of\x20the&nbsp;<strong>myelin\x20</strong>sheath<strong>.\x20</strong>Genetic\x20predisposition\x20with\x20<strong>HLA-DRB1</strong>,\x20cigarette\x20smoking,\x20vitamin\x20D\x20deficiency,\x20and\x20exposure\x20to\x20Epstein\x20Barr\x20virus\x20(<strong>EBV</strong>)\x20are\x20known\x20risk\x20factors.&nbsp;Clinical\x20features\x20of\x20MS\x20include:</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x201271\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<ul>\x0a<li>Visual\x20impairment\x20due\x20to\x20the\x20involvement\x20of\x20the\x20optic\x20nerve&nbsp;<strong>(optic\x20neuritis).</strong></li>\x0a<li>Involvement\x20of\x20the\x20brainstem\x20causes\x20cranial\x20nerve\x20signs\x20such\x20as&nbsp;<strong>ataxia,\x20nystagmus,</strong>&nbsp;and&nbsp;<strong>internuclear\x20ophthalmoplegia\x20(INO).</strong></li>\x0a<li><strong>Weakness</strong>\x20of\x20limb\x20(usually\x20<strong>UMN</strong>\x20type),\x20facial\x20weakness,\x20<strong>spasticity</strong>,\x20<strong>hyperreflexia</strong>,\x20Babinski\x20signs,&nbsp;<strong>sensory\x20impairment</strong>&nbsp;of\x20the\x20trunk\x20and\x20limbs,&nbsp;and&nbsp;<strong>loss\x20of\x20bladder\x20control.</strong></li>\x0a</ul>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p><strong>Guillain-Barre\x20syndrome\x20</strong>(<strong>GBS</strong>)&nbsp;is\x20an\x20<strong>acute</strong>\x20inflammatory\x20demyelinating\x20neuropathy\x20causing&nbsp;<strong>rapidly</strong>\x20evolving&nbsp;<strong>ascending&nbsp;paralysis</strong>.&nbsp;\x20It\x20is\x20associated\x20with&nbsp;<strong>diminished\x20reflexes\x20(areflexia)&nbsp;</strong>and\x20autonomic\x20involvement\x20with\x20or\x20without\x20sensory\x20impairment.</p>\x0a<p><strong>Tropical\x20spastic\x20paraparesis\x20</strong>also\x20known\x20as&nbsp;<strong>HTLV-1\x20associated\x20myelopathy</strong><strong>&nbsp;</strong>is\x20a\x20<strong>slowly</strong>\x20progressive\x20<strong>spastic</strong>\x20syndrome\x20with\x20<strong>variable\x20sensory\x20and\x20bladder</strong>\x20disturbance\x20but\x20<strong>no\x20LMN</strong>\x20involvement.\x20Diagnosis\x20is\x20by\x20demonstration\x20of<strong>\x20HTLV-1\x20specific\x20antibody</strong>\x20in\x20serum\x20by\x20<strong>ELISA</strong>\x20and\x20confirmation\x20is\x20done\x20using\x20radioimmunoprecipitation\x20or\x20Western\x20blot\x20analysis.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x31f),'choices':[{'id':0x1,'text':_0xf5d6bd(0x190)},{'id':0x2,'text':_0xf5d6bd(0x3c4)},{'id':0x3,'text':'2\x20and\x204'},{'id':0x4,'text':_0xf5d6bd(0x264)}],'correct_choice_id':0x3,'solution':_0xf5d6bd(0x18a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x1b7),'choices':[{'id':0x1,'text':'Start\x20ART\x20if\x20CD4<200'},{'id':0x2,'text':_0xf5d6bd(0x29a)},{'id':0x3,'text':'Start\x20ATT\x20and\x20then\x20ART\x20after\x202\x20weeks'},{'id':0x4,'text':'Start\x20ATT\x20and\x20ART\x20simultaneously'}],'correct_choice_id':0x3,'solution':_0xf5d6bd(0x2bb),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x263),'choices':[{'id':0x1,'text':_0xf5d6bd(0x16b)},{'id':0x2,'text':_0xf5d6bd(0x109)},{'id':0x3,'text':_0xf5d6bd(0x3b6)},{'id':0x4,'text':_0xf5d6bd(0x1a7)}],'correct_choice_id':0x2,'solution':'<p><strong>Option\x20D:</strong>\x20The\x20image\x20below\x20shows\x20airflow\x20limitation\x20and\x20flattening\x20in\x20the\x20<strong>inspiratory\x20limb</strong>\x20of\x20the\x20loop.\x20It\x20is\x20seen\x20in\x20nonfixed\x20variable\x20extrathoracic\x20obstruction.</p>\x0a<p>Examples:\x20vocal\x20cord\x20paralysis,\x20extrathoracic\x20tracheomalacia,\x20polychondritis,\x20etc.</p>','explanation_video':'','question_images':[_0xf5d6bd(0x3bf)],'explanation_images':[_0xf5d6bd(0x393),_0xf5d6bd(0x123),_0xf5d6bd(0x3a5),_0xf5d6bd(0x1a4)]},{'text':_0xf5d6bd(0x283),'choices':[{'id':0x1,'text':_0xf5d6bd(0x335)},{'id':0x2,'text':'Multiple\x20myeloma'},{'id':0x3,'text':_0xf5d6bd(0x30c)},{'id':0x4,'text':'Milk\x20alkali\x20syndrome'}],'correct_choice_id':0x2,'solution':_0xf5d6bd(0x2d9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x374),'choices':[{'id':0x1,'text':_0xf5d6bd(0x107)},{'id':0x2,'text':_0xf5d6bd(0x31e)},{'id':0x3,'text':_0xf5d6bd(0x319)},{'id':0x4,'text':_0xf5d6bd(0x363)}],'correct_choice_id':0x1,'solution':_0xf5d6bd(0x13d),'explanation_video':'','question_images':[],'explanation_images':[_0xf5d6bd(0x38a)]},{'text':_0xf5d6bd(0x1aa),'choices':[{'id':0x1,'text':'Calcium\x20oxalate'},{'id':0x2,'text':_0xf5d6bd(0x159)},{'id':0x3,'text':_0xf5d6bd(0x1c7)},{'id':0x4,'text':_0xf5d6bd(0x2b4)}],'correct_choice_id':0x1,'solution':_0xf5d6bd(0x142),'explanation_video':'','question_images':[_0xf5d6bd(0x108)],'explanation_images':[]},{'text':_0xf5d6bd(0x14e),'choices':[{'id':0x1,'text':_0xf5d6bd(0x1d8)},{'id':0x2,'text':'2,\x203\x20and\x204'},{'id':0x3,'text':_0xf5d6bd(0x1c6)},{'id':0x4,'text':_0xf5d6bd(0x24b)}],'correct_choice_id':0x3,'solution':_0xf5d6bd(0x2f1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x23e),'choices':[{'id':0x1,'text':_0xf5d6bd(0x1a3)},{'id':0x2,'text':'MRI\x20to\x20look\x20for\x20infarct'},{'id':0x3,'text':_0xf5d6bd(0x3b9)},{'id':0x4,'text':_0xf5d6bd(0x125)}],'correct_choice_id':0x1,'solution':_0xf5d6bd(0x1e5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x1b8),'choices':[{'id':0x1,'text':_0xf5d6bd(0x34c)},{'id':0x2,'text':_0xf5d6bd(0x229)},{'id':0x3,'text':_0xf5d6bd(0xfb)},{'id':0x4,'text':'1\x20and\x204\x20correct'}],'correct_choice_id':0x3,'solution':_0xf5d6bd(0x341),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x210),'choices':[{'id':0x1,'text':'Area\x20postrema\x20syndrome'},{'id':0x2,'text':'Acute\x20Myelitis'},{'id':0x3,'text':_0xf5d6bd(0x20c)},{'id':0x4,'text':_0xf5d6bd(0x20e)}],'correct_choice_id':0x3,'solution':_0xf5d6bd(0x122),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x2ea),'choices':[{'id':0x1,'text':_0xf5d6bd(0x38c)},{'id':0x2,'text':_0xf5d6bd(0x12a)},{'id':0x3,'text':_0xf5d6bd(0x344)},{'id':0x4,'text':_0xf5d6bd(0x11f)}],'correct_choice_id':0x1,'solution':'<p><strong>Arterial</strong>\x20and\x20<strong>Venous\x20pH</strong>\x20can\x20be\x20used\x20to\x20determine<strong>\x20acid-base\x20imbalance.</strong></p>\x0a<p><strong>Arterial\x20blood\x20gas</strong>\x20(ABG)\x20analysis\x20is\x20the\x20<strong>gold\x20standard</strong>\x20method\x20for\x20the\x20assessment\x20of\x20oxygen\x20and\x20acid-base\x20status.</p>\x0a<p>Venous\x20blood\x20gas\x20(VBG)\x20analysis\x20is\x20increasingly\x20being\x20used\x20as\x20a\x20substitute\x20for\x20ABG\x20as\x20the\x20difference\x20between\x20the\x20pH\x20obtained\x20from\x20VBG\x20and\x20ABG\x20is\x20clinically\x20insignificant\x20(arterial\x20pH\x20typically\x200.03\x20higher\x20than\x20venous\x20pH),\x20thus\x20making\x20venous\x20pH\x20values\x20acceptable.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x203:</strong>\x20The\x20pO2\x20values\x20also\x20show\x20a\x20significant\x20difference,\x20with\x20arterial\x20pO2\x20(normal\x2095mmHg)\x20values\x20typically\x2055mmHg\x20greater\x20than\x20the\x20venous\x20pO2\x20(normal\x2040mmHg),\x20making\x20venous\x20pO2\x20values\x20unacceptable.<br\x20/>\x20<br\x20/><strong>Option\x204:</strong>\x20Venous\x20pCO2\x20(normal\x20range\x2041\x20to\x2051mmHg)\x20values\x20differ\x20significantly\x20from\x20arterial\x20pCO2\x20(normal\x20range\x2035\x20to\x2045mmHg)\x20by\x20a\x20range\x20of\x205\x20to\x2015mmHg\x20which\x20makes\x20venous\x20pCO2\x20values\x20unacceptable.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20does\x20not\x20show\x20both\x20hyperkinetic\x20and\x20hypokinetic\x20movements?','choices':[{'id':0x1,'text':'Parkinson\x27s\x20disease'},{'id':0x2,'text':_0xf5d6bd(0x2e6)},{'id':0x3,'text':'Neurodegeneration\x20with\x20Brain\x20Iron\x20Accumulation'},{'id':0x4,'text':'Huntington\x27s\x20chorea'}],'correct_choice_id':0x4,'solution':_0xf5d6bd(0x1c2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x25d),'choices':[{'id':0x1,'text':_0xf5d6bd(0x292)},{'id':0x2,'text':_0xf5d6bd(0x104)},{'id':0x3,'text':'Alpha\x20blocker'},{'id':0x4,'text':_0xf5d6bd(0x3c5)}],'correct_choice_id':0x4,'solution':_0xf5d6bd(0x212),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x14d),'choices':[{'id':0x1,'text':_0xf5d6bd(0x255)},{'id':0x2,'text':_0xf5d6bd(0x39a)},{'id':0x3,'text':'Gitelman\x20syndrome'},{'id':0x4,'text':_0xf5d6bd(0x2ce)}],'correct_choice_id':0x2,'solution':'<p><strong>Liddle\x27s\x20syndrome&nbsp;</strong>is\x20associated\x20with\x20<strong>hypokalemic</strong>\x20metabolic\x20<strong>alkalosis</strong>\x20with\x20<strong>hypertension.</strong></p>\x0a<p>It\x20is\x20an\x20<strong>autosomal\x20dominant</strong>\x20condition\x20due\x20to\x20a\x20<strong>gain\x20of\x20function\x20mutation</strong>\x20in\x20the\x20<strong>ENaC\x20gene,</strong>\x20which\x20codes\x20for\x20the\x20<strong>epithelial\x20sodium\x20channels</strong>\x20present\x20in\x20the\x20kidney.\x20</p>\x0a<p><strong>Hypertension</strong>\x20is\x20the\x20result\x20of\x20increased\x20sodium\x20retention\x20through\x20<strong>ENaC\x20channel</strong>\x20and\x20<strong>volume\x20expansion.</strong>\x20Volume\x20expansion\x20suppresses\x20renin\x20and\x20aldosterone\x20secretion,\x20leading\x20to<strong>\x20hypokalemic\x20metabolic\x20alkalosis.</strong></p>\x0a<p\x20class=\x22p1\x22>Treatment\x20is\x20with\x20diuretics\x20that\x20directly\x20block\x20the\x20ENaC\x20channels,\x20like&nbsp;<strong>amiloride</strong>&nbsp;and\x20<strong>triamterene.\x20</strong>Spironolactone\x20is\x20not\x20effective\x20as\x20it\x20is\x20an\x20aldosterone-receptor\x20antagonist.</p>\x0a<p\x20class=\x22p1\x22>Other\x20options:</p>\x0a<p\x20class=\x22p1\x22>Option\x20A:\x20<strong>Bartter\x20syndrome</strong>\x20is\x20an\x20<strong>autosomal\x20recessive</strong>\x20disorder\x20occurring\x20due\x20to\x20defects\x20in\x20various\x20genes\x20involved\x20in\x20the\x20regulated\x20<strong>Na+,\x20K+,\x20and\x20Cl&ndash;</strong>\x20transport\x20by\x20the\x20<strong>thick\x20ascending\x20loop\x20of\x20Henle.</strong>\x20There\x20is\x20extracellular\x20fluid\x20volume\x20depletion\x20with\x20low\x20or\x20normal\x20blood\x20pressure.\x20It\x20is\x20characterized\x20by\x20metabolic\x20alkalosis,\x20hypokalemia,\x20hypochloremia,\x20and\x20hypercalciuria.</p>\x0a<p\x20class=\x22p1\x22><br\x20/>Option\x20C:\x20<strong>Gitelman\x20syndrome</strong>\x20is\x20an<strong>\x20autosomal\x20recessive</strong>\x20disorder\x20due\x20to\x20a\x20loss\x20of\x20function\x20mutation\x20in\x20the\x20thiazide-sensitive\x20<strong>Na+-Cl&ndash;\x20cotransporter</strong>\x20of\x20the\x20distal\x20convoluted\x20tubule.\x20It\x20is\x20characterized\x20by\x20hypokalemic\x20metabolic\x20alkalosis\x20with\x20hypomagnesemia\x20and\x20hypocalciuria\x20with\x20low\x20blood\x20pressure.</p>\x0a<p\x20class=\x22p1\x22>Option\x20D-\x20<strong>Gordon\x20syndrome&nbsp;</strong>is\x20a\x20state\x20of\x20pseudohypoaldosteronism.\x20It\x20is\x20characterized\x20by\x20hypertension,\x20<strong>hyperkalemia</strong>,\x20metabolic\x20<strong>acidosis,</strong>\x20and\x20low-normal\x20plasma\x20renin\x20activity\x20and\x20aldosterone\x20concentrations.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x11a),'choices':[{'id':0x1,'text':'Urinary\x20sodium\x20<20\x20mEq/L'},{'id':0x2,'text':_0xf5d6bd(0x29e)},{'id':0x3,'text':_0xf5d6bd(0x2c5)},{'id':0x4,'text':'Patient\x20can\x20be\x20clinically\x20euvolemic\x20to\x20hypervolemic'}],'correct_choice_id':0x1,'solution':_0xf5d6bd(0x106),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x1d0),'choices':[{'id':0x1,'text':'Right\x20to\x20left\x20shunt'},{'id':0x2,'text':'Ventilation/Perfusion\x20mismatch'},{'id':0x3,'text':_0xf5d6bd(0x124)},{'id':0x4,'text':'Alveolar\x20membrane\x20damage'}],'correct_choice_id':0x3,'solution':'<p>All\x20of\x20the\x20given\x20options\x20can\x20cause\x20<strong>hypoxemia</strong>\x20out\x20of\x20which\x20the\x20<strong>alveolar-arterial\x20oxygen\x20gradient\x20(A-a\x20gradient)</strong>\x20remains\x20<strong>normal</strong>\x20in\x20<strong>hypoventilation</strong>.</p>\x0a<p>The\x20A-a\x20gradient\x20or\x20the\x20alveolar-arterial\x20oxygen\x20gradient\x20refers\x20to\x20the\x20<strong>difference</strong>\x20between\x20the\x20<strong>oxygen\x20concentration\x20in\x20the\x20alveoli\x20(PAO<sub>2</sub>)</strong>\x20and\x20oxygen\x20concentration\x20in\x20the\x20<strong>arterial\x20system\x20(PaO<sub>2</sub>).</strong></p>\x0a<p>A-a\x20gradient=&nbsp;PAO<sub>2\x20</sub>-&nbsp;PaO<sub>2</sub></p>\x0a<p>In\x20<strong>hypoventilation</strong>,\x20patients\x20lack\x20oxygen\x20tension\x20in\x20the\x20respiratory\x20system\x20as\x20well\x20as\x20their\x20arterial\x20system.\x20This\x20results\x20in\x20a\x20<strong>decrease\x20in\x20both\x20PAO2\x20and\x20PaO2</strong>\x20and\x20<strong>A-a\x20gradient</strong>\x20remains\x20<strong>normal</strong>.\x20Hypoventilation\x20can\x20be\x20seen\x20in<strong>\x20CNS\x20depression,</strong>\x20neuromuscular\x20diseases\x20such\x20as\x20<strong>myasthenia\x20gravis,</strong>\x20<strong>kyphoscoliosis</strong>,\x20vertebral\x20fractures,\x20etc.</p>\x0a<p><strong>Other\x20options:&nbsp;</strong></p>\x0a<p>Option\x20A-\x20In\x20a\x20<strong>right-to-left\x20shunt</strong>,\x20a\x20portion\x20of\x20the\x20pulmonary\x20blood\x20flow\x20gets\x20shunted\x20away\x20from\x20the\x20alveoli.\x20This\x20results\x20in\x20ventilation\x20without\x20perfusion\x20which\x20causes\x20a\x20higher\x20V/Q\x20ratio.\x20Here,\x20diffusion\x20between\x20capillaries\x20and\x20alveoli\x20is\x20unaffected,&nbsp;\x20but\x20the\x20<strong>arterial\x20PaO<sub>2</sub></strong>\x20is\x20<strong>decreased</strong>\x20due\x20to\x20the\x20lack\x20of\x20oxygenation\x20of\x20the\x20shunted\x20blood.\x20This\x20results\x20in\x20hypoxemia\x20and\x20an\x20<strong>increased\x20A-a\x20gradient.\x20</strong>In\x20the\x20cases\x20of\x20the\x20shunt,\x20oxygenation\x20does\x20not\x20improve\x20hypoxemia.</p>\x0a<p>Option\x20B-\x20<strong>Ventilation/Perfusion\x20(V/Q)\x20mismatch</strong>\x20is\x20the\x20most\x20common\x20cause\x20of\x20hypoxemia.</p>\x0a<p><strong>Low\x20V/Q\x20mismatch</strong>\x20occurs\x20in\x20<strong>chronic\x20obstructive\x20pulmonary\x20disorder</strong>\x20(COPD),\x20<strong>asthma,\x20interstitial\x20lung\x20disease,</strong>\x20etc.\x20In\x20these\x20cases,\x20the\x20<strong>A-a\x20oxygen\x20gradient</strong>\x20is\x20<strong>increased</strong>\x20due\x20to\x20a\x20defect\x20in\x20diffusion\x20resulting\x20in\x20hypoxemia.\x20</p>\x0a<p>A\x20<strong>high\x20V/Q</strong>\x20ratio\x20is\x20seen\x20in<strong>\x20pulmonary\x20embolism</strong>\x20(PE)\x20where\x20there\x20is\x20wasted\x20ventilation.\x20The\x20alveolar\x20oxygen\x20is\x20normal\x20but\x20there\x20is\x20decreased\x20perfusion\x20resulting\x20in\x20<strong>increased\x20A-a\x20gradient.</strong>\x20</p>\x0a<p>Inspiratory\x20hypoxia,\x20seen\x20at\x20h<strong>igh\x20altitudes,</strong>\x20can\x20cause\x20a\x20<strong>V/Q\x20mismatch.</strong>\x20The\x20decreased\x20atmospheric\x20pressure\x20causes\x20a\x20decreased\x20PAO2.\x20There\x20is\x20normal\x20diffusion\x20which\x20suggests\x20a\x20<strong>normal\x20A-a\x20gradient</strong>\x20while\x20the\x20arterial\x20PaO2\x20decreases,\x20leading\x20to\x20<strong>hypoxemia</strong>.</p>\x0a<p>Hypoventilation\x20is\x20the\x20better\x20answer\x20as\x20the\x20cause\x20of\x20the\x20V/Q\x20mismatch\x20is\x20not\x20specified.</p>\x0a<p>Option\x20D:\x20<strong>Alveolar\x20membrane\x20damage</strong>\x20affects\x20diffusion\x20between\x20the\x20alveoli\x20and\x20capillaries.\x20The\x20oxygen\x20levels\x20in\x20the\x20arterial\x20blood\x20decrease\x20even\x20though\x20alveoli\x20are\x20being\x20ventilated.\x20This\x20leads\x20to\x20an\x20<strong>increased\x20A-a\x20gradient.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x321),'choices':[{'id':0x1,'text':_0xf5d6bd(0x18d)},{'id':0x2,'text':_0xf5d6bd(0x205)},{'id':0x3,'text':_0xf5d6bd(0x2b8)},{'id':0x4,'text':_0xf5d6bd(0x21d)}],'correct_choice_id':0x2,'solution':_0xf5d6bd(0x30d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'All\x20are\x20true\x20regarding\x20heart\x20failure\x20except:','choices':[{'id':0x1,'text':_0xf5d6bd(0x259)},{'id':0x2,'text':_0xf5d6bd(0x303)},{'id':0x3,'text':_0xf5d6bd(0x2cf)},{'id':0x4,'text':'Atrial\x20fibrillation\x20is\x20common\x20in\x20elderly\x20and\x20is\x20the\x20cause\x20of\x20stroke\x20in\x20quarter\x20of\x20the\x20stroke\x20cases'}],'correct_choice_id':0x2,'solution':_0xf5d6bd(0x2fb),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x364),'choices':[{'id':0x1,'text':_0xf5d6bd(0x1da)},{'id':0x2,'text':_0xf5d6bd(0x306)},{'id':0x3,'text':'Nifedipine'},{'id':0x4,'text':'Epoprostenol'}],'correct_choice_id':0x2,'solution':_0xf5d6bd(0x1bb),'explanation_video':'','question_images':[],'explanation_images':[_0xf5d6bd(0x146)]},{'text':'A\x2030-year-old\x20female\x20patient\x20came\x20to\x20the\x20outpatient\x20department\x20with\x20complaints\x20of\x20neck\x20swelling.\x20She\x20gives\x20a\x20history\x20of\x20weight\x20loss\x20and\x20palpitations.\x20On\x20examination,\x20she\x20has\x20exophthalmos\x20and\x20a\x20diffusely\x20enlarged\x20thyroid\x20gland.\x20What\x20are\x20the\x20essential\x20investigations\x20that\x20should\x20be\x20done\x20for\x20the\x20patient?','choices':[{'id':0x1,'text':_0xf5d6bd(0x24e)},{'id':0x2,'text':_0xf5d6bd(0x1e0)},{'id':0x3,'text':_0xf5d6bd(0x37c)},{'id':0x4,'text':'1,\x203,\x204\x20and\x205\x20only'}],'correct_choice_id':0x4,'solution':_0xf5d6bd(0x167),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x32e),'choices':[{'id':0x1,'text':_0xf5d6bd(0x102)},{'id':0x2,'text':_0xf5d6bd(0x329)},{'id':0x3,'text':'Fingolimod'},{'id':0x4,'text':_0xf5d6bd(0x347)}],'correct_choice_id':0x2,'solution':_0xf5d6bd(0x1f4),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x138),'choices':[{'id':0x1,'text':_0xf5d6bd(0x20f)},{'id':0x2,'text':'Chronic\x20hepatitis\x20B'},{'id':0x3,'text':'Remote\x20infection\x20with\x20hepatitis\x20B'},{'id':0x4,'text':_0xf5d6bd(0x3bd)}],'correct_choice_id':0x3,'solution':'<p><br\x20/>The\x20most\x20probable\x20diagnosis\x20is\x20<strong>remote</strong>\x20infection\x20with\x20<strong>hepatitis\x20B\x20virus\x20(HBV).</strong></p>\x0a<p>A\x20non-reactive\x20HbsAg\x20rules\x20out\x20active\x20HBV\x20infection<strong>\x20(Options\x20A\x20and\x20B).</strong></p>\x0a<p>Non-reactive\x20IgM\x20anti-HbcAg\x20suggests\x20that\x20the\x20patient\x20is\x20not\x20in\x20the\x20window\x20period\x20<strong>(Option\x20C).</strong></p>\x0a<p><strong>Reactive</strong>\x20<strong>IgG</strong>\x20HBcAg\x20is\x20seen\x20in\x20the\x20l<strong>ate\x20convalescence\x20stage</strong>\x20and\x20remains\x20<strong>lifelong</strong>.</p>\x0a<p><strong>Option\x20A:</strong>\x20In\x20acute\x20hepatitis\x20B,\x20HBsAg\x20is\x20reactive,\x20HBeAg\x20can\x20be\x20reactive\x20in\x20highly\x20infectious\x20individuals,\x20and\x20IgM\x20Anti\x20HBcAg\x20is\x20reactive.\x20Anti-Hbs\x20is\x20reactive\x20in\x20recovery.</p>\x0a<p><strong>Option\x20B:</strong>\x20In\x20chronic\x20hepatitis\x20B,\x20HBsAg\x20is\x20reactive,\x20and\x20IgG\x20Anti\x20HBcAg\x20is\x20reactive.\x20Anti-HBs\x20is\x20non-reactive.</p>\x0a<p><strong>Option\x20D:</strong>\x20Core\x20window\x20period\x20is\x20a\x20phase\x20where\x20even\x20though\x20hepatitis\x20infection\x20is\x20present,\x20HBsAg\x20is\x20non-reactive.\x20Diagnosis\x20is\x20based\x20on\x20the\x20presence\x20of\x20IgM\x20Anti\x20HBcAg.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x315),'choices':[{'id':0x1,'text':_0xf5d6bd(0x1ae)},{'id':0x2,'text':_0xf5d6bd(0x3c4)},{'id':0x3,'text':'2,\x203\x20and\x204'},{'id':0x4,'text':'1,\x202,\x203\x20and\x204'}],'correct_choice_id':0x2,'solution':_0xf5d6bd(0x10c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x12d),'choices':[{'id':0x1,'text':'1-5%\x20of\x20the\x20population\x20can\x20have\x20epileptiform\x20discharges'},{'id':0x2,'text':_0xf5d6bd(0x253)},{'id':0x3,'text':_0xf5d6bd(0x32c)},{'id':0x4,'text':_0xf5d6bd(0x32b)}],'correct_choice_id':0x3,'solution':_0xf5d6bd(0x396),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x358),'choices':[{'id':0x1,'text':'4\x20and\x205'},{'id':0x2,'text':_0xf5d6bd(0x13f)},{'id':0x3,'text':_0xf5d6bd(0x190)},{'id':0x4,'text':_0xf5d6bd(0x291)}],'correct_choice_id':0x3,'solution':_0xf5d6bd(0x1e3),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0xf5d6bd(0x36c),'choices':[{'id':0x1,'text':'1'},{'id':0x2,'text':'2'},{'id':0x3,'text':'3'},{'id':0x4,'text':'4'}],'correct_choice_id':0x2,'solution':_0xf5d6bd(0x276),'explanation_video':'','question_images':[_0xf5d6bd(0x39d)],'explanation_images':[_0xf5d6bd(0x35b)]}],quizName=_0xf5d6bd(0x118),hierarchy=['Marrow',_0xf5d6bd(0x21c),_0xf5d6bd(0x2a9)];if(window[_0xf5d6bd(0x12b)][_0xf5d6bd(0x2d8)][_0xf5d6bd(0x362)](_0xf5d6bd(0x300))){const customData=JSON[_0xf5d6bd(0x2d2)](localStorage['getItem']('customQuizData'));if(customData){const sNyIGV=_0xf5d6bd(0x2e4)[_0xf5d6bd(0x3bb)]('|');let LNySBJ=0x0;while(!![]){switch(sNyIGV[LNySBJ++]){case'0':document[_0xf5d6bd(0x235)]=quizName+_0xf5d6bd(0x196);continue;case'1':quizName=customData['name'];continue;case'2':document[_0xf5d6bd(0x38e)](_0xf5d6bd(0x19a))[_0xf5d6bd(0x355)]=hierarchy['join'](_0xf5d6bd(0x1b0));continue;case'3':questionsData=customData[_0xf5d6bd(0x34e)];continue;case'4':hierarchy=customData[_0xf5d6bd(0x2dd)];continue;case'5':document[_0xf5d6bd(0x38e)](_0xf5d6bd(0x24c))['textContent']=questionsData['length'];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0xf5d6bd(0x280),timer=null,timeRemaining=0x0,questionStartTime=Date[_0xf5d6bd(0x1b1)](),quizStartTime=Date[_0xf5d6bd(0x1b1)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0xf5d6bd(0x236)])['fill'](null)['map'](()=>({'status':_0xf5d6bd(0x25e),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0xf5d6bd(0x236)]};const urlParams=new URLSearchParams(window[_0xf5d6bd(0x12b)][_0xf5d6bd(0x113)]);currentQuestionIndex=Math[_0xf5d6bd(0x234)](parseInt(urlParams[_0xf5d6bd(0x382)](_0xf5d6bd(0x27d)))||0x0,questionsData[_0xf5d6bd(0x236)]-0x1);function goBack(){const _0x1e286c=_0xf5d6bd,_0x4cd2c7={'tKElb':_0x1e286c(0x183),'ROUqz':function(_0x1fd238,_0x2abddf){return _0x1fd238===_0x2abddf;},'yRmxv':_0x1e286c(0x1f2)};if(isQuizCompleted||confirm(_0x4cd2c7['tKElb'])){if(_0x4cd2c7['ROUqz']('YxHZg',_0x4cd2c7[_0x1e286c(0x2bc)]))window[_0x1e286c(0x302)]['back']();else{const _0x49241d=_0x500efc[_0x1e286c(0x239)](_0x5e75dc,arguments);return _0x433827=null,_0x49241d;}}}function selectMode(_0x5e3aea){const _0x2376e2=_0xf5d6bd,_0x17a7b7={'YJDyC':_0x2376e2(0x316),'qZlAc':_0x2376e2(0x38b),'RbCqP':function(_0x201dc4){return _0x201dc4();}};currentMode=_0x5e3aea,document[_0x2376e2(0x38e)](_0x17a7b7[_0x2376e2(0x25c)])[_0x2376e2(0x189)][_0x2376e2(0x162)]=_0x17a7b7[_0x2376e2(0x1a0)],_0x17a7b7[_0x2376e2(0x3ad)](initializeQuiz);}function initializeQuiz(){const _0x3d5554=_0xf5d6bd,_0x42f5cb={'wQdMd':'bookmarkBtn','EZgSW':'testModeReviewLegend','WXlGi':function(_0x1d9d17,_0x4193f2){return _0x1d9d17===_0x4193f2;},'TGWHM':'test','ipWme':function(_0x5cb03f,_0x36022c){return _0x5cb03f===_0x36022c;},'shoOa':_0x3d5554(0x3a9),'YjYhN':_0x3d5554(0x268),'wnjxg':'none','CQIsr':_0x3d5554(0x103),'vmvxo':_0x3d5554(0x290),'zitUJ':_0x3d5554(0x372),'exiCW':_0x3d5554(0x317),'mlSWm':_0x3d5554(0x33f),'nTWsC':'hidden','szVlo':function(_0x26844e){return _0x26844e();},'DUheA':function(_0x4f47b7){return _0x4f47b7();}};quizStartTime=Date[_0x3d5554(0x1b1)]();const _0x11518c=document[_0x3d5554(0x38e)](_0x42f5cb[_0x3d5554(0x294)]),_0x1fa01b=document['getElementById']('markReviewBtn'),_0x2ac1f5=document[_0x3d5554(0x38e)](_0x42f5cb[_0x3d5554(0x200)]),_0x3b494a=_0x42f5cb[_0x3d5554(0x164)](currentMode,_0x42f5cb[_0x3d5554(0x22b)])||_0x42f5cb[_0x3d5554(0x271)](currentMode,_0x42f5cb['shoOa']);document[_0x3d5554(0x38e)](_0x42f5cb[_0x3d5554(0x135)])[_0x3d5554(0x189)][_0x3d5554(0x162)]=_0x3b494a?_0x42f5cb[_0x3d5554(0x352)]:_0x3d5554(0x290),document['getElementById'](_0x42f5cb[_0x3d5554(0x391)])[_0x3d5554(0x189)]['display']=_0x3b494a?_0x42f5cb['wnjxg']:_0x42f5cb[_0x3d5554(0x2d0)],document['getElementById'](_0x42f5cb[_0x3d5554(0x2c6)])[_0x3d5554(0x189)][_0x3d5554(0x162)]=_0x3b494a?_0x3d5554(0x290):_0x42f5cb[_0x3d5554(0x352)],document[_0x3d5554(0x38e)](_0x3d5554(0x3ba))[_0x3d5554(0x189)][_0x3d5554(0x162)]=_0x3b494a?'block':_0x42f5cb[_0x3d5554(0x352)],_0x11518c[_0x3d5554(0x189)][_0x3d5554(0x162)]=_0x3b494a?_0x42f5cb[_0x3d5554(0x352)]:_0x42f5cb[_0x3d5554(0x2a7)],_0x1fa01b['style'][_0x3d5554(0x162)]=_0x3b494a?_0x42f5cb['exiCW']:_0x3d5554(0x38b),_0x2ac1f5[_0x3d5554(0x189)]['display']=_0x3b494a?_0x42f5cb['exiCW']:_0x42f5cb[_0x3d5554(0x352)],(currentMode===_0x42f5cb[_0x3d5554(0x365)]||_0x42f5cb[_0x3d5554(0x271)](currentMode,_0x42f5cb['shoOa']))&&document[_0x3d5554(0x38e)]('timerContainer')['classList'][_0x3d5554(0x39e)](_0x42f5cb['nTWsC']),loadBookmarkedQuestions(),_0x42f5cb[_0x3d5554(0x1ce)](generateQuestionNav),updateStats(),_0x42f5cb['DUheA'](displayQuestion);}function _0x2d0e(_0xb4674e,_0x522376){const _0x22d0a7=_0x5131();return _0x2d0e=function(_0x474c72,_0x154c9c){_0x474c72=_0x474c72-0xf8;let _0x5f4a3c=_0x22d0a7[_0x474c72];return _0x5f4a3c;},_0x2d0e(_0xb4674e,_0x522376);}function generateQuestionNav(){const _0x410876=_0xf5d6bd,_0x5f25ac={'wFTFf':_0x410876(0x110),'bOfPw':_0x410876(0x1e1),'zGlob':function(_0x3daa34,_0x4cfebd){return _0x3daa34+_0x4cfebd;},'qQnHE':_0x410876(0x172),'jmBJh':function(_0x3c41c8){return _0x3c41c8();}},_0x165649=document[_0x410876(0x38e)](_0x5f25ac[_0x410876(0x1ee)]);_0x165649[_0x410876(0x266)]='';for(let _0x55c263=0x0;_0x55c263<questionsData[_0x410876(0x236)];_0x55c263++){const _0x20a46d=document['createElement'](_0x5f25ac['bOfPw']);_0x20a46d[_0x410876(0x355)]=_0x5f25ac[_0x410876(0x147)](_0x55c263,0x1),_0x20a46d[_0x410876(0x2c9)]=_0x5f25ac[_0x410876(0x1fc)],_0x20a46d['onclick']=()=>jumpToQuestion(_0x55c263),_0x20a46d['id']='navBtn_'+_0x55c263,_0x165649[_0x410876(0x214)](_0x20a46d);}_0x5f25ac['jmBJh'](updateQuestionNav);}function updateQuestionNav(){const _0x42e4eb=_0xf5d6bd,_0x40d852={'aVgim':_0x42e4eb(0x3c2),'IjcwS':function(_0x247043,_0x371b53,_0x25d30e){return _0x247043(_0x371b53,_0x25d30e);},'QytDv':_0x42e4eb(0x10e),'mwOan':_0x42e4eb(0x19a),'BWqgn':_0x42e4eb(0x1b0),'GWSML':function(_0x57392a,_0x31b1a2){return _0x57392a+_0x31b1a2;},'Mubon':_0x42e4eb(0x196),'HxQvp':_0x42e4eb(0x24c),'FRGBP':function(_0x4a9821){return _0x4a9821();},'ILTCY':function(_0x11d7a5,_0x57af53){return _0x11d7a5(_0x57af53);},'jOwtM':_0x42e4eb(0x163),'IgfOg':function(_0x5d4086){return _0x5d4086();},'WOdrT':function(_0x226777,_0x404381){return _0x226777<_0x404381;},'FPaJy':function(_0x18702e,_0x3b987a){return _0x18702e===_0x3b987a;},'WXuvX':_0x42e4eb(0x385),'HBpPT':_0x42e4eb(0x31b),'favFv':function(_0xdcccd0,_0x408e67){return _0xdcccd0!==_0x408e67;},'SpyDI':_0x42e4eb(0x233),'dRVqx':_0x42e4eb(0x15d),'IydhB':'study','nkStB':function(_0x2dffb4,_0x4e5364){return _0x2dffb4===_0x4e5364;},'VKOWC':_0x42e4eb(0x33f),'xljgh':function(_0x43ac17,_0x1be3ce){return _0x43ac17!==_0x1be3ce;},'gERdc':'bYOJy','kZjrr':function(_0x12170e,_0xcfcf3f){return _0x12170e===_0xcfcf3f;},'oljut':_0x42e4eb(0x265),'xiMeM':'nav-btn-correct','OOUun':function(_0x2d9814,_0x19d4c6){return _0x2d9814===_0x19d4c6;},'FCofE':_0x42e4eb(0x19b),'dItCz':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','sownr':_0x42e4eb(0x3b8),'yqcgp':_0x42e4eb(0x2d7)};for(let _0x578f50=0x0;_0x40d852['WOdrT'](_0x578f50,questionsData[_0x42e4eb(0x236)]);_0x578f50++){const _0x6edc05=document[_0x42e4eb(0x38e)](_0x42e4eb(0x140)+_0x578f50),_0x40468a=questionStates[_0x578f50];let _0x1122d8='';if(_0x40d852[_0x42e4eb(0x3c0)](_0x578f50,currentQuestionIndex)){if(_0x40d852[_0x42e4eb(0x3c0)](_0x42e4eb(0x385),_0x40d852[_0x42e4eb(0x356)]))_0x1122d8=_0x40d852[_0x42e4eb(0x19f)];else{_0x34cc05[_0x42e4eb(0x139)][_0x42e4eb(0x39e)](_0x42e4eb(0x254));if(_0x3ad69c[_0x42e4eb(0x24d)](_0x40d852[_0x42e4eb(0x37a)]))_0x40d852[_0x42e4eb(0x33a)](_0x5c7102,_0xf5b791,_0x337b53);else _0x43dcfc['src']=_0xe7b9a3;}}else{if(_0x40468a['bookmarked']){if(_0x40d852['favFv'](_0x40d852[_0x42e4eb(0x238)],_0x40d852['SpyDI'])){const _0x823fc8=_0x40d852['QytDv'][_0x42e4eb(0x3bb)]('|');let _0x53686f=0x0;while(!![]){switch(_0x823fc8[_0x53686f++]){case'0':_0x133fe8=_0x18c4e2[_0x42e4eb(0x2ed)];continue;case'1':_0x4e22e3[_0x42e4eb(0x38e)](_0x40d852[_0x42e4eb(0x284)])[_0x42e4eb(0x355)]=_0x4aa27a['join'](_0x40d852['BWqgn']);continue;case'2':_0x42b44e=_0x50f9fa[_0x42e4eb(0x34e)];continue;case'3':_0xabf60f=_0x320bf0[_0x42e4eb(0x2dd)];continue;case'4':_0x2a88ab[_0x42e4eb(0x235)]=_0x40d852[_0x42e4eb(0x2dc)](_0x130a3e,_0x40d852[_0x42e4eb(0x25a)]);continue;case'5':_0x381257[_0x42e4eb(0x38e)](_0x40d852[_0x42e4eb(0x11b)])[_0x42e4eb(0x355)]=_0xca20b6[_0x42e4eb(0x236)];continue;}break;}}else _0x1122d8=_0x40d852['dRVqx'];}else{if(_0x40468a[_0x42e4eb(0x245)])_0x40d852[_0x42e4eb(0x1b5)]('eVFdN',_0x42e4eb(0x270))?_0x1122d8=_0x42e4eb(0x2f3):_0x40d852[_0x42e4eb(0x394)](_0x4d842f);else{if(_0x40d852['FPaJy'](currentMode,_0x40d852[_0x42e4eb(0x1cb)])||_0x40d852[_0x42e4eb(0x36f)](currentMode,_0x40d852[_0x42e4eb(0x13a)])){if(_0x40d852['xljgh'](_0x42e4eb(0x1c1),_0x40d852['gERdc'])){if(_0x40d852[_0x42e4eb(0x2c7)](_0x40468a['status'],_0x40d852[_0x42e4eb(0x27e)]))_0x1122d8=_0x40d852['xiMeM'];else{if(_0x40d852[_0x42e4eb(0x1f7)](_0x40468a['status'],_0x40d852['FCofE']))_0x1122d8=_0x42e4eb(0x27f);else _0x1122d8=_0x40d852[_0x42e4eb(0x240)];}}else _0x40d852[_0x42e4eb(0x12f)](_0x1656fb,_0x40d852['jOwtM'])&&_0x40d852['IgfOg'](_0x45b497);}else{if(_0x40d852[_0x42e4eb(0x3c0)](_0x40d852[_0x42e4eb(0x2b3)],_0x40d852['sownr'])){if(_0x40d852['xljgh'](_0x40468a['selectedAnswer'],null))_0x1122d8=_0x40d852[_0x42e4eb(0x171)];else _0x1122d8=_0x40d852[_0x42e4eb(0x240)];}else _0x5c08f5[_0x42e4eb(0x266)]+=_0x42e4eb(0x2da)+_0x4e9227[_0x42e4eb(0x267)]+_0x42e4eb(0x1fe);}}}}_0x6edc05[_0x42e4eb(0x2c9)]=_0x42e4eb(0x251)+_0x1122d8;}}function jumpToQuestion(_0x289e2e){const _0x27c9c2=_0xf5d6bd,_0xfe294f={'NZRbL':function(_0x284f72,_0x370348){return _0x284f72>=_0x370348;},'IbCmV':function(_0x2c3ace,_0x900227){return _0x2c3ace<_0x900227;},'FxMtP':function(_0x5005a1,_0x329aa4){return _0x5005a1-_0x329aa4;},'lFqZX':function(_0x56aa80){return _0x56aa80();}};_0xfe294f[_0x27c9c2(0x334)](_0x289e2e,0x0)&&_0xfe294f['IbCmV'](_0x289e2e,questionsData[_0x27c9c2(0x236)])&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x27c9c2(0x18f)]+=_0xfe294f[_0x27c9c2(0x3a6)](Date[_0x27c9c2(0x1b1)](),questionStartTime)),currentQuestionIndex=_0x289e2e,_0xfe294f['lFqZX'](displayQuestion));}function updateStats(){const _0xa20981=_0xf5d6bd,_0x544a19={'IdNpW':function(_0x1bfdf7,_0x4f0cc4){return _0x1bfdf7===_0x4f0cc4;},'tIudE':_0xa20981(0x280),'gFZVU':function(_0xa8c38d,_0x1bfac3){return _0xa8c38d===_0x1bfac3;},'AmWiZ':_0xa20981(0x33f),'KenEZ':_0xa20981(0x2ab),'Ircsw':function(_0x305a92,_0x4520bf){return _0x305a92>_0x4520bf;},'tJxxf':function(_0x3b015b,_0x57ef49){return _0x3b015b*_0x57ef49;},'QEiec':_0xa20981(0x2a1),'kIhvR':function(_0x499721,_0x14b1b2){return _0x499721+_0x14b1b2;},'SGXWA':function(_0xa9b0b,_0x59b8d2){return _0xa9b0b/_0x59b8d2;},'nGboH':_0xa20981(0x18f),'QanVY':function(_0x182639,_0x366a9e){return _0x182639+_0x366a9e;}};if(_0x544a19['IdNpW'](currentMode,_0x544a19[_0xa20981(0x2f2)])||_0x544a19[_0xa20981(0x2fa)](currentMode,_0x544a19['AmWiZ'])){document[_0xa20981(0x38e)]('correctCount')[_0xa20981(0x355)]=stats[_0xa20981(0x370)],document[_0xa20981(0x38e)](_0xa20981(0x156))[_0xa20981(0x355)]=stats['incorrectAnswers'],document[_0xa20981(0x38e)](_0x544a19[_0xa20981(0x2e3)])[_0xa20981(0x355)]=stats[_0xa20981(0x2ab)];const _0x5042b0=_0x544a19[_0xa20981(0x10f)](stats[_0xa20981(0x2ab)],0x0)?Math[_0xa20981(0x2c4)](_0x544a19[_0xa20981(0x131)](stats[_0xa20981(0x370)]/stats['totalAttempted'],0x64)):0x0;document[_0xa20981(0x38e)](_0x544a19[_0xa20981(0x357)])['textContent']=_0x544a19[_0xa20981(0x30e)](_0x5042b0,'%'),stats[_0xa20981(0x2df)]=questionStates['reduce']((_0x21f7e7,_0x42ecfc)=>_0x21f7e7+_0x42ecfc[_0xa20981(0x18f)],0x0);const _0x4bdce4=Math[_0xa20981(0x222)](stats[_0xa20981(0x2df)]/0x3e8),_0x2f7576=Math[_0xa20981(0x222)](_0x544a19[_0xa20981(0x22d)](_0x4bdce4,0x3c)),_0x1ba4ff=_0x4bdce4%0x3c;document[_0xa20981(0x38e)](_0x544a19[_0xa20981(0x3ae)])['textContent']=_0x544a19[_0xa20981(0x1ab)](_0x2f7576+':',_0x1ba4ff['toString']()[_0xa20981(0x1bf)](0x2,'0'));}}function setupVideo(_0x3b6643,_0x576fe0){const _0x3c6cf8=_0xf5d6bd,_0x84715d={'oabWY':_0x3c6cf8(0x2f5),'KMKuJ':_0x3c6cf8(0x232),'uSmfD':'totalQuestions','aJCZi':function(_0x1d2974,_0x2b5169){return _0x1d2974+_0x2b5169;},'ZnBvp':_0x3c6cf8(0x196),'HScxe':'quizHierarchy','zzVeH':_0x3c6cf8(0x169),'Rmehk':function(_0x18e455,_0x5561b0){return _0x18e455!==_0x5561b0;},'pzkkg':_0x3c6cf8(0x399)};if(Hls[_0x3c6cf8(0x17c)]()){const _0x3b8e82=new Hls();_0x3b8e82['loadSource'](_0x576fe0),_0x3b8e82[_0x3c6cf8(0x350)](_0x3b6643);}else{if(_0x3b6643[_0x3c6cf8(0x11d)](_0x84715d['zzVeH'])){if(_0x84715d['Rmehk'](_0x84715d[_0x3c6cf8(0x387)],_0x84715d[_0x3c6cf8(0x387)])){const _0x39c44a=_0x23c2c9[_0x3c6cf8(0x2d2)](_0x34eb2d[_0x3c6cf8(0x136)](_0x84715d[_0x3c6cf8(0x213)]));if(_0x39c44a){const _0x17aeee=_0x84715d[_0x3c6cf8(0x23c)]['split']('|');let _0xa81268=0x0;while(!![]){switch(_0x17aeee[_0xa81268++]){case'0':_0x470edd[_0x3c6cf8(0x38e)](_0x84715d[_0x3c6cf8(0x368)])[_0x3c6cf8(0x355)]=_0x211e59[_0x3c6cf8(0x236)];continue;case'1':_0x2fca2c=_0x39c44a[_0x3c6cf8(0x2dd)];continue;case'2':_0xda47ec=_0x39c44a[_0x3c6cf8(0x34e)];continue;case'3':_0x312925['title']=_0x84715d[_0x3c6cf8(0x1b9)](_0x117354,_0x84715d[_0x3c6cf8(0x193)]);continue;case'4':_0x4c2c98=_0x39c44a[_0x3c6cf8(0x2ed)];continue;case'5':_0xdae22f[_0x3c6cf8(0x38e)](_0x84715d[_0x3c6cf8(0x2f6)])[_0x3c6cf8(0x355)]=_0x345566[_0x3c6cf8(0x3b0)](_0x3c6cf8(0x1b0));continue;}break;}}}else _0x3b6643['src']=_0x576fe0;}}}function displayQuestion(){const _0x290008=_0xf5d6bd,_0x197d0c={'RtvsX':function(_0x22faa9){return _0x22faa9();},'ZLiGm':_0x290008(0x265),'KyxmS':function(_0x3ac261,_0x3eb1d9){return _0x3ac261===_0x3eb1d9;},'nygEs':_0x290008(0x384),'OenPZ':function(_0x1a169f,_0x2a9120){return _0x1a169f+_0x2a9120;},'RcYeq':'div','pguyG':_0x290008(0x1ba),'JBzAS':_0x290008(0x2bd),'OyZwq':function(_0x535036,_0x48bbd1){return _0x535036(_0x48bbd1);},'MgnDr':function(_0x4426c3,_0x107ae9){return _0x4426c3(_0x107ae9);},'qpYFM':function(_0x3c4a7e,_0x5b1a1d){return _0x3c4a7e===_0x5b1a1d;},'LKQyL':_0x290008(0x1d2),'vqugj':'No\x20questions\x20available\x20for\x20this\x20quiz.','pMorK':function(_0x3ea082,_0x4285fd){return _0x3ea082*_0x4285fd;},'PZvCN':function(_0x4b6325,_0x2ee803){return _0x4b6325/_0x2ee803;},'lrSsq':function(_0x1815ff,_0x56f858){return _0x1815ff+_0x56f858;},'vwHyY':function(_0x15db61){return _0x15db61();},'rHTuW':_0x290008(0x1de),'oEYXH':function(_0x5b31ec,_0x1afe64){return _0x5b31ec===_0x1afe64;},'ApQfN':'solutionContainer','ywGBf':_0x290008(0x19e),'dVGLF':function(_0x2b270e,_0x4c7148){return _0x2b270e!==_0x4c7148;},'QSssd':_0x290008(0x2e5),'vBXPG':_0x290008(0x2fd),'NysCt':'optionsContainer','cfUpd':_0x290008(0x338),'eoxfY':function(_0x47c7bc){return _0x47c7bc();},'Fivfg':function(_0x25745e){return _0x25745e();},'noGyM':_0x290008(0x33f),'jdeXr':_0x290008(0x3a9)};if(!questionsData||_0x197d0c[_0x290008(0x241)](questionsData[_0x290008(0x236)],0x0)){document['getElementById'](_0x197d0c[_0x290008(0x367)])['innerHTML']=_0x197d0c[_0x290008(0x3b7)];return;};const _0x3d6ba0=questionsData[currentQuestionIndex];questionStartTime=Date[_0x290008(0x1b1)](),selectedOption=questionStates[currentQuestionIndex][_0x290008(0x2cb)];const _0x28c87c=_0x197d0c[_0x290008(0x348)](_0x197d0c[_0x290008(0x191)](_0x197d0c[_0x290008(0x188)](currentQuestionIndex,0x1),questionsData['length']),0x64);document['getElementById'](_0x290008(0x158))[_0x290008(0x189)][_0x290008(0x343)]=_0x28c87c+'%',document[_0x290008(0x38e)](_0x290008(0x1cf))['textContent']=_0x197d0c[_0x290008(0x3af)](currentQuestionIndex,0x1),_0x197d0c[_0x290008(0x20a)](updateQuestionNav),document[_0x290008(0x38e)](_0x197d0c[_0x290008(0x33b)])[_0x290008(0x2c0)]=_0x197d0c['oEYXH'](currentQuestionIndex,0x0),document['getElementById'](_0x197d0c[_0x290008(0x15c)])[_0x290008(0x139)][_0x290008(0x3b3)](_0x290008(0x254)),document[_0x290008(0x38e)]('questionText')[_0x290008(0x266)]=_0x3d6ba0[_0x290008(0x380)]||_0x197d0c[_0x290008(0x327)];let _0x340a01='';if(_0x3d6ba0[_0x290008(0x261)])_0x340a01+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22'+_0x3d6ba0[_0x290008(0x261)]+_0x290008(0x1fe);if(_0x3d6ba0[_0x290008(0x308)])_0x340a01+=_0x290008(0x168)+_0x3d6ba0[_0x290008(0x308)]+'\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>';_0x3d6ba0[_0x290008(0x215)]&&(_0x197d0c[_0x290008(0x392)](_0x197d0c[_0x290008(0x2be)],_0x197d0c[_0x290008(0x2be)])?_0x197d0c[_0x290008(0x1cd)](_0x27ac02):_0x3d6ba0[_0x290008(0x215)][_0x290008(0x326)](_0x384265=>{const _0x19075c=_0x290008;if(_0x384265)_0x340a01+=_0x19075c(0x30a)+_0x384265+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}));document[_0x290008(0x38e)](_0x197d0c[_0x290008(0x199)])['innerHTML']=_0x340a01;const _0x50481b=document[_0x290008(0x38e)](_0x197d0c[_0x290008(0x1ec)]);_0x50481b[_0x290008(0x266)]='',_0x50481b[_0x290008(0x139)]['remove'](_0x197d0c[_0x290008(0x1e8)]),_0x3d6ba0[_0x290008(0x17b)]&&Array[_0x290008(0x3a7)](_0x3d6ba0[_0x290008(0x17b)])&&(_0x3d6ba0[_0x290008(0x17b)]['forEach']((_0x1108ba,_0x223244)=>{const _0x41563f=_0x290008,_0xbede31={'HVSII':function(_0x214dfc,_0x3bcc4f){return _0x214dfc===_0x3bcc4f;},'WEKlu':_0x197d0c[_0x41563f(0x28a)]};if(_0x197d0c[_0x41563f(0x227)](_0x197d0c['nygEs'],_0x197d0c[_0x41563f(0x14b)])){const _0xf008a9=String[_0x41563f(0x1ad)](_0x197d0c[_0x41563f(0x3af)](0x41,_0x223244)),_0x496eed=selectedOption===_0x223244,_0x58b7c6=document['createElement'](_0x197d0c[_0x41563f(0x37f)]);_0x58b7c6[_0x41563f(0x266)]=_0x41563f(0x296)+(_0x496eed?_0x197d0c['pguyG']:'')+_0x41563f(0x1bd)+_0x223244+_0x41563f(0x202)+_0xf008a9+_0x41563f(0x16a)+(_0x1108ba[_0x41563f(0x380)]||_0x197d0c[_0x41563f(0x3af)](_0x41563f(0x2e8),_0x197d0c['OenPZ'](_0x223244,0x1)))+_0x41563f(0x250),_0x50481b['appendChild'](_0x58b7c6);}else{_0x18c09d['classList']['remove']('selected');if(_0xbede31[_0x41563f(0x2b6)](_0x21da81,_0x1977df))_0x3877e3[_0x41563f(0x139)][_0x41563f(0x3b3)](_0xbede31[_0x41563f(0x1db)]);else{if(_0x4faece===_0x7bbe5e&&!_0x80d1ce)_0x4756d3[_0x41563f(0x139)][_0x41563f(0x3b3)](_0x41563f(0x19b));}}}),_0x50481b[_0x290008(0x390)]('click',function(_0x352044){const _0x2a2a0c=_0x290008,_0x3a7470=_0x352044['target']['closest'](_0x197d0c[_0x2a2a0c(0x174)]);if(_0x3a7470){const _0x39eab2=_0x197d0c['OyZwq'](parseInt,_0x3a7470['getAttribute']('data-option-index'));_0x197d0c[_0x2a2a0c(0x36b)](selectOption,_0x39eab2);}})),_0x197d0c[_0x290008(0x18e)](updateBookmarkButton),_0x197d0c[_0x290008(0x2a0)](updateMarkReviewButton),(currentMode===_0x197d0c[_0x290008(0x231)]||_0x197d0c[_0x290008(0x227)](currentMode,_0x197d0c['jdeXr']))&&!isQuizCompleted&&_0x197d0c[_0x290008(0x20a)](startTimer);}function selectOption(_0x323ca3){const _0x336b6a=_0xf5d6bd,_0x234706={'rKvLE':'selected','OOHou':_0x336b6a(0x25f),'pmmmi':_0x336b6a(0x156),'GyHyN':function(_0x166ea9,_0x5b8a0d){return _0x166ea9>_0x5b8a0d;},'sMTfz':function(_0x1458d5,_0x23bd7f){return _0x1458d5*_0x23bd7f;},'uNWfh':function(_0x2b5f9d,_0x13ba42){return _0x2b5f9d/_0x13ba42;},'jYAAz':function(_0x26f497,_0x2dffe9){return _0x26f497+_0x2dffe9;},'IAQSN':function(_0x4422b2,_0xa79816){return _0x4422b2%_0xa79816;},'zTWzu':_0x336b6a(0x18f),'fWIrp':function(_0x1cbde8,_0x5ecbe3){return _0x1cbde8+_0x5ecbe3;},'qHMkD':_0x336b6a(0x3bc),'NUYDY':_0x336b6a(0x338),'NQyJZ':function(_0x140b47,_0x25dba8){return _0x140b47-_0x25dba8;},'YfgTF':'.option-button','PXcFC':'study','CpzpF':'timed_study','bKlbb':function(_0xae36c2,_0x3c0d80){return _0xae36c2===_0x3c0d80;},'Hbjci':_0x336b6a(0x1a6),'QFzKV':_0x336b6a(0x25e),'PpVHm':function(_0x46ce24,_0x138e29){return _0x46ce24!==_0x138e29;},'MgRRW':'UODIm','Aljhd':function(_0x39d23c){return _0x39d23c();}},_0x48f364=document[_0x336b6a(0x38e)](_0x234706[_0x336b6a(0x16f)]);if(_0x48f364[_0x336b6a(0x139)][_0x336b6a(0x117)](_0x234706[_0x336b6a(0x15f)]))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x336b6a(0x18f)]+=_0x234706[_0x336b6a(0x26c)](Date[_0x336b6a(0x1b1)](),questionStartTime),questionStartTime=Date[_0x336b6a(0x1b1)]());selectedOption=_0x323ca3,questionStates[currentQuestionIndex]['selectedAnswer']=_0x323ca3,document['querySelectorAll'](_0x234706[_0x336b6a(0x2a2)])[_0x336b6a(0x326)]((_0x1191c6,_0x173290)=>{const _0x1397f8=_0x336b6a;_0x1191c6[_0x1397f8(0x139)][_0x1397f8(0x2cc)](_0x234706[_0x1397f8(0x307)],_0x173290===_0x323ca3);});if(currentMode===_0x234706[_0x336b6a(0x333)]||currentMode===_0x234706[_0x336b6a(0x3ac)])_0x234706[_0x336b6a(0x130)](_0x234706[_0x336b6a(0x361)],_0x234706['Hbjci'])?setTimeout(processAnswer,0x12c):(_0x351bc6[_0x336b6a(0x12b)][_0x336b6a(0x2d8)][_0x336b6a(0x362)](_0x336b6a(0x300))&&_0x1e0899[_0x336b6a(0x277)](_0x336b6a(0x2f5)),_0x4a3276['reload']());else{if(_0x234706[_0x336b6a(0x130)](questionStates[currentQuestionIndex]['status'],_0x234706[_0x336b6a(0x16c)])){if(_0x234706[_0x336b6a(0x3b2)](_0x234706[_0x336b6a(0x195)],'UODIm')){_0x3b4a47[_0x336b6a(0x38e)](_0x234706['OOHou'])[_0x336b6a(0x355)]=_0x218eb9['correctAnswers'],_0x13226b[_0x336b6a(0x38e)](_0x234706[_0x336b6a(0x1c8)])['textContent']=_0x51659f[_0x336b6a(0x217)],_0x451ccf['getElementById'](_0x336b6a(0x2ab))[_0x336b6a(0x355)]=_0x23bb11[_0x336b6a(0x2ab)];const _0x38c6bd=_0x234706[_0x336b6a(0x170)](_0x19363e[_0x336b6a(0x2ab)],0x0)?_0x3cec45[_0x336b6a(0x2c4)](_0x234706[_0x336b6a(0x324)](_0x234706[_0x336b6a(0x21a)](_0x47b1b6[_0x336b6a(0x370)],_0x5ad935['totalAttempted']),0x64)):0x0;_0x417827[_0x336b6a(0x38e)](_0x336b6a(0x2a1))['textContent']=_0x234706['jYAAz'](_0x38c6bd,'%'),_0x421fae[_0x336b6a(0x2df)]=_0x50ed38[_0x336b6a(0x187)]((_0x2ffa07,_0x30d6f0)=>_0x2ffa07+_0x30d6f0[_0x336b6a(0x18f)],0x0);const _0x1f0856=_0x5a2bce[_0x336b6a(0x222)](_0x234706[_0x336b6a(0x21a)](_0x39cf86[_0x336b6a(0x2df)],0x3e8)),_0x35f809=_0x1f6fe0[_0x336b6a(0x222)](_0x234706[_0x336b6a(0x21a)](_0x1f0856,0x3c)),_0xf43b4b=_0x234706[_0x336b6a(0x127)](_0x1f0856,0x3c);_0x113998[_0x336b6a(0x38e)](_0x234706[_0x336b6a(0x154)])['textContent']=_0x234706[_0x336b6a(0x1ff)](_0x234706['jYAAz'](_0x35f809,':'),_0xf43b4b[_0x336b6a(0x121)]()['padStart'](0x2,'0'));}else questionStates[currentQuestionIndex]['status']=_0x234706[_0x336b6a(0x15f)],stats['totalAttempted']++,stats[_0x336b6a(0x389)]--;}_0x234706[_0x336b6a(0x194)](updateQuestionNav);}}function processAnswer(){const _0x527d1c=_0xf5d6bd,_0x4751ee={'XAvqv':'No\x20questions\x20available\x20for\x20this\x20quiz.','RiSRv':function(_0x58ae61,_0x2cb4ea){return _0x58ae61===_0x2cb4ea;},'yWwFF':_0x527d1c(0x25e),'oZJFr':'MCfQt','gMbZJ':'correct','OclHF':function(_0x17bfaa){return _0x17bfaa();}},_0x353a38=questionsData[currentQuestionIndex],_0x202b5e=_0x353a38['correct_choice_id'];if(selectedOption===null)return;const _0x3620c7=_0x353a38[_0x527d1c(0x17b)][selectedOption],_0x22b0a3=_0x4751ee[_0x527d1c(0x150)](_0x3620c7['id'],_0x202b5e);if(_0x4751ee[_0x527d1c(0x150)](questionStates[currentQuestionIndex][_0x527d1c(0x137)],_0x4751ee[_0x527d1c(0x3b4)])){if(_0x4751ee['oZJFr']===_0x4751ee[_0x527d1c(0x369)]){stats[_0x527d1c(0x2ab)]++,stats[_0x527d1c(0x389)]--;if(_0x22b0a3)stats['correctAnswers']++;else stats['incorrectAnswers']++;}else{_0x359948[_0x527d1c(0x38e)](_0x527d1c(0x1d2))[_0x527d1c(0x266)]=_0x4751ee[_0x527d1c(0x2b7)];return;}}questionStates[currentQuestionIndex]['status']=_0x22b0a3?_0x4751ee[_0x527d1c(0x134)]:_0x527d1c(0x19b),updateStats(),showInlineFeedback(_0x22b0a3),_0x4751ee[_0x527d1c(0x178)](updateQuestionNav);}function _0x5131(){const _0x5dff1a=['A\x2062-year-old\x20male\x20patient\x20with\x20heart\x20failure\x20is\x20scheduled\x20for\x20a\x20heart\x20transplant.\x20His\x20renal\x20function\x20test\x20is\x20deranged\x20and\x20hemoglobin\x20is\x206\x20gm%.\x20The\x20physician\x20ordered\x202\x20units\x20of\x20whole\x20blood.\x20Four\x20hours\x20after\x20transfusion,\x20he\x20developed\x20severe\x20respiratory\x20distress.\x20On\x20examination,\x20he\x20is\x20hypoxemic,\x20\x20has\x20tachycardia\x20and\x20his\x20mean\x20arterial\x20pressure\x20is\x20elevated.\x20Which\x20of\x20the\x20following\x20are\x20the\x20best\x20investigations\x20for\x20the\x20above\x20scenario?','fTocR','etOky','https://dhmbxeygs57ff.cloudfront.net/uploads/20f8fcfb42a241858420a39210256d38x1280x1083.JPEG','GbLoo','SEAqi','totalQuestionsResult','KpNzn','mZYOa','Hbjci','endsWith','BAL','A\x2035-year-old\x20female\x20patient\x20with\x20class\x20II\x20pulmonary\x20hypertension\x20presents\x20with\x20a\x20negative\x20vasoreactivity\x20test.\x20Which\x20of\x20the\x20following\x20is\x20used\x20in\x20the\x20next\x20step\x20of\x20management?','mlSWm','knhip','LKQyL','uSmfD','oZJFr','bToyu','MgnDr','A\x20chronic\x20smoker\x20presented\x20with\x20shortness\x20of\x20breath,\x20bilateral\x20pitting\x20pedal\x20edema,\x20and\x20abdominal\x20distension.\x20On\x20examination,\x20jugular\x20venous\x20pulse\x20was\x20found\x20to\x20be\x20elevated\x20and\x20liver\x20was\x20palpable\x208\x20cm\x20below\x20the\x20costal\x20margin.\x20An\x20abnormality\x20in\x20which\x20of\x20the\x20following\x20structures\x20is\x20responsible\x20for\x20the\x20patient\x27s\x20symptoms?','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','VtFoc','nkStB','correctAnswers','dataset','testModeLegend','Aspergillus\x20fumigatus\x20-\x20Micafungin','A\x20patient\x20presented\x20with\x20sinusitis,\x20ulcerative\x20lesions\x20on\x20the\x20nasopharynx,\x20nodular\x20lesions\x20with\x20cavitations\x20of\x20the\x20lung,\x20and\x20renal\x20failure.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20useful\x20investigation\x20in\x20this\x20patient?','QpVKC','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','yONdw','gray','jTVnw','aVgim','(((.+)+)+)+$','3,\x204,\x205\x20only','FuMxW','135892eZuvQF','RcYeq','text','VqbnK','get','closest','scUEC','brflx','reload','pzkkg','gREQu','notAttempted','https://dhmbxeygs57ff.cloudfront.net/uploads/b3e170e22ce1491fa9047ef06e13bc16x358x285.PNG','none','1,\x202','VQvvh','getElementById','SiocH','addEventListener','CQIsr','dVGLF','https://dhmbxeygs57ff.cloudfront.net/uploads/0080bcd3ba994b41814ab15ba2ea1347x1279x967.JPEG','FRGBP','Identify\x20the\x20correct\x20\x27organism-\x20drug\x20to\x20which\x20it\x20is\x20intrinsically\x20resistant\x27\x20pair:','<p>Doing\x20<strong>EEG</strong>\x20is\x20<strong>not</strong>\x20mandatory\x20for\x20the\x20diagnosis\x20of\x20<strong>seizures</strong>.\x20The\x20diagnosis\x20of\x20a\x20seizure\x20in\x20most\x20cases\x20is\x20based\x20only\x20on\x20<strong>clinical</strong>\x20grounds\x20when\x20examination\x20and\x20laboratory\x20studies\x20are\x20often\x20normal.</p>\x0a<p>All\x20patients\x20who\x20are\x20suspected\x20to\x20have\x20a\x20seizure\x20disorder\x20should\x20be\x20evaluated\x20with\x20an\x20EEG.\x20EEG\x20may\x20provide\x20support\x20to\x20the\x20clinical\x20diagnosis,\x20prognosis,\x20and\x20classification\x20of\x20the\x20seizure\x20disorder.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20A:</strong>\x20Approximately\x201&ndash;5%\x20of\x20the\x20population\x20will\x20have\x20epileptiform\x20discharges\x20on\x20EEG.\x20The\x20presence\x20of\x20epileptiform\x20activity\x20on\x20EEG\x20is\x20not\x20specific\x20to\x20epilepsy.\x20Even\x20in\x20known\x20cases\x20of\x20epilepsy,\x20the\x20routine\x20inter-ictal\x20EEG\x20can\x20be\x20normal\x20in\x2060%\x20of\x20cases.\x20Thus,\x20the\x20EEG\x20cannot\x20establish\x20the\x20diagnosis\x20of\x20epilepsy\x20in\x20many\x20cases.</p>\x0a<p><strong>Option\x20B:</strong>\x20Scalp\x20EEG\x20recording\x20is\x20sometimes\x20helpful\x20in\x20the\x20localization\x20of\x20frontal\x20lobe\x20epilepsy\x20but\x20is\x20usually\x20normal\x20or\x20misleading.\x20When\x20focal\x20seizures\x20arise\x20from\x20regions\x20distant\x20from\x20the\x20scalp\x20such\x20as\x20the\x20inferior\x20frontal\x20lobe\x20or\x20medial\x20temporal\x20lobe,\x20the\x20EEG\x20recorded\x20during\x20the\x20seizure\x20may\x20be\x20non-localizing.</p>\x0a<p><strong>Option\x20D:</strong>\x20Progressive\x20multifocal\x20leukoencephalopathy\x20is\x20a\x20demyelinating\x20disease\x20of\x20the\x20central\x20nervous\x20system\x20due\x20to\x20infection\x20by\x20the\x20John\x20Cunningham\x20virus\x20(JC)\x20virus.\x20Electroencephalography\x20(EEG)\x20is\x20characterized\x20by\x20a\x20slow\x20background\x20activity\x20with\x20triphasic\x20waves\x20and\x20slow\x20waves\x20predominantly\x20in\x20the\x20frontal\x20regions.</p>\x0a<p>Characteristic\x20<strong>EEG\x20findings</strong>\x20in\x20different\x20conditions:</p>\x0a<ul>\x0a<li>Typical\x20<strong>absence</strong>\x20seizures:<strong>\x203-Hz\x20spike-and-slow-wave\x20discharges</strong></li>\x0a<li><strong>Lennox-Gastaut\x20syndrome:</strong>\x20Slow\x20(&lt;3\x20Hz)\x20spike-and-wave\x20discharges</li>\x0a<li><strong>Generalized\x20tonic\x20clonic\x20seizure\x20(GTCS)\x20-</strong>\x20in\x20tonic\x20phase,\x20increasing\x20generalized\x20low-voltage\x20fast\x20activity,\x20followed\x20by\x20high-amplitude,\x20polyspike\x20discharges\x20&amp;\x20in\x20clonic\x20phase\x20a\x20spike-and-slow-wave\x20pattern\x20is\x20seen</li>\x0a<li><strong>Creutzfeldt-Jakob\x20disease:</strong>\x20generalized\x20periodic\x20sharp\x20waves</li>\x0a<li><strong>Hepatic\x20encephalopathy:</strong>\x20triphasic\x20waves</li>\x0a</ul>','table','sCBVp','RVVEl','Liddle\x20syndrome','No\x20solution\x20provided','SOEci','https://cdn1.dailyrounds.org/uploads/2f76f0e1f4c54dd0acdfdbe17fe53558.JPEG','remove','baXGC','ILDQZ','quizPerformanceData','reviewQuestionsContainer','onclick','yJnfQ','https://dhmbxeygs57ff.cloudfront.net/uploads/9b7ff9aff2ef46e1b8363e4e90c5ac28x1279x967.JPEG','FxMtP','isArray','No\x20solution\x20available.','timed_exam','BCJWT','APaRs','CpzpF','RbCqP','nGboH','OenPZ','join','DSKTt','PpVHm','add','yWwFF','NRfGy','Variable\x20intrathoracic\x20obstruction','vqugj','RxDlL','Tab\x20labetalol\x2010\x20mg\x20stat','submitSection','split','optionsContainer','Core\x20window\x20period','questionReviewSection','https://cdn1.dailyrounds.org/uploads/8e975e35ca394842a564002a6f641a73.JPEG','FPaJy','OqDpD','.m3u8','avgTimeResult','2\x20and\x203','Diuretic','HmlJK','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Kobuz','querySelectorAll','2\x20and\x203\x20correct','strokeDasharray','fcsba','EBpZG','GYmdd','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','toLowerCase','Natalizumab','studyModeLegend','Beta\x20blocker','sDQFA','<p>In\x20<strong>SIADH</strong>,\x20the\x20kidneys\x20retain\x20water,\x20leading\x20to<strong>\x20volume\x20expansion</strong>\x20and\x20<strong>natriuresis</strong>.\x20Therefore,\x20urinary\x20sodium\x20levels\x20are\x20typically\x20<strong>higher</strong>\x20<strong>than\x2020\x20mEq/L.</strong></p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20B:</strong>\x20SIADH\x20is\x20a\x20condition\x20where\x20there\x20is\x20an\x20inappropriate\x20release\x20of\x20antidiuretic\x20hormone\x20(ADH),\x20leading\x20to\x20impaired\x20water\x20excretion\x20and\x20dilutional\x20hyponatremia.</p>\x0a<p><strong>Option\x20C:</strong>\x20ADH\x20promotes\x20the\x20reabsorption\x20of\x20water\x20and\x20not\x20the\x20solutes\x20resulting\x20in\x20concentrated\x20urine.\x20This\x20is\x20depicted\x20as\x20high\x20urine\x20osmolality.</p>\x0a<p><strong>Option\x20D:</strong>\x20Patients\x20can\x20be\x20hypervolemic\x20due\x20to\x20water\x20retention.\x20However,\x20persistently\x20elevated\x20ADH\x20levels\x20can\x20induce\x20vasopressin\x20escape\x20mechanism,\x20resulting\x20in\x20the\x20typical\x20euvolemic\x20status.</p>\x0a<p>Patients\x20usually\x20present\x20with\x20<strong>hyponatremia</strong>\x20with\x20a\x20<strong>euvolemic</strong>\x20status.</p>\x0a<p><strong>Acute\x20hyponatremia</strong>\x20may\x20present\x20with\x20mild\x20headache,\x20confusion,\x20anorexia,\x20nausea,\x20vomiting,\x20coma,\x20and\x20convulsions.</p>\x0a<p><strong>Chronic\x20hyponatremia</strong>\x20allows\x20cerebral\x20adaptation,\x20and\x20the\x20patients\x20are\x20asymptomatic\x20despite\x20the\x20hyponatremia.</p>\x0a<p>Laboratory\x20findings\x20in\x20<strong>SIADH</strong>\x20include:</p>\x0a<ul>\x0a<li>Hyponatremia:\x20serum\x20Na+&lt;135\x20mEq/L</li>\x0a<li>Urinary\x20Na+\x20&gt;25\x20mEq/L\x20</li>\x0a<li>Urine\x20osmolality\x20&gt;100\x20mOsm/kg</li>\x0a<li>Blood\x20urea\x20nitrogen\x20(BUN)\x20levels\x20are\x20low,\x20usually\x20&lt;10\x20mg/dL</li>\x0a<li>Serum\x20urate\x20is\x20low</li>\x0a<li>Serum\x20K+\x20and\x20serum\x20bicarbonate\x20are\x20normal</li>\x0a</ul>\x0a<p><strong>Mild\x20and\x20symptomatic\x20hyponatremia</strong>\x20can\x20be\x20managed\x20by\x20<strong>restricting\x20fluid\x20intake.</strong></p>\x0a<p><strong>Severe,\x20symptomatic</strong>\x20hyponatremia\x20can\x20be\x20corrected\x20using\x20<strong>hypertonic</strong>\x20<strong>saline</strong>\x20or\x20<strong>vasopressin\x20receptor-2\x20antagonists</strong>\x20(tolvaptan\x20and\x20conivaptan).</p>\x0a<p>Other\x20drugs\x20which\x20are\x20useful\x20in\x20the\x20management\x20are\x20demeclocycline\x20and\x20fludrocortisone.</p>','Test\x20for\x20ANCA','https://cdn1.dailyrounds.org/uploads/2cdcf8ec7d5f4ec6b32232e7adf9ae52.JPEG','Fixed\x20central\x20airway\x20obstruction','markReviewBtn','LgBbR','<p>Statements<strong>\x202\x20and\x203</strong>\x20are\x20<strong>true</strong>\x20regarding\x20the\x20prevention\x20of\x20stroke\x20in\x20this\x20patient.</p>\x0a<p><strong>Statement\x201:</strong>\x20Clopidogrel\x20combined\x20with\x20aspirin\x20is\x20better\x20than\x20aspirin\x20alone\x20for\x20stroke\x20prevention.\x20<strong>Warfarin\x20is\x20superior</strong>\x20to\x20antiplatelets\x20in\x20stroke\x20prevention.</p>\x0a<p><strong>Statement\x202:</strong>\x20Warfarin\x20is\x20the\x20recommended\x20anticoagulant\x20for\x20patients\x20with\x20<strong>mitral\x20stenosis\x20(MS)</strong>\x20and<strong>\x20mechanical\x20prosthetic\x20valves.</strong></p>\x0a<p><strong>Statement\x203:</strong>\x20Direct\x20oral\x20anticoagulants\x20(DOACs)\x20like\x20dabigatran,\x20rivaroxaban,\x20apixaban,\x20and\x20edoxaban\x20are\x20not\x20used\x20in\x20the\x20treatment\x20of\x20moderate\x20to\x20severe\x20MS\x20and\x20in\x20patients\x20with\x20prosthetic\x20heart\x20valves\x20due\x20to\x20limited\x20clinical\x20evidence.</p>\x0a<p><strong>DOACs</strong>\x20have\x20a\x20<strong>lower</strong>\x20<strong>risk</strong>\x20of\x20intracranial\x20hemorrhage\x20compared\x20to\x20warfarin\x20and\x20are\x20as\x20effective\x20as\x20warfarin\x20for\x20stroke\x20prevention\x20in\x20valvular\x20heart\x20disease\x20(except\x20moderate\x20to\x20severe\x20mitral\x20stenosis\x20or\x20a\x20mechanical\x20heart\x20valve),\x20ischemic\x20stroke\x20or\x20TIA,\x20and\x20AF.</p>\x0a<p><strong>Statement\x204:</strong>\x20Mitral\x20valvotomy\x20is\x20not\x20recommended\x20for\x20the\x20prevention\x20of\x20stroke\x20in\x20this\x20patient.\x20It\x20is\x20indicated\x20in\x20<strong>symptomatic</strong>\x20(New\x20York\x20Heart\x20Association\x20Functional\x20Class\x20II-IV)\x20patients\x20with\x20<strong>isolated\x20severe\x20mitral\x20stenosis,</strong>\x20whose\x20effective\x20orifice<strong>\x20(valve\x20area)\x20is\x20&lt;\x201.5\x20cm2</strong>\x20in\x20normal-sized\x20adults.\x20It\x20is\x20<strong>contraindicated</strong>\x20in\x20cases\x20of<strong>\x20left\x20atrial\x20thrombus.</strong></p>','wiqcY','2|0|3|4|5|1','Ircsw','questionNav','fQuwp','prototype','search','QIfAe','map','SFRxf','contains','218\x20Medicine\x20Ini-Cet\x202021','KGBcn','Which\x20of\x20the\x20following\x20is\x20not\x20true\x20about\x20syndrome\x20of\x20inappropriate\x20antidiuretic\x20hormone\x20secretion\x20(SIADH)?','HxQvp','zIGAp','canPlayType','createElement','1,\x202,\x203,\x204','VpeOP','toString','<p>Focal\x20epilepsy\x20is\x20<strong>not</strong>\x20considered\x20a\x20major\x20diagnostic\x20criterion\x20of\x20<strong>neuromyelitis\x20optica\x20(NMO).</strong></p>\x0a<p><strong>Neuromyelitis\x20optica\x20(Devic&rsquo;s\x20disease)</strong>\x20is\x20an\x20aggressive\x20inflammatory\x20<strong>demyelinating</strong>\x20disorder\x20characterized\x20by\x20<strong>recurrent</strong>\x20attacks\x20of\x20<strong>optic\x20neuritis\x20and\x20myelitis.</strong></p>\x0a<p>It\x20is\x20associated\x20with\x20a\x20highly\x20specific\x20autoantibody\x20directed\x20against\x20<strong>aquaporin-4(AQP-4).</strong>\x20AQP-4\x20is\x20localized\x20to\x20the\x20<strong>foot</strong>\x20<strong>processes</strong>\x20of\x20astrocytes\x20in\x20close\x20proximity\x20to\x20endothelial\x20surfaces.</p>\x0a<p>The\x20core\x20clinical\x20characteristics\x20include\x20optic\x20neuritis,\x20acute\x20myelitis,\x20area\x20postrema\x20syndrome\x20(unexplained\x20hiccups/\x20nausea/\x20vomiting),\x20acute\x20brainstem\x20syndrome,\x20symptomatic\x20narcolepsy\x20or\x20acute\x20diencephalic\x20clinical\x20syndrome\x20with\x20<strong>Neuromyelitis\x20Optica\x20Spectrum\x20Disorder\x20(NMOSD)-</strong>typical\x20diencephalic\x20MRI\x20lesions,\x20and\x20symptomatic\x20cerebral\x20syndrome\x20with\x20NMSOD-typical\x20brain\x20lesions.</p>\x0a<p>Attacks\x20of\x20optic\x20neuritis\x20are\x20bilateral\x20and\x20severe\x20in\x20NMO,\x20whereas\x20in\x20multiple\x20sclerosis\x20(MS)\x20optic\x20neuritis\x20is\x20usually\x20unilateral.\x20Progressive\x20symptoms\x20are\x20not\x20typical\x20of\x20NMO,\x20unlike\x20in\x20MS.\x20CSF\x20findings\x20in\x20NMO\x20show\x20higher\x20pleocytosis,\x20with\x20neutrophils\x20and\x20eosinophils\x20in\x20acute\x20cases,\x20and\x20rare\x20occurrence\x20of\x20oligoclonal\x20bands,\x20distinguishing\x20it\x20from\x20MS.</p>\x0a<p>Acute\x20attacks\x20of\x20NMO\x20are\x20treated\x20with\x20<strong>high-dose\x20glucocorticoids.</strong>\x20<strong>Plasma\x20exchange</strong>\x20can\x20be\x20used\x20in\x20acute\x20attacks\x20that\x20do\x20not\x20respond\x20to\x20glucocorticoids.</p>\x0a<p>Drugs\x20used\x20for\x20<strong>prophylaxis</strong>\x20against\x20relapses\x20include\x20<strong>mycophenolate\x20mofetil,\x20rituximab,\x20glucocorticoids,\x20</strong>and<strong>\x20azathioprine.</strong>\x20Three\x20monoclonal\x20antibodies\x20approved\x20for\x20attack\x20prevention\x20include\x20<strong>eculizumab</strong>\x20(terminal\x20complement\x20inhibitor),\x20<strong>inebilizumab</strong>\x20(B-cell\x20depleter),\x20and\x20<strong>satralizumab</strong>\x20(IL-6\x20receptor\x20blocker).</p>\x0a<p>NMO\x20typically\x20presents\x20as\x20a\x20recurrent\x20disease,\x20with\x20a\x20monophasic\x20course\x20observed\x20in\x20less\x20than\x2010%\x20of\x20patients.\x20Untreated\x20NMO\x20can\x20lead\x20to\x20disability,\x20including\x20respiratory\x20failure,\x20blindness,\x20and\x20limb\x20paralysis.\x20</p>','https://dhmbxeygs57ff.cloudfront.net/uploads/0adba9b55d634cd08f5e15ab97dd37fbx1279x967.JPEG','Hypoventilation','Thrombolysis','warn','IAQSN','XAHLA','uoemb','1,\x202,\x203','location','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','True\x20about\x20electroencephalogram\x20(EEG)\x20is\x20all\x20except:','ALS','ILTCY','bKlbb','tJxxf','EJDRg','ouLWT','gMbZJ','YjYhN','getItem','status','The\x20blood\x20investigation\x20of\x20a\x20patient\x20is\x20given\x20below.\x20What\x20is\x20the\x20probabale\x20diagnosis?','classList','VKOWC','RpIvz','notAttemptedResult','<p>The\x20given\x20patient\x20has\x20the\x20involvement\x20of\x20<strong>upper\x20respiratory\x20tract</strong>\x20(chronic\x20sinusitis,\x20ulcerations\x20on\x20nasopharynx),\x20<strong>lower\x20respiratory\x20tract</strong>\x20(nodular\x20lesions\x20with\x20lung\x20cavitations),\x20and\x20<strong>kidneys</strong>\x20(renal\x20failure)\x20which\x20are\x20suggestive\x20of\x20<strong>granulomatosis\x20with\x20polyangiitis</strong>\x20(Wegener\x27s\x20granulomatosis)\x20and\x20testing\x20for\x20cytoplasmic\x20ANCA\x20(<strong>c-ANCA</strong>)\x20would\x20be\x20the\x20most\x20helpful\x20investigation\x20in\x20this\x20condition.</p>\x0a<p>Granulomatosis\x20with\x20polyangiitis\x20is\x20a\x20granulomatous\x20and\x20<strong>necrotizing</strong>\x20<strong>vasculitis</strong>\x20of\x20the\x20<strong>small</strong>\x20arteries\x20and\x20veins\x20that\x20mainly\x20affects:</p>\x0a<ul>\x0a<li><strong>Upper\x20respiratory\x20tract:</strong>\x20chronic\x20<strong>sinusitis</strong>,\x20serous\x20otitis\x20media\x20due\x20to\x20eustachian\x20tube\x20blockage,\x20nasal\x20septal\x20perforation,\x20and\x20mucosal\x20<strong>ulceration</strong>\x20of\x20the\x20nasopharynx.</li>\x0a<li><strong>Lower\x20respiratory\x20tract:</strong>\x20presenting\x20with\x20cough,<strong>&nbsp;</strong><strong>hemoptysis,</strong>&nbsp;dyspnea,\x20and\x20persistent\x20pneumonitis.<strong>&nbsp;</strong>Lung\x20involvement\x20typically\x20appears\x20as\x20multiple,\x20bilateral\x20<strong>nodular</strong>&nbsp;<strong>cavitary</strong>\x20<strong>infiltrates</strong>.</li>\x0a<li><strong>Kidneys</strong>:\x20focal\x20or\x20segmental&nbsp;<strong>glomerulonephritis</strong>\x20presenting\x20with\x20proteinuria,\x20hematuria,\x20and\x20hypertension.\x20If\x20left\x20untreated\x20it\x20can\x20lead\x20to\x20rapidly\x20progressive\x20glomerulonephritis.</li>\x0a</ul>\x0a<p>Apart\x20from\x20these\x20organs,\x20it\x20can\x20also\x20affect\x20the\x20eyes\x20and\x20skin.\x20Skin\x20lesions\x20present\x20as\x20<strong>palpable\x20purpura</strong>\x20or\x20<strong>subcutaneous</strong>\x20<strong>nodules</strong>.</p>\x0a<p>Lab\x20investigations\x20will\x20show&nbsp;<strong>anemia,&nbsp;</strong>leucocytosis,\x20elevated\x20ESR,\x20and\x20<strong>high\x20titers</strong>\x20of\x20cytoplasmic\x20ANCA\x20(<strong>c-ANCA</strong>)\x20targetted\x20against\x20<strong>anti-proteinase-3</strong>\x20(anti-PR-3)<strong>.</strong>&nbsp;The\x20specificity\x20of\x20a\x20positive\x20PR-3\x20ANCA\x20for\x20Wegener\x27s\x20is\x20very\x20high,\x20especially\x20in\x20the\x20presence\x20of\x20active\x20glomerulonephritis.\x20Following\x20treatment,\x20PR-3\x20ANCA\x20titers\x20fall\x20and\x20subsequent\x20rise\x20in\x20titers\x20is\x20predictive\x20of\x20<strong>relapse</strong>.<strong>&nbsp;</strong>Chest\x20radiograph\x20will\x20show\x20<strong>multiple,\x20bilateral\x20cavitating\x20nodules\x20</strong>and\x20<strong>pulmonary\x20infiltrates</strong>.</p>\x0a<p>The\x20diagnosis\x20is\x20<strong>confirmed</strong>\x20by\x20the\x20presence\x20of\x20<strong>necrotizing\x20granulomatous\x20vasculitis</strong>\x20on\x20<strong>biopsy</strong>.\x20This\x20finding\x20is\x20commonly\x20seen\x20in\x20the\x20tissues\x20obtained\x20from\x20the\x20<strong>lungs</strong>,\x20upper\x20airways,\x20skin,\x20and\x20rarely\x20in\x20the\x20kidneys.</p>\x0a<p>The\x20radiograph\x20below\x20shows\x20cavitating\x20nodules\x20in\x20a\x20patient\x20with\x20granulomatosis\x20with\x20polyangiitis\x20(Wegener\x27s).</p>','zkSHr','3\x20and\x205','navBtn_','sOVuq','<p>The\x20given\x20urinary\x20crystal\x20is\x20the\x20<strong>bipyramidal</strong>\x20or<strong>\x20envelope-shaped\x20crystals</strong>\x20of<strong>\x20calcium\x20oxalate\x20dihydrate.</strong>\x20Risk\x20factors\x20for\x20calcium\x20oxalate\x20stones\x20include\x20<strong>higher\x20urine\x20calcium,\x20urine\x20oxalate,\x20</strong>and<strong>\x20lower\x20urine\x20citrate.</strong></p>\x0a<p><strong>Oxalate-rich</strong>\x20<strong>foods</strong>\x20like\x20spinach,\x20rhubarb,\x20almonds,\x20and\x20potatoes\x20should\x20be\x20avoided.\x20Avoiding\x20high-dose\x20vitamin\x20C\x20supplements\x20reduces\x20endogenous\x20oxalate\x20production.</p>\x0a<p><strong>Chlorthalidone</strong>\x20can\x20lower\x20urine\x20calcium\x20excretion\x20and\x20can\x20reduce\x20the\x20recurrence\x20of\x20calcium\x20oxalate\x20stones.\x20Consumption\x20of\x20fruits\x20and\x20vegetables\x20or\x20supplemental\x20alkali\x20is\x20advised\x20to\x20increase\x20urine\x20citrate,\x20which\x20is\x20a<strong>\x20natural\x20inhibitor</strong>\x20of\x20calcium\x20oxalate\x20and\x20calcium\x20phosphate\x20stones.</p>','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','cXKua','wZGbB','https://dhmbxeygs57ff.cloudfront.net/uploads/e78da2196a8f48dc97e5db27603061c7x1280x1794.JPEG','zGlob','cicYu','ycAbp','bookmarkText','nygEs','QCRLp','Which\x20of\x20the\x20following\x20conditions\x20is\x20associated\x20with\x20hypokalemic\x20metabolic\x20alkalosis\x20with\x20hypertension?','During\x20the\x20discharge\x20of\x20a\x20COVID\x20patient\x20who\x20was\x20treated\x20with\x20steroids\x20and\x20remdesivir,\x20which\x20of\x20the\x20following\x20will\x20you\x20inform\x20him\x20about?','setItem','RiSRv','questionIndex','ZEVni','QNEwy','zTWzu','HCByh','incorrectCount','ejmNv','progressBar','Calcium\x20phosphate','ZmLEJ','NGrjQ','ApQfN','nav-btn-bookmarked','quizFile','NUYDY','xrWSM','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','display','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','WXlGi','fasAz','jVhka','<p>The\x20given\x20clinical\x20scenario\x20of\x20a\x20female\x20patient\x20presenting\x20with\x20<strong>weight\x20loss,</strong>\x20<strong>palpitations</strong>,\x20<strong>exophthalmos</strong>,\x20and\x20diffusely\x20<strong>enlarged\x20thyroid</strong>\x20gland\x20is\x20suggestive\x20of\x20<strong>Graves\x27\x20disease</strong>.</p>\x0a<p>The\x20essential\x20investigations\x20in\x20this\x20patient\x20would\x20be\x20<strong>thyroid\x20function\x20tests,</strong>\x20<strong>ultrasound</strong>\x20of\x20the\x20neck,\x20thyroid\x20<strong>scan</strong>,\x20and\x20<strong>anti-thyroid\x20antibody.</strong>\x20FNAC\x20is\x20not\x20an\x20essential\x20investigation\x20in\x20this\x20condition.\x20<strong>FNAC</strong>\x20should\x20be\x20done\x20on\x20nodules\x20that\x20are\x20not\x20classified\x20as\x20fully\x20benign\x20on\x20ultrasound.</p>\x0a<p>The\x20hyperthyroidism\x20of\x20Graves&rsquo;\x20disease\x20is\x20caused\x20by\x20<strong>thyroid-stimulating\x20immunoglobulin</strong>\x20(TSI)\x20synthesized\x20by\x20lymphocytes\x20in\x20the\x20thyroid\x20gland\x20as\x20well\x20as\x20in\x20bone\x20marrow\x20and\x20lymph\x20nodes.\x20TSI\x20antibodies\x20cause\x20stimulation\x20of\x20the\x20thyroid\x20gland\x20causing\x20features\x20of\x20hyperthyroidism.</p>\x0a<p>Symptoms\x20include\x20hyperactivity,\x20heat\x20intolerance,\x20sweating,\x20palpitations,\x20weakness,\x20weight\x20loss,\x20increased\x20appetite,\x20and\x20diarrhea.</p>\x0a<p>Signs\x20include\x20tachycardia,\x20goiter,\x20tremor,\x20muscle\x20weakness,\x20and\x20atrial\x20fibrillation\x20in\x20the\x20elderly.</p>\x0a<p><strong>Thyroid\x20ophthalmopathy</strong>\x20seen\x20in\x20one-third\x20of\x20patients\x20with\x20Grave&rsquo;s\x20disease.</p>\x0a<p><strong>NO\x20SPECS\x20scoring\x20system</strong>\x20as\x20describe\x20below\x20can\x20be\x20used\x20to\x20evaluate\x20ophthalmopathy.</p>\x0a<ul>\x0a<li><strong>N</strong>o\x20signs\x20or\x20symptoms</li>\x0a<li><strong>O</strong>nly\x20signs\x20(lid\x20retraction,\x20or\x20lag)</li>\x0a<li><strong>S</strong>oft\x20tissue\x20involvement\x20(periorbital\x20edema)</li>\x0a<li><strong>P</strong>roptosis</li>\x0a<li><strong>E</strong>xtraocular\x20muscle\x20involvement</li>\x0a<li><strong>C</strong>orneal\x20involvement</li>\x0a<li><strong>S</strong>ight\x20loss</li>\x0a</ul>\x0a<p><strong>Thyroid\x20dermopathy</strong>\x20usually\x20occurs\x20in\x20the\x20presence\x20of\x20moderate\x20or\x20severe\x20ophthalmopathy.\x20It\x20primarily\x20manifests\x20as\x20noninflamed,\x20indurated\x20plaques\x20with\x20a\x20deep\x20pink\x20or\x20purple\x20color\x20and\x20an<strong>\x20\x22orange\x20skin\x22\x20appearance,</strong>\x20commonly\x20found\x20on\x20the\x20anterior\x20and\x20lateral\x20aspects\x20of\x20the\x20lower\x20leg\x20(known\x20as\x20<strong>pretibial\x20myxedema).</strong></p>\x0a<p>Investigations\x20done\x20in\x20a\x20patient\x20with\x20Graves\x27\x20disease\x20include:</p>\x0a<ul>\x0a<li><strong>Thyroid\x20function\x20tests-</strong>\x20TSH\x20levels\x20are\x20decreased\x20with\x20or\x20without\x20elevated\x20T3\x20and\x20T4\x20levels.</li>\x0a<li><strong>Anti-thyroid\x20antibodies-</strong>\x20Elevated\x20levels\x20of\x20TSH\x20receptor\x20antibodies\x20are\x20diagnostic\x20of\x20Graves\x27\x20disease.\x20Other\x20antibodies\x20like\x20anti-Tg\x20and\x20anti-TPO\x20are\x20elevated\x20in\x20most\x20of\x20the\x20patients.</li>\x0a<li><strong>Ultrasound</strong>\x20of\x20the\x20neck\x20is\x20performed\x20to\x20evaluate\x20vascularity,\x20echogenicity,\x20nodules,\x20and\x20clinical\x20landmarks\x20for\x20surgical\x20planning.</li>\x0a<li>A\x20<strong>radioactive\x20iodine\x20uptake\x20(RAIU)\x20scan</strong>\x20(thyroid\x20scan)\x20should\x20be\x20performed\x20and\x20a\x20diffuse\x20uptake\x20confirms\x20the\x20diagnosis\x20of\x20Graves\x27\x20disease.\x20It\x20is\x20also\x20useful\x20to\x20differentiate\x20TSI-negative\x20Graves\x20disease\x20from\x20toxic\x20nodular\x20disease\x20based\x20on\x20diffuse\x20or\x20nodular\x20uptake\x20patterns.</li>\x0a<li><strong>CT\x20or\x20MRI</strong>\x20scans\x20of\x20the\x20orbits\x20are\x20useful\x20to\x20evaluate\x20Graves&rsquo;\x20ophthalmopathy.</li>\x0a</ul>\x0a<p>Hyperthyroidism\x20can\x20be\x20treated\x20by\x20<strong>antithyroid</strong>\x20<strong>drugs</strong>,\x20r<strong>adioiodine\x20treatment\x20(I131)</strong>,\x20or\x20<strong>thyroidectomy</strong>.</p>','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','application/vnd.apple.mpegurl','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','Fixed\x20distal\x20airway\x20obstruction','QFzKV','TBnpF','zQjLP','qHMkD','GyHyN','yqcgp','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','GwajK','JBzAS','IjkjJ','kkRie','<div\x20class=\x22mt-4\x22><img\x20src=\x22','OclHF','MTkZk','veQof','choices','isSupported','ArrowRight','bookmarked','timeDisplay','idzzV','rMqHW','iTvxM','Are\x20you\x20sure\x20you\x20want\x20to\x20leave\x20the\x20quiz?\x20Your\x20progress\x20will\x20be\x20lost.','GGRwI','aEIkG','GOTHW','reduce','lrSsq','style','<p>Fasting\x20blood\x20sugar<strong>\x20&gt;126\x20mg/dL</strong>\x20and\x202-hour\x20postprandial\x20blood\x20sugar<strong>\x20&gt;200\x20mg/dl</strong>\x20can\x20be\x20used\x20as\x20screening\x20tests\x20for\x20diabetes\x20in\x20a\x20primary\x20health\x20center\x20(PHC).</p>\x0a<p><strong>HbA1c</strong>\x20estimation\x20is\x20usually\x20unavailable\x20for\x20screening\x20at\x20many\x20PHCs\x20due\x20to\x20low\x20resources.\x20In\x20India,\x20facilities\x20for\x20HbA1c\x20estimation\x20are\x20usually\x20available\x20only\x20at\x20<strong>tertiary\x20centers.</strong></p>\x0a<p>Random\x20blood\x20sugar\x20<strong>&gt;200\x20mg/dL</strong>\x20can\x20be\x20used\x20for\x20diagnosis\x20only\x20if\x20the\x20patient\x20presents\x20with\x20symptoms\x20of\x20diabetes,\x20hence\x20it\x20is\x20<strong>not\x20a\x20useful\x20screening\x20test.</strong></p>','explanationVideoPlayer','sWgcx','Oral\x20sumatriptan','eoxfY','timeSpent','1\x20and\x202','PZvCN','UYCJI','ZnBvp','Aljhd','MgRRW','\x20-\x20Brain\x20And\x20Scalpel','EQojE','WCVJS','vBXPG','quizHierarchy','incorrect','RcFVq','nAJTO','No\x20question\x20text\x20available','HBpPT','qZlAc','ohRaA','zpuDu','CT\x20angiography\x20to\x20look\x20for\x20large\x20vessel\x20occlusion','https://dhmbxeygs57ff.cloudfront.net/uploads/d654d63968a24c23abee8962cbd54874x978x662.PNG','CkeEn','kOTGQ','Variable\x20extrathoracic\x20obstruction','ASUSE','Cubda','Identify\x20the\x20urinary\x20crystal\x20shown\x20below:','QanVY','WNfTE','fromCharCode','1\x20only','6005784utbFDF','\x20>\x20','now','AyfqX','__proto__','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','favFv','performanceModal','A\x20newly\x20diagnosed\x20HIV\x20patient\x20presented\x20with\x20fever,\x20cough,\x20and\x20hemoptysis.\x20His\x20sputum\x20sample\x20showed\x20acid-fast\x20bacilli.\x20What\x20is\x20the\x20appropriate\x20management\x20for\x20this\x20patient?','In\x20atrial\x20fibrillation,\x20choose\x20the\x20correct\x20statements:','aJCZi','selected','<p>Revised\x20<strong>WHO\x20classification</strong>\x20of\x20pulmonary\x20hypertension:</p>\x0a<ul>\x0a<li>Group\x20I:\x20Pulmonary\x20arterial\x20hypertension\x20(PAH)</li>\x0a<li>Group\x20II:\x20Pulmonary\x20hypertension\x20with\x20left\x20heart\x20disease</li>\x0a<li>Group\x20III:\x20Pulmonary\x20hypertension\x20associated\x20with\x20lung\x20diseases\x20and/or\x20hypoxemia</li>\x0a<li>Group\x20IV:\x20Pulmonary\x20hypertension\x20due\x20to\x20chronic\x20thrombotic\x20and/or\x20embolic\x20disease\x20(CTEPH)</li>\x0a<li>Group\x20V:\x20Pulmonary\x20hypertension\x20due\x20to\x20miscellaneous\x20causes</li>\x0a</ul>\x0a<p>The\x20table\x20below\x20provides\x20guidance\x20on\x20the\x20prognosis\x20of\x20PAH.</p>\x0a<table\x20style=\x22height:\x20116px;\x20width:\x20324px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22><strong>Determinants</strong>&nbsp;</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22><strong>Low\x20risk&nbsp;</strong></td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22><strong>High\x20risk</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>Clinical\x20evidence\x20of\x20RV\x20failure</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>No</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>Yes</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>Progression\x20of\x20symptoms</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>Gradual</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>\x0a<p>Rapid</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>Echocardiography</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>Minimal\x20RV\x20dysfunction</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>Pericardial\x20effusion,\x20significant\x20RV\x20enlargement/dysfunction,\x20right\x20atrial\x20enlargement</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22><strong>WHO\x20functional\x20class&nbsp;</strong></td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22><strong>II,\x20III</strong></td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22><strong>IV</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>6min\x20walk\x20distance</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>Longer\x20(&gt;400\x20m)</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>Shorter\x20(&lt;300\x20m)</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20124.84375px;\x22>BNP</td>\x0a<td\x20style=\x22width:\x2080.953125px;\x22>Minimally\x20elevated</td>\x0a<td\x20style=\x22width:\x20181.234375px;\x22>Significantly\x20elevated</td>\x0a</tr>\x0a</tbody>\x0a</table>','KcIuz','\x22\x20data-option-index=\x22','oTCBJ','padStart','DOMContentLoaded','wdJcK','<p><strong>Huntington\x27s\x20disease\x20</strong>(formerly\x20known\x20as\x20Huntington&rsquo;s\x20chorea)\x20is\x20a<strong>\x20movement\x20disorder</strong>\x20that\x20shows\x20predominantly\x20only\x20<strong>hyperkinetic\x20movements</strong>\x20like\x20chorea.</p>\x0a<p>Hyperkinetic\x20movement\x20disorders\x20include\x20tremor,\x20dystonia,\x20athetosis,\x20chorea,\x20myoclonus,\x20and\x20tics.\x20Hypokinetic\x20movements\x20include\x20rigidity,\x20stiffness,\x20and\x20bradykinesia.</p>\x0a<p>Huntington\x27s\x20disease\x20is\x20a\x20<strong>degenerative</strong>\x20disease\x20of\x20the\x20<strong>caudate</strong>\x20<strong>nucleus</strong>\x20and\x20<strong>putamen</strong>\x20(striate\x20neurons)\x20caused\x20by\x20a\x20<strong>trinucleotide\x20repeat\x20(CAG)</strong>\x20in\x20the\x20Huntingtin\x20gene\x20on\x20<strong>chromosome\x204.</strong>\x20It\x20is\x20inherited\x20in\x20an<strong>\x20autosomal\x20dominant</strong>\x20pattern\x20and\x20is\x20characterized\x20by\x20chorea,\x20dysarthria,\x20gait\x20disturbance,\x20behavioral\x20disturbance\x20and\x20cognitive\x20impairment\x20with\x20dementia.\x20The\x20clinical\x20manifestations\x20increase\x20in\x20severity\x20with\x20each\x20successive\x20generation\x20<strong>(anticipation).</strong>\x20Treatment\x20includes\x20<strong>haloperidol,\x20</strong>and<strong>\x20tetrabenazine.</strong></p>\x0a<p>With\x20advancing\x20disease,\x20a\x20reduction\x20in\x20chorea\x20may\x20be\x20seen\x20along\x20with\x20the\x20emergence\x20of\x20dystonia,\x20rigidity,\x20myoclonus,\x20and\x20bradykinesia.\x20It\x20can\x20also\x20have\x20an\x20akinetic,\x20rigid,\x20or\x20Parkinsonian\x20presentation\x20in\x20younger\x20patients\x20(~10%\x20of\x20cases)\x20known\x20as\x20the\x20Westphal\x20variant.\x20However,\x20the\x20typical\x20presentation\x20of\x20Huntington\x27s\x20disease\x20is\x20characterized\x20by\x20hyperkinetic\x20movements\x20like\x20<strong>chorea</strong>.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20A:</strong>\x20Parkinson\x27s\x20disease\x20is\x20characterized\x20by\x20both\x20hyperkinetic\x20(resting\x20tremor)\x20and\x20hypokinetic\x20(rigidity,\x20stiffness,\x20bradykinesia)\x20movements.</p>\x0a<p><strong>Option\x20B:</strong>\x20The\x20neurological\x20manifestations\x20in\x20Wilson\x27s\x20disease\x20occur\x20due\x20to\x20damage\x20of\x20basal\x20ganglia\x20resulting\x20in\x20dystonia\x20and\x20tremor\x20(hyperkinetic),\x20parkinsonism\x20with\x20bradykinesia\x20(hypokinetic),\x20incoordination,\x20dysarthria,\x20and\x20dysphagia.\x20In\x20advanced\x20disease,\x20the\x20tremor\x20progresses\x20to\x20a\x20characteristic\x20wing-beating\x20flapping\x20tremor.</p>\x0a<p><strong>Option\x20C:</strong>\x20Pantothenate\x20kinase-associated\x20neurodegeneration\x20(PKAN)\x20formerly\x20known\x20as\x20Hallervorden-Spatz\x20disease\x20caused\x20by\x20PANK2\x20gene\x20mutation\x20is\x20the\x20most\x20common\x20form\x20of\x20Neurodegeneration\x20with\x20Brain\x20Iron\x20Accumulation\x20(NBIA)\x20and\x20is\x20manifested\x20as\x20a\x20combination\x20of\x20dystonia\x20(hyperkinetic),\x20parkinsonism\x20(hypokinetic),\x20and\x20spasticity.\x20T2W-MRI\x20shows\x20the\x20characteristic\x20eye\x20of\x20the\x20tiger\x20sign\x20due\x20to\x20iron\x20accumulation\x20in\x20globus\x20pallidus.</p>','WKCaZ','cTJts','GGWrw','3,\x204\x20and\x205','Uric\x20acid','pmmmi','SLyHo','WCQZR','IydhB','{}.constructor(\x22return\x20this\x22)(\x20)','RtvsX','szVlo','currentQuestion','A\x20patient\x20came\x20with\x20hypoxemia\x20and\x20a\x20normal\x20alveolar-arterial\x20oxygen\x20gradient.\x20What\x20can\x20be\x20the\x20cause?','replace','questionText','hRCNQ','red','nYjes','bookmarkBtn','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','1,\x203\x20and\x204','oYyfB','Iloprost','WEKlu','Mark\x20for\x20Review','abyTj','prevBtn','19299500WLKLpB','1,\x203,\x205\x20only','button','ClsEo','<p>The\x20clinical\x20scenario\x20describes\x20an\x20<strong>elderly</strong>\x20patient\x20with<strong>\x20heart\x20failure</strong>\x20who\x20develops\x20<strong>severe\x20respiratory\x20distress</strong>\x20associated\x20with\x20hypoxia,\x20tachycardia,\x20and\x20elevated\x20mean\x20arterial\x20pressure\x20following\x20a\x20<strong>blood\x20transfusion.</strong>\x20The\x20most\x20likely\x20diagnosis\x20is\x20<strong>transfusion-associated\x20circulatory\x20overload\x20(TACO).</strong>\x20The\x20recommended\x20investigations\x20for\x20suspected\x20TACO\x20include\x20<strong>chest\x20X-ray</strong>\x20and\x20<strong>BNP</strong>\x20levels.</p>\x0a<p><strong>Chest\x20X-ray</strong>\x20in\x20TACO\x20may\x20show\x20<strong>bilateral</strong>\x20and\x20<strong>predominant\x20alveolar\x20infiltrates.</strong>\x20<strong>BNP</strong>\x20levels\x20are\x20usually\x20<strong>elevated</strong>\x20in\x20TACO\x20secondary\x20to\x20volume\x20overload.</p>\x0a<p><strong>Anti-leukocyte\x20antibodies</strong>\x20are\x20present\x20in\x20<strong>transfusion-related\x20acute\x20lung\x20injury\x20(TRALI),</strong>\x20not\x20in\x20TACO\x20patients.</p>\x0a<p>TACO\x20is\x20usually\x20a\x20clinical\x20diagnosis\x20suspected\x20in\x20any\x20patient\x20who\x20has\x20acute\x20respiratory\x20distress\x20and/or\x20hypertension\x20during\x20transfusion\x20or\x20within\x206\x20hours\x20of\x20completion.</p>\x0a<p><strong>Risk\x20factors</strong>\x20include\x20older\x20age,\x20pre-existing\x20fluid\x20overload,\x20cardiac\x20dysfunction,\x20renal\x20dysfunction,\x20and\x20transfusion\x20of\x20large\x20volumes\x20of\x20blood\x20components.<br\x20/>Management\x20of\x20TACO\x20involves\x20discontinuing\x20the\x20transfusion\x20and\x20providing\x20oxygen\x20and\x20diuretics.</p>\x0a<p>Identification\x20of\x20at-risk\x20patients,\x20a\x20<strong>slow\x20transfusion\x20rate</strong>\x20(1\x20PRBC\x20over\x203-4\x20hours),\x20close\x20monitoring,\x20and\x20the\x20use\x20of\x20<strong>diuretics</strong>\x20in\x20hemodynamically\x20stable\x20patients\x20with\x20a\x20history\x20of\x20TACO\x20can\x20prevent\x20TACO.</p>\x0a<p>&nbsp;</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Features&nbsp;</td>\x0a<td>TRALI</td>\x0a<td>TACO</td>\x0a</tr>\x0a<tr>\x0a<td>Body\x20temperature</td>\x0a<td>Fever\x20+</td>\x0a<td>Fever\x20+/-</td>\x0a</tr>\x0a<tr>\x0a<td>Blood\x20pressure</td>\x0a<td>Hypotension</td>\x0a<td>Hypertension</td>\x0a</tr>\x0a<tr>\x0a<td>Respiratory\x20symptoms</td>\x0a<td>Acute\x20dyspnea</td>\x0a<td>Acute\x20dyspnea</td>\x0a</tr>\x0a<tr>\x0a<td>Neck\x20veins</td>\x0a<td>Unchanged</td>\x0a<td>Distended</td>\x0a</tr>\x0a<tr>\x0a<td>Chest\x20radiograph</td>\x0a<td>Diffuse\x20bilateral\x20infiltrates</td>\x0a<td>Diffuse\x20bilateral\x20infiltrates</td>\x0a</tr>\x0a<tr>\x0a<td>Ejection\x20fraction</td>\x0a<td>Normal</td>\x0a<td>Decreased</td>\x0a</tr>\x0a<tr>\x0a<td>Pulmonary\x20edema\x20fluid</td>\x0a<td>Exudate</td>\x0a<td>Transudate</td>\x0a</tr>\x0a<tr>\x0a<td>Fluid\x20balance</td>\x0a<td>Neutral\x20or\x20negative</td>\x0a<td>Positive</td>\x0a</tr>\x0a<tr>\x0a<td>Response\x20to\x20diuretics</td>\x0a<td>Inconsistent</td>\x0a<td>Significant\x20improvement</td>\x0a</tr>\x0a<tr>\x0a<td>White\x20cell\x20count</td>\x0a<td>Transient\x20leukopenia\x20may\x20be\x20present</td>\x0a<td>Unchanged</td>\x0a</tr>\x0a<tr>\x0a<td>BNP</td>\x0a<td>Maybe\x20elevated\x20in\x20critically\x20ill\x20patients\x20with\x20TRALI</td>\x0a<td>Elevated</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<div\x20class=\x22layoutArea\x22>&nbsp;</div>','HjGNP','<p>The\x20next\x20step\x20in\x20management\x20would\x20be\x20<strong>CT\x20angiography.</strong>\u00a0<strong>NCCT\x20and\x20CT\x20angiography</strong>\x20must\x20be\x20<strong>done\x20concurrently</strong>\u00a0during\x20stroke\x20evaluation.\x20The\x20given\x20features\x20of\x20hemiparesis\x20with\x20aphasia\x20and\x20a\x20clear\x20NCCT\x20are\x20suggestive\x20of\x20an\x20acute\x20<strong>ischemic\x20stroke</strong>\x20with\x20a\x20<strong>proximal\x20large\x20vessel\x20occlusion</strong>.\u00a0</p>\x0a<p>Though\x20thrombolysis\x20is\x20the\x20treatment\x20of\x20choice,\x20occlusions\x20in\x20large\x20vessels\x20often\x20fail\x20to\x20open\x20up\x20with\x20thrombolysis\x20alone.\x20Hence,\x20<strong>mechanical</strong>\x20<strong>thrombectomy\x20is\x20also\x20indicated</strong>\x20and\x20should\x20be\x20done\x20ideally\x20within\x20<strong>6\x20hours</strong>\x20and\x20not\x20beyond\x2024\x20hours\x20of\x20symptom\x20onset.</p>\x0a<p><strong>CT\x20angiography\x20</strong>determines\x20if\x20there\x20is\x20an\x20emergent\x20large\x20vessel\x20occlusion\x20(ELVO),\x20and\x20can\x20be\x20used\x20to\x20triage\x20patients\x20for\x20management\x20by\x20intra-arterial\x20mechanical\x20thrombectomy\x20using\x20a\x20retriever\x20device.\u00a0</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20D:</strong>\x20Thrombolysis\x20with\x20alteplase\x20is\x20the\x20first-line\x20therapy\x20for\x20acute\x20ischemic\x20stroke\x20and\x20should\x20be\x20initiated\x20within\x204.5\x20hours\x20of\x20symptom\x20onset.\x20However,\x20<strong>mechanical\x20thrombectomy</strong>\x20is\x20<strong>indicated</strong>\x20as\x20well\x20for\x20acute\x20ischemic\x20stroke\x20due\x20to\x20a\x20<strong>large\x20artery\x20occlusion</strong>\x20in\x20the\x20anterior\x20circulation.\x20Thus,\x20<strong>CT\x20angiography\x20</strong>to\x20look\x20for<strong>\x20large\x20vessel\x20occlusion</strong>\x20would\x20be\x20the\x20next\x20best\x20step\x20in\x20the\x20management.</p>\x0a<p><strong>Option\x20B:</strong>\x20MRI\x20with\x20diffusion-weighted\x20imaging\x20(DWI)\x20is\x20superior\x20to\x20NCCT\x20for\x20detecting\x20an\x20acute\x20infarct.\x20However,\x20MRI\x20is\x20not\x20preferred\x20to\x20NCCT\x20because\x20of\x20longer\x20scan\x20completion\x20time,\x20limited\x20availability\x20in\x20emergency\x20settings,\x20and\x20higher\x20cost.</p>\x0a<p><strong>Option\x20C:</strong>\x20Labetalol,\x20nicardipine,\x20and\x20clevidipine\x20are\x20the\x20first-line\x20anti-hypertensive\x20agents\x20used\x20in\x20the\x20acute\x20phase\x20of\x20stroke.\x20The\x20blood\x20pressure\x20goals\x20in\x20ischemic\x20stroke\x20are:</p>\x0a<ul>\x0a<li>If\x20the\x20patient\x20is\x20to\x20receive\x20thrombolytic\x20therapy,\x20maintain\x20BP\x20185/110\x20mmHg.</li>\x0a<li>After\x20thrombolytic\x20therapy,\x20maintain\x20BP\x20180/105\x20mmHg\x20for\x20at\x20least\x20the\x20next\x2024\x20hours.</li>\x0a<li>If\x20not\x20treated\x20with\x20thrombolytic\x20therapy,\x20BP\x20should\x20not\x20be\x20treated\x20acutely\x20unless\x20it\x20is\x20more\x20than\x20220/120\x20mmHg.\x20BP\x20should\x20be\x20lowered\x20cautiously\x20by\x20only\x2015\x20percent\x20in\x20the\x20first\x2024\x20hours\x20in\x20order\x20to\x20preserve\x20perfusion\x20to\x20the\x20ischemic\x20penumbra.</li>\x0a</ul>\x0a<p>\u00a0</p>','ONVOZ','OsIxN','cfUpd','KKMpN','jjtVS','KvNbo','NysCt','djBoe','wFTFf','strokeDashoffset','log','UObJr','YxHZg','test','<p><strong>Ocrelizumab</strong>\x20is\x20preferred\x20in\x20the\x20management\x20of<strong>\x20primary\x20progressive\x20multiple\x20sclerosis\x20(PPMS).\x20Natalizumab</strong>,\x20<strong>fingolimod</strong>,\x20and\x20<strong>alemtuzumab</strong>\x20are\x20used\x20in\x20the\x20management\x20of\x20relapsing\x20<strong>multiple\x20sclerosis</strong>\x20and\x20not\x20PPMS.</p>\x0a<p><strong>Ocrelizumab</strong>\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20against\x20<strong>CD20</strong>\x20molecules\x20present\x20on\x20<strong>B\x20cells.</strong>\x20It\x20reduces\x20the\x20progression\x20of\x20the\x20disease\x20and\x20improves\x20other\x20clinical\x20parameters.</p>\x0a<p><strong>Multiple\x20sclerosis</strong>\x20(MS)\x20is\x20an\x20<strong>autoimmune</strong>\x20disease\x20characterized\x20by\x20chronic\x20inflammation,\x20demyelination,\x20gliosis\x20(scarring),\x20and\x20neuronal\x20loss.</p>\x0a<p>Based\x20on\x20<strong>clinical</strong>\x20<strong>course</strong>,\x20MS\x20is\x20<strong>classified</strong>\x20as:</p>\x0a<ul>\x0a<li>Relapsing\x20or\x20bout\x20onset\x20MS\x20(RMS)</li>\x0a<li>Secondary\x20progressive\x20MS\x20(SPMS)</li>\x0a<li>Primary\x20progressive\x20MS\x20(PPMS)</li>\x0a</ul>\x0a<p>The\x20drugs\x20used\x20in\x20the\x20management\x20of\x20RMS\x20are\x20listed\x20in\x20the\x20table\x20below:</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Highly\x20effective</td>\x0a<td>Moderately\x20effective</td>\x0a<td>Modestly\x20effective</td>\x0a</tr>\x0a<tr>\x0a<td>\x0a<ul>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Anti\x20CD20\x20antibodies:\x20Ocrelizumab,\x20Ofatumumab,\x20Rituximab</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Anti\x20integrin\x20antibody:\x20Natalizumab</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Anti\x20CD\x2052\x20antibody:\x20Alemtuzumab</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Mitoxantrone</li>\x0a</ul>\x0a</td>\x0a<td>\x0a<ul>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Sphingosine-1-phosphate\x20inhibitor:\x20Fingolimod</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Dimethyl\x20fumarate</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Cladribine</li>\x0a</ul>\x0a</td>\x0a<td>\x0a<ul>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Glatiramer\x20acetate</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Interferon\x20beta</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Teriflunomide</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>&nbsp;<strong>Siponimod</strong>,\x20a\x20selective\x20<strong>S1P1\x20S1P5\x20modulator,</strong>\x20reduces\x20the\x20risk\x20of\x20progression\x20of\x20SPMS.\x20Ocrelizumab,\x20cladribine\x20and\x20high\x20dose\x20interferon\x20beta\x20can\x20also\x20be\x20used.</p>\x0a<p><strong>Ocrelizumab</strong>\x20is\x20the\x20<strong>first</strong>\x20drug\x20to\x20alter\x20the\x20progression\x20of\x20disability\x20in\x20<strong>PPMS.</strong></p>','FQneT','MOjKp','OOUun','LafAF','GkMzg','utKjg','pMJzc','qQnHE','GGBcn','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','fWIrp','EZgSW','tIHAS','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','TBvOK','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','Subcutaneous\x20sumatriptan','PNmxy','eCIHZ','VVpAN','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','vwHyY','error','Focal\x20epilepsy','JQHhW','Optic\x20neuritis','Acute\x20hepatitis\x20B','Which\x20of\x20the\x20following\x20is\x20not\x20a\x20major\x20diagnostic\x20criterion\x20of\x20neuromyelitis\x20optica?','xwmQX','<p>For\x20the\x20diagnosis\x20of<strong>\x20resistant\x20hypertension,</strong>\x20the\x20patient\x20should\x20have\x20<strong>uncontrolled\x20hypertension</strong>\x20despite\x20taking\x20<strong>three</strong>\x20antihypertensive\x20drugs,\x20including\x20at\x20least\x20one\x20<strong>diuretic</strong>.</p>\x0a<p>While\x20a\x20<strong>calcium\x20channel\x20blocker,\x20beta\x20blocker,\x20</strong>or<strong>\x20alpha-blocker</strong>\x20can\x20be\x20part\x20of\x20the\x20antihypertensive\x20regimen,\x20the\x20inclusion\x20of\x20a\x20<strong>diuretic</strong>\x20is\x20necessary\x20for\x20the\x20diagnosis\x20of\x20resistant\x20hypertension.\x20The\x20diuretic\x20helps\x20in\x20addressing<strong>\x20fluid\x20retention</strong>\x20which\x20is\x20often\x20a\x20significant\x20contributor\x20to\x20hypertension.</p>\x0a<p>Resistant\x20hypertension\x20is\x20more\x20common\x20in\x20patients\x20aged\x20<strong>&gt;60\x20years</strong>\x20than\x20in\x20younger\x20patients.\x20It\x20may\x20be\x20related\x20to\x20<strong>nonadherence</strong>\x20to\x20therapy,\x20obesity,\x20and\x20excessive\x20alcohol\x20intake.</p>\x0a<p>In\x20the\x20absence\x20of\x20a\x20specific\x20identifiable\x20cause,\x20<strong>mineralocorticoid\x20receptor\x20antagonists</strong>\x20like\x20spironolactone\x20have\x20been\x20found\x20to\x20be\x20most\x20effective\x20add-on\x20drugs\x20for\x20the\x20treatment\x20of\x20resistant\x20hypertension.</p>','oabWY','appendChild','question_images','FmfBr','incorrectAnswers','GwnUu','xrLGs','uNWfh','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','PYQs','100%\x20oxygen\x20at\x208\x20L/minute','eYqSH','TzWkG','HnYur','QOBAS','floor','kisgr','Rupgo','lXoyI','frnyp','KyxmS','fSNKf','1,\x202,\x20and\x203\x20correct','Aspergillus\x20niger\x20-\x20Voriconazole','TGWHM','UKKpD','SGXWA','HbOXA','ajUfB','871485jMBahW','noGyM','2|4|1|3|0|5','EvlEl','min','title','length','bind','SpyDI','apply','sjlhn','Marked','KMKuJ','4316721ZwFeHy','A\x2050-year-old\x20man\x20suddenly\x20developed\x20right-sided\x20weakness\x20and\x20aphasia\x20within\x202\x20hours.\x20His\x20BP\x20recorded\x20was\x20160/110mmHg\x20and\x20NCCT\x20was\x20clear.\x20What\x20is\x20the\x20next\x20step\x20in\x20\x20management?','AMMAs','dItCz','qpYFM','GcLXb','totalTimeResult','cgdvp','markedForReview','stringify','FqAbY','Correct','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','Bookmark','1,\x202,\x203,\x204\x20and\x205','totalQuestions','includes','1,\x202,\x203,\x204,\x20and\x205','pop','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','Tropical\x20spastic\x20paraparesis','Scalp\x20EEG\x20may\x20be\x20helpful\x20in\x20localizing\x20frontal\x20lobe\x20epilepsy','hidden','Bartter\x20syndrome','ZoQQz','keydown','-600\x20text-white\x22>','Regardless\x20of\x20ejection\x20fraction\x20and\x20the\x20type\x20of\x20heart\x20failure,\x20the\x205\x20year\x20mortality\x20rate\x20is\x20around\x2050%','Mubon','WwXLn','YJDyC','For\x20the\x20diagnosis\x20of\x20resistant\x20hypertension,\x20the\x20patient\x20should\x20have\x20uncontrolled\x20hypertension\x20despite\x20taking\x20three\x20antihypertensive\x20drugs.\x20This\x20should\x20include\x20at\x20least\x20one:','not_attempted','correctCount','VlmlV','question_audio','vhILK','Identify\x20the\x20pathology\x20from\x20the\x20given\x20flow-volume\x20loop:','1,\x202\x20and\x203','correct','innerHTML','explanation_audio_eng','statsBar','bwkzN','solutionVideo','ArrowLeft','NQyJZ','iprwt','xuTOA','ChlDd','knZYD','ipWme','OZKei','DtdKf','faAZa','uZUav','<p>The\x20given\x20clinical\x20scenario\x20of\x20a\x20patient\x20with\x20dyspnea,\x20bilateral\x20pitting\x20pedal\x20edema,\x20abdominal\x20distension,\x20elevated\x20jugular\x20venous\x20pulse\x20(JVP)\x20and\x20a\x20palpable\x20liver\x20are\x20suggestive\x20of\x20<strong>right\x20ventricular\x20(RV)\x20failure.</strong>\x20The\x20history\x20of<strong>\x20chronic\x20smoking</strong>\x20points\x20towards\x20<strong>chronic\x20obstructive\x20pulmonary\x20disease</strong>\x20(COPD)\x20as\x20the\x20etiology\x20for\x20RV\x20failure\x20<strong>(cor\x20pulmonale).</strong>\x20The\x20label\x202\x20points\x20to\x20the\x20right\x20ventricle\x20(RV),\x20which\x20is\x20affected\x20in\x20this\x20patient.</p>\x0a<p><strong>Cor\x20pulmonale</strong>\x20is\x20defined\x20as\x20altered\x20RV\x20structure/function\x20secondary\x20to\x20pulmonary\x20hypertension\x20in\x20the\x20context\x20of\x20chronic\x20lung\x20diseases.</p>\x0a<p>The\x20main\x20pathophysiology\x20behind\x20cor\x20pulmonale\x20is\x20<strong>pulmonary\x20hypertension</strong>\x20and\x20<strong>increased\x20right\x20ventricular\x20(RV)\x20afterload</strong>\x20which\x20is\x20sufficient\x20to\x20cause\x20<strong>RV\x20dilation</strong>\x20with\x20or\x20without\x20<strong>hypertrophy</strong>.\x20Sustained\x20pressure\x20overload\x20leads\x20to\x20RV\x20<strong>dysfunction\x20and\x20failure.</strong></p>\x0a<p><strong>Dyspnea</strong>\x20is\x20the\x20<strong>most\x20common</strong>\x20symptom.\x20Signs\x20include\x20elevated\x20JVP\x20with\x20prominent\x20v\x20waves,\x20hepatomegaly,\x20pulsatile\x20liver,\x20ascites,\x20pedal\x20edema,\x20S3\x20gallop\x20and\x20murmur\x20of\x20tricuspid\x20regurgitation.</p>\x0a<p>The\x20ECG\x20in\x20severe\x20pulmonary\x20hypertension\x20shows\x20<strong>p-pulmonale,\x20right\x20axis\x20deviation,</strong>\x20and\x20<strong>RV\x20hypertrophy.</strong>\x20Echo\x20can\x20be\x20used\x20to\x20measure\x20RV\x20wall\x20thickness\x20and\x20chamber\x20dimensions,\x20while\x20doppler\x20can\x20be\x20used\x20to\x20assess\x20pulmonary\x20artery\x20pressures.&nbsp;</p>\x0a<p>A\x20specimen\x20of\x20the\x20heart\x20with\x20the\x20various\x20parts\x20labeled\x20is\x20given\x20below:</p>','removeItem','jHScr','opWKd','kNupE','border-green-500','solutionAudio','startAt','oljut','nav-btn-incorrect','study','mKhst','explanation_audio_hin','An\x20elderly\x20woman\x20presented\x20with\x20symptoms\x20of\x20confusion,\x20thirst,\x20and\x20abdominal\x20pain.\x20On\x20examination,\x20she\x20had\x20pallor\x20and\x20thoracic\x20spine\x20tenderness.\x20X-ray\x20spine\x20showed\x20osteolytic\x20lesions.\x20Her\x20lab\x20investigations\x20showed\x20the\x20following\x20findings.\x20\x20What\x20is\x20the\x20most\x20likely\x20diagnosis?','mwOan','ACPkz','kgdyd','DNChm','EuYsV','jvzzJ','ZLiGm','correctResult','rVekJ','incorrectResult','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','explanation_images','block','2\x20only','Calcium\x20channel\x20blocker','UdihZ','wQdMd','Bookmarked','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','2191293qoojvG','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','constructor','Start\x20ART\x20and\x20then\x20ATT\x20after\x202\x20weeks','preventDefault','JxtaI','push','Serum\x20sodium\x20<135\x20mEq/L','gmceR','Fivfg','accuracy','YfgTF','iotXN','src','QnJQB','qzWTy','exiCW','LxYxF','Medicine','RXyyC','totalAttempted','RGyfk','solutionText','DODkq','2jZbHRZ','bEmHD','16AlugLX','WKAzK','sownr','Cysteine','aKSns','HVSII','XAvqv','100%\x20oxygen\x20at\x206\x20L/minute','<p>Among\x20the\x20given\x20options,\x20<strong>Candida\x20krusei</strong>\x20shows\x20an<strong>\x20intrinsic\x20resistance\x20</strong>to\x20<strong>fluconazole.&nbsp;</strong>The\x20<strong>primary</strong>\x20or\x20<strong>intrinsic</strong>\x20resistance\x20of\x20C.\x20krusei\x20to\x20azoles\x20(<strong>fluconazole</strong>\x20and\x20<strong>itraconazole</strong>)\x20is\x20mediated\x20through\x20<strong>reduced</strong>\x20<strong>susceptibility</strong>\x20of\x20the\x20target\x20<strong>enzyme&nbsp;</strong>(lanosterol\x2014&alpha;-demethylase)<strong>&nbsp;</strong>to\x20inhibition\x20by\x20these\x20drugs.\x20However,\x20improved\x20<strong>susceptibility</strong>\x20is\x20seen\x20with\x20newer\x20generation\x20azoles\x20such\x20as\x20<strong>voriconazole</strong>.</p>\x0a<p>Life-threatening\x20systemic\x20infections\x20caused\x20by\x20<strong>Candida</strong>\x20and\x20<strong>Aspergillus</strong>\x20species\x20are\x20usually\x20seen\x20in\x20<strong>severely\x20ill</strong>\x20and\x20<strong>immunocompromised</strong>\x20patients\x20such\x20as\x20HIV,\x20chemotherapy-induced\x20neutropenia,\x20and\x20transplant\x20recipients\x20on\x20immunosuppressants.\x20C.\x20albicans\x20and\x20C.\x20dubliniensis\x20are\x20most\x20susceptible\x20to\x20currently\x20available\x20azoles,\x20C.\x20glabrata\x20is\x20less\x20susceptible,\x20whereas\x20<strong>C.\x20krusei\x20is\x20intrinsically\x20resistant\x20to\x20fluconazole.&nbsp;</strong>Resistance\x20occurs\x20due\x20to\x20overexpression\x20or\x20point\x20mutation\x20in\x20the\x20gene\x20encoding\x20the\x20target\x20enzyme&nbsp;<strong>lanosterol\x2014&alpha;-demethylase.\x20Voriconazole&nbsp;</strong>is\x20the\x20preferred\x20therapy\x20for\x20multi-drug\x20resistant\x20infection\x20with\x20C.\x20krusei.</p>\x0a<p><strong>C.\x20albicans</strong>&nbsp;showing\x20<strong>resistance</strong>\x20to\x20<strong>Amphotericin\x20B</strong>\x20has\x20been\x20increasingly\x20reported\x20over\x20the\x20past\x20several\x20years.\x20But\x20this\x20is\x20a\x20<strong>secondary</strong>\x20<strong>resistance</strong>&nbsp;due\x20to\x20alteration\x20or\x20a\x20<strong>decrease</strong>\x20<strong>in</strong>\x20the\x20amount\x20of\x20<strong>ergosterol</strong>\x20in\x20the\x20cell\x20membrane.</p>\x0a<p><strong>Aspergillus\x20fumigatus,\x20</strong>the&nbsp;most\x20common\x20species\x20to\x20cause\x20Aspergillus\x20infection\x20worldwide,\x20also\x20shows\x20an\x20<strong>intrinsic\x20resistance</strong>\x20to\x20<strong>fluconazole.&nbsp;</strong>It\x20is\x20<strong>susceptible</strong>\x20to\x20echinocandins\x20like\x20<strong>micafungin,\x20</strong>which\x20acts\x20by<strong>\x20inhibiting\x20beta-(1,3)-D-glucan\x20synthase,\x20</strong>an\x20enzyme\x20necessary\x20for\x20the\x20synthesis\x20of\x20the&nbsp;<strong>cell\x20wall.</strong></p>\x0a<p><strong>A.\x20niger&nbsp;</strong>is\x20a\x20common\x20cause\x20of\x20<strong>otomycosis</strong>\x20and\x20is\x20<strong>susceptible</strong>\x20to\x20azoles\x20like\x20<strong>voriconazole</strong>,\x20amphotericin\x20B,\x20and\x20echinocandins.</p>','tBwIy','<p>In\x20an\x20<strong>HIV</strong>\x20patient\x20with\x20<strong>TB</strong>,\x20start\x20<strong>antitubercular\x20therapy\x20(ATT)</strong>\x20first\x20and\x20then\x20start\x20<strong>antiretroviral\x20therapy\x20(ART)</strong>\x20as\x20soon\x20as\x20ATT\x20is\x20tolerated\x20(between\x20<strong>2\x20weeks\x20and\x202\x20months)</strong>\x20by\x20the\x20patient.\x20This\x20is\x20done\x20to\x20avoid<strong>\x20immune\x20reconstitution\x20inflammatory\x20syndrome\x20(IRIS).</strong></p>\x0a<p>Among\x20persons\x20living\x20with\x20<strong>HIV\x20with\x20TB\x20meningitis,</strong>\x20ART\x20should\x20be\x20delayed\x20for\x20at\x20least\x20<strong>4\x20weeks</strong>\x20(and\x20initiated\x20within\x208\x20weeks)\x20after\x20treatment\x20for\x20TB\x20meningitis\x20is\x20initiated.</p>\x0a<p>Patients\x20with<strong>\x20HIV-related\x20TB</strong>\x20may\x20experience\x20a\x20<strong>temporary\x20paradoxical\x20exacerbation</strong>\x20of\x20symptoms\x20and\x20radiographic\x20manifestations\x20of\x20TB\x20after\x20starting<strong>\x20ART\x20(IRIS).</strong>\x20This\x20occurs\x20as\x20a\x20result\x20of\x20<strong>immune</strong>\x20<strong>reconstitution</strong>\x20due\x20to\x20the\x20simultaneous\x20administration\x20of\x20ART\x20and\x20ATT.</p>\x0a<p>It\x20is\x20characterized\x20by\x20high\x20fever,\x20lymphadenopathy,\x20expanding\x20intra-thoracic\x20lesions,\x20and\x20worsening\x20of\x20chest\x20X-ray\x20findings.\x20Diagnosis\x20should\x20be\x20made\x20only\x20after\x20ruling\x20out\x20treatment\x20failure\x20and\x20other\x20infections.\x20For\x20severe\x20cases,\x20<strong>prednisone</strong>\x201-2\x20mg/kg\x20is\x20used\x20for\x201-2\x20weeks\x20and\x20then\x20gradually\x20tapered.</p>\x0a<p>Note:\x20<strong>CBNAAT</strong>\x20is\x20the\x20<strong>preferred</strong>\x20diagnostic\x20technique\x20for\x20testing\x20TB\x20in\x20PLHIV\x20(people\x20living\x20with\x20HIV).\x20Smear\x20microscopy\x20has\x20<strong>poor\x20sensitivity</strong>\x20in\x20detecting\x20TB\x20in\x20PLHIV\x20due\x20to\x20fewer\x20organisms\x20in\x20sputum,\x20and\x20hence\x20is\x20not\x20preferred.</p>','yRmxv','.option-button','QSssd','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','disabled','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','console','\x22\x20data-src=\x22','round','Urine\x20osmolality\x20>100\x20mOsm/kg','zitUJ','kZjrr','qFckt','className','lXGPd','selectedAnswer','toggle','JpDRn','Gordon\x20syndrome','Angiotensin\x20converting\x20enzyme\x20(ACE)\x20inhibitors\x20cause\x20cough\x20in\x2015%\x20and\x20angioedema\x20in\x201%','vmvxo','return\x20(function()\x20','parse','YwVjq','key','BXELQ','CeOhj','nav-btn-answered','pathname','<p>The\x20given\x20clinical\x20scenario\x20describes\x20an\x20<strong>elderly</strong>\x20woman\x20with<strong>\x20confusion,\x20thirst\x20</strong>and<strong>\x20abdominal\x20pain</strong>\x20along\x20with\x20elevated\x20serum\x20calcium\x20levels\x20(<strong>hypercalcemia</strong>),\x20elevated\x20creatinine\x20suggestive\x20of\x20<strong>renal\x20failure,\x20anemia</strong>\x20and\x20<strong>osteolytic</strong>\x20bone\x20lesions<strong>\x20(CRAB\x20features);</strong>\x20and\x20<strong>hypoalbuminemia</strong>\x20with\x20<strong>elevated\x20total\x20proteins.</strong>\x20The\x20most\x20likely\x20diagnosis\x20is<strong>\x20multiple\x20myeloma\x20(MM).</strong></p>\x0a<p>MM\x20is\x20a\x20<strong>malignant\x20plasma\x20cell\x20dyscrasia</strong>\x20with\x20the\x20proliferation\x20of\x20plasma\x20cells\x20derived\x20from\x20a\x20single\x20clone.\x20It\x20is\x20associated\x20with\x20increased\x20osteoclast\x20activity\x20with\x20suppression\x20of\x20osteoblast\x20activity,\x20causing\x20<strong>punched-out\x20lytic</strong>\x20lesions\x20in\x20the\x20bone\x20and\x20hypercalcemia.</p>\x0a<p>Signs\x20and\x20symptoms\x20include\x20bone\x20pain\x20(most\x20common),\x20pathological\x20fractures,\x20recurrent\x20bacterial\x20infections,\x20normocytic\x20normochromic\x20anemia,\x20elevated\x20ESR,\x20and\x20normal\x20ALP.</p>\x0a<p>Electrophoresis\x20shows\x20<strong>monoclonal\x20elevation</strong>\x20of\x20one\x20immunoglobulin\x20<strong>(M\x20spike)</strong></p>\x0a<p>Urine\x20analysis\x20shows\x20free\x20kappa\x20&amp;\x20lambda\x20light\x20chains\x20<strong>(Bence\x20Jones\x20proteins)</strong></p>\x0a<p>Peripheral\x20smear\x20shows\x20<strong>rouleaux</strong>\x20formation.</p>\x0a<p>The\x20diagnosis\x20of\x20MM\x20is\x20made\x20by\x20using\x20the<strong>\x20Revised\x20International\x20Myeloma\x20Working\x20Group\x20criteria.</strong></p>\x0a<p>Clonal\x20bone\x20marrow\x20plasma\x20cells<strong>\x20&ge;10%</strong>\x20(or)\x20Biopsy-proven\x20bony\x20or\x20extramedullary\x20plasmacytoma\x20and\x20any\x20one\x20or\x20more\x20of\x20the\x20following\x20myeloma-defining\x20events\x20is\x20required\x20to\x20meet\x20the\x20criteria:</p>\x0a<p>Evidence\x20of\x20end-organ\x20damage\x20attributable\x20to\x20the\x20underlying\x20plasma\x20cell\x20proliferative\x20disorder,\x20specifically:\x20<strong>(CRAB\x20features)</strong></p>\x0a<ul>\x0a<li><strong>Hypercalcemia</strong>:\x20Serum\x20calcium\x20level\x20&gt;1\x20mg/dL\x20higher\x20than\x20the\x20upper\x20limit\x20of\x20normal\x20or\x20&gt;11\x20mg/dL</li>\x0a<li><strong>Renal\x20insufficiency:</strong>\x20Creatinine\x20clearance\x20&lt;40\x20mL/min\x20or\x20serum\x20creatinine\x20&gt;2\x20mg/dL</li>\x0a<li><strong>Anemia:</strong>\x20Hemoglobin\x20level\x20of\x20&gt;20\x20g/L\x20(2gm/dl)\x20below\x20the\x20lowest\x20limit\x20of\x20normal,\x20or\x20Hb\x20&lt;10\x20g/dL</li>\x0a<li><strong>Bone\x20lesions</strong>:\x20One\x20or\x20more\x20osteolytic\x20lesions\x20on\x20skeletal\x20radiography,\x20computed\x20tomography\x20(CT),\x20or\x20positron\x20emission\x20tomography\x20(PET-CT).</li>\x0a</ul>\x0a<p>Any\x20<strong>one\x20or\x20more</strong>\x20of\x20the\x20following\x20biomarkers\x20of\x20malignancy:</p>\x0a<ul>\x0a<li>Clonal\x20bone\x20marrow\x20plasma\x20cells\x20&ge;60%</li>\x0a<li>Serum\x20involved/uninvolved\x20free\x20light-chain\x20ratio\x20of\x20100\x20or\x20greater</li>\x0a<li>&gt;1\x20focal\x20lesion\x20on\x20magnetic\x20resonance\x20imaging\x20(MRI)\x20that\x20is\x20at\x20least\x205\x20mm\x20or\x20greater\x20in\x20size.</li>\x0a</ul>\x0a<p><strong>Treatment</strong>\x20includes\x20a\x20combination\x20of\x20<strong>lenalidomide/thalidomide</strong>\x20(immunomodulatory\x20agents),\x20<strong>bortezomib</strong>\x20(proteasome\x20inhibitor),\x20and\x20<strong>dexamethasone</strong>.</p>\x0a<p><strong>International\x20Staging\x20System\x20</strong>(ISS)\x20is\x20used\x20for\x20assessing\x20<strong>prognosis</strong>\x20in\x20multiple\x20myeloma\x20patients.<strong>\x20Serum\x20&beta;2-microglobulin</strong>\x20is\x20the\x20most\x20important\x20prognostic\x20marker.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20A:</strong>\x20The\x20bony\x20metastasis\x20in\x20breast\x20carcinoma\x20is\x20usually\x20osteolytic.\x20However,\x20CRAB\x20features,\x20hypoalbuminemia,\x20and\x20elevated\x20total\x20protein\x20suggest\x20multiple\x20myeloma.</p>\x0a<p><strong>Option\x20C:</strong>\x20Primary\x20hyperparathyroidism\x20is\x20characterized\x20by\x20hypercalcemia\x20and\x20low\x20phosphorus\x20but\x20is\x20not\x20associated\x20with\x20anemia\x20and\x20hypoalbuminemia.</p>\x0a<p><strong>Option\x20D:</strong>\x20Milk-alkali\x20syndrome\x20occurs\x20after\x20ingestion\x20of\x20large\x20amounts\x20of\x20calcium\x20and\x20vitamin\x20D\x20supplementation.\x20It\x20results\x20in\x20hypercalcemia,\x20alkalosis,\x20nephrocalcinosis,\x20and\x20nephrolithiasis.</p>','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','yItXG','GWSML','hierarchy','isrpa','totalTime','Mxskd','Not\x20Attempted','3521707kZgXcO','KenEZ','3|1|4|0|5|2','ilcuM','Wilson\x27s\x20disease','correct_choice_id','Option\x20','solutionContainer','Acid-base\x20imbalance\x20is\x20suspected\x20in\x20a\x20patient.\x20Which\x20of\x20the\x20following\x20would\x20you\x20use\x20to\x20determine\x20it?','yNXPe','hdcDf','name','KiEqj','CRSZX','border-red-500','<p>The\x20given\x20clinical\x20scenario\x20describes\x20a\x20patient\x20treated\x20with\x20<strong>steroids</strong>\x20and\x20<strong>remedesivir</strong>\x20for<strong>\x20COVID-19</strong>\x20infection\x20being\x20discharged.\x20This\x20patient\x20should\x20be\x20advised\x20to\x20monitor\x20blood\x20<strong>glucose</strong>\x20levels\x20as\x20steroids\x20can\x20worsen\x20glycemic\x20status.\x20He\x20should\x20be\x20advised\x20to\x20watch\x20for\x20headache,\x20nasal\x20discharge,\x20and\x20sinusitis-like\x20symptoms\x20as\x20there\x20is\x20a\x20higher\x20incidence\x20of\x20<strong>mucormycosis</strong>\x20among\x20COVID\x20patients.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x201:</strong>\x20Repeat\x20RT-PCR\x20after\x207\x20days\x20of\x20discharge\x20is\x20not\x20needed\x20as\x20per\x20the\x20updated\x20discharge\x20criteria.</p>\x0a<p><strong>Option\x202:</strong>\x20Anosmia\x20may\x20persist\x20for\x20weeks\x20to\x20months\x20in\x20those\x20who\x20recovered\x20from\x20COVID-19.\x20Its\x20persistence\x20is\x20not\x20a\x20dangerous\x20sign.</p>\x0a<p><strong>Mucormycosis</strong>\x20is\x20most\x20commonly\x20caused\x20by\x20the\x20fungus\x20<strong>Rhizopus</strong>\x20<strong>oryzae</strong>\x20that\x20is\x20acquired\x20through\x20the\x20inhalation\x20of\x20fungal\x20spores\x20from\x20the\x20air.\x20It\x20may\x20occur\x20during\x20<strong>COVID</strong>\x20infection\x20or\x20after\x20a\x20few\x20weeks\x20(usually\x20around\x20the\x203rd\x20week)\x20of\x20recovery\x20from\x20it.</p>\x0a<p><strong>Risk\x20factors</strong>\x20in\x20COVID-19\x20patients\x20include\x20uncontrolled\x20hyperglycemia,\x20misuse\x20and\x20irrational\x20use\x20of\x20steroids,\x20leukopenia,\x20and\x20unhygienic\x20humidifiers.</p>\x0a<p>Symptoms\x20of\x20rhino-orbital-cerebral\x20mucormycosis\x20include\x20facial\x20pain,\x20facial\x20numbness,\x20brownish\x20or\x20blood-tinged\x20nasal\x20discharge,\x20conjunctival\x20suffusion\x20and\x20swelling,\x20black\x20eschar\x20over\x20the\x20face,\x20and\x20hard\x20palate.</p>\x0a<p>The\x20presence\x20of\x20<strong>bilateral\x20proptosis,\x20chemosis,\x20vision\x20loss,</strong>\x20and\x20<strong>ophthalmoplegia</strong>\x20suggests\x20<strong>cavernous\x20sinus\x20thrombosis</strong>\x20which\x20is\x20seen\x20in\x20advanced\x20disease.</p>\x0a<p>Diagnosis\x20is\x20done\x20by\x20<strong>biopsy</strong>\x20with\x20the\x20<strong>histopathological\x20examination</strong>\x20which\x20shows\x20the\x20presence\x20of\x20<strong>ribbon-like\x20aseptate\x20hyphae</strong>\x20(5-15\x20&micro;\x20thick)\x20<strong>branching</strong>\x20at\x20<strong>right</strong>\x20<strong>angles</strong>.</p>\x0a<p>CT\x20chest\x20in\x20pulmonary\x20mucormycosis\x20may\x20show<strong>\x20lobar\x20consolidation,\x20isolated\x20masses,\x20cavities,\x20nodules,\x20pleural\x20effusion,\x20</strong>or<strong>\x20wedge-shaped\x20infarct.</strong>\x20MRI\x20can\x20be\x20utilized\x20to\x20assess\x20the\x20degree\x20of\x20<strong>orbital\x20</strong>and<strong>\x20brain\x20involvement.</strong></p>\x0a<p>Management\x20includes\x20<strong>strict\x20glycemic\x20control.</strong>\x20<strong>Antifungal\x20therapy</strong>\x20started\x20early\x20on\x20high\x20clinical\x20suspicion\x20even\x20prior\x20to\x20microbiological\x20confirmation\x20can\x20reduce\x20mortality.</p>\x0a<p><strong>Liposomal\x20Amphotericin\x20B</strong>\x20(5-10\x20mg/kg)\x20is\x20the\x20drug\x20of\x20choice\x20and\x20has\x20to\x20be\x20continued\x20for\x203-6\x20weeks.\x20It\x20should\x20be\x20diluted\x20in\x205%\x20dextrose\x20and\x20is\x20incompatible\x20with\x20normal\x20saline\x20and\x20Ringer\x20lactate.\x20Step-down\x20therapy\x20is\x20to\x20be\x20done\x20with\x20<strong>oral</strong>\x20<strong>posaconazole</strong>\x20or\x20<strong>isavuconazole</strong>.\x20<strong>Renal\x20function</strong>\x20must\x20be\x20monitored\x20during\x20the\x20entire\x20treatment\x20period.</p>\x0a<p><strong>Blood\x20vessel\x20thrombosis</strong>\x20and\x20<strong>tissue\x20necrosis</strong>\x20in\x20mucormycosis\x20can\x20lead\x20to\x20limited\x20penetration\x20of\x20antifungal\x20drugs\x20at\x20the\x20infection\x20site.\x20To\x20address\x20this,\x20debridement\x20of\x20necrotic\x20tissues\x20is\x20crucial\x20in\x20eradicating\x20the\x20disease.</p>\x0a<p><strong>Revised\x20discharge\x20policy</strong>\x20for\x20COVID-19:</p>\x0a<p>Mild\x20cases\x20discharged\x20after\x20at\x20least\x207\x20days\x20have\x20passed\x20from\x20testing\x20positive\x20and\x20with\x20no\x20fever\x20for\x203\x20consecutive\x20days.\x20No\x20testing\x20is\x20needed\x20prior\x20to\x20discharge.</p>\x0a<p>For\x20moderate\x20cases,\x20in\x20patients\x20whose\x20signs\x20and\x20symptoms\x20resolve\x20and\x20maintain\x20saturation\x20above\x2093%\x20for\x203\x20consecutive\x20days,\x20patient\x20will\x20be\x20discharged\x20as\x20per\x20the\x20advice\x20of\x20the\x20treating\x20medical\x20officer.\x20No\x20testing\x20is\x20needed\x20prior\x20to\x20discharge.</p>\x0a<p>In\x20severe\x20cases\x20including\x20immunocompromised,\x20discharge\x20criteria\x20will\x20be\x20based\x20on\x20clinical\x20recovery\x20at\x20the\x20discretion\x20of\x20the\x20treating\x20medical\x20officer.</p>','tIudE','nav-btn-marked-review','data-option-index','customQuizData','HScxe','mevwD','qUsiK','open','gFZVU','<p><strong>Non-cardiovascular\x20deaths</strong>\x20are\x20more\x20in\x20heart\x20failure\x20with\x20<strong>preserved</strong>\x20ejection\x20fraction\x20(HFpEF)\x20as\x20compared\x20to\x20heart\x20failure\x20with\x20reduced\x20ejection\x20fraction\x20(HFrEF).</p>\x0a<p><strong>Non-cardiac\x20causes</strong>\x20accounted\x20for\x20<strong>62%</strong>\x20of\x20deaths\x20in\x20HFpEF,\x20<strong>54%</strong>\x20in\x20HFmrEF\x20(heart\x20failure\x20with\x20mildly\x20reduced\x20ejection\x20fraction),\x20and\x20<strong>35%</strong>\x20in\x20HFrEF.\x20Cancer\x20was\x20twice\x20as\x20frequent\x20as\x20a\x20cause\x20of\x20death\x20in\x20HFpEF\x20and\x20HFmrEF\x20versus\x20HFrEF.</p>\x0a<p>Heart\x20failure\x20is\x20divided\x20according\x20to\x20the\x20ejection\x20fraction:</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x2087\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<ul>\x0a<li>Heart\x20failure\x20with\x20<strong>preserved\x20ejection\x20fraction</strong>\x20<strong>(HFpEF)</strong>:\x20Left\x20ventricular\x20ejection\x20fraction\x20is\x20<strong>&gt;40-50%</strong></li>\x0a<li>Heart\x20failure\x20with\x20<strong>reduced\x20ejection\x20fraction\x20(HFrPF):</strong>&nbsp;Left\x20ventricular\x20ejection\x20fraction\x20is\x20<strong>&lt;40%</strong></li>\x0a</ul>\x0a<p>Patients\x20with\x20a\x20left\x20ventricular\x20ejection\x20fraction\x20between\x2040%\x20and\x2050%\x20are\x20considered\x20to\x20have\x20borderline\x20or\x20mid-range\x20EF.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p>Option\x20A:\x20\x27Regardless\x20of\x20the\x20EF\x20and\x20the\x20type\x20of\x20heart\x20failure,\x20the\x205-year\x20mortality\x20rate\x20is\x20around\x2050%\x27\x20is\x20a\x20true\x20statement.\x20The\x20development\x20of\x20symptomatic\x20heart\x20failure\x20has\x20a\x20poor\x20prognosis.\x2030-40%\x20of\x20patients\x20die\x20within\x201\x20year\x20of\x20diagnosis.\x20<strong>More\x20than\x2050%</strong>\x20(60-70%)\x20die\x20within\x205\x20years.</p>\x0a<p>Option\x20C:&nbsp;Angiotensin-converting\x20enzyme\x20(ACE)\x20inhibitors\x20cause\x20cough\x20in\x20<strong>15%</strong>\x20and\x20rashes\x20and\x20angioedema\x20in<strong>\x201%</strong>.\x20ACE\x20inhibitors\x20inhibit\x20the\x20angiotensin-converting\x20enzyme\x20and\x20inhibit\x20the\x20conversion\x20of\x20angiotensin\x20I\x20to\x20angiotensin\x20II.\x20ACE\x20also\x20splits\x20bradykinin,\x20substance\x20P,\x20enkephalins,\x20etc.\x20The\x20bradykinin\x20and\x20substance\x20P\x20which\x20are\x20not\x20broken\x20down\x20lead\x20to\x20cough,\x20urticaria,\x20and\x20rarely\x20angioedema.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20263\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Option\x20D:\x20The\x20prevalence\x20of\x20atrial\x20fibrillation\x20increases\x20with\x20age,\x20and\x20&gt;95%\x20of\x20AF\x20patients\x20are\x20<strong>&gt;60\x20years</strong>\x20of\x20age.\x20Atrial\x20fibrillation\x20increases\x20the\x20risk\x20of\x20stroke\x20by\x20five-fold\x20and\x20is\x20estimated\x20to\x20be\x20the\x20cause\x20of\x20<strong>25%\x20of\x20strokes</strong>.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','green','questionMedia','not-attempted','video[data-src]','custom_quiz.html','oNdQl','history','Non-cardiovascular\x20death\x20is\x20more\x20in\x20HFrEF\x20-30-40%\x20as\x20compared\x20to\x20HFpEF\x20-15%','filter','Candida\x20albicans\x20-\x20Amphotericin\x20B','Ambrisentan','rKvLE','question_video','RFxfT','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','Primary\x20hyperparathyroidism','<p>Among\x20the\x20given\x20options,\x20<strong>subcutaneous\x20injection</strong>\x20of\x20<strong>sumatriptan</strong>\x20<strong>(6\x20mg)</strong>\x20is\x20used\x20in\x20the\x20treatment\x20of\x20an\x20<strong>acute\x20attack\x20</strong>of<strong>\x20cluster\x20headache.</strong></p>\x0a<p>The\x20<strong>treatment\x20of\x20choice</strong>\x20for\x20an\x20acute\x20attack\x20of\x20cluster\x20headache\x20is\x20<strong>100\x20%\x20oxygen</strong>\x20at\x20<strong>10-12\x20L\x20/min.</strong>\x20High\x20flow\x20and\x20high\x20oxygen\x20content\x20are\x20important.\x20100\x20%\x20oxygen\x20at\x20<strong>6\x20or\x208\x20L/min\x20(Options\x20C\x20and\x20D)</strong>\x20is\x20<strong>insufficient</strong>.</p>\x0a<p><strong>Oral\x20sumatriptan\x20(Option\x20A)</strong>\x20is\x20<strong>not</strong>\x20effective\x20for\x20the\x20treatment\x20of\x20acute\x20attack\x20of\x20cluster\x20headaches.</p>\x0a<p><strong>Sumatriptan\x20(20\x20mg)</strong>\x20and\x20<strong>zolmitriptan\x20(5\x20mg)</strong>\x20<strong>nasal\x20spray</strong>\x20and\x20noninvasive\x20vagus\x20nerve\x20stimulation\x20(nVNS)\x20can\x20also\x20be\x20used\x20for\x20the\x20treatment\x20of\x20acute\x20episodes\x20of\x20cluster\x20headaches.</p>\x0a<p><strong>Cluster\x20headache</strong>\x20is\x20a\x20rare\x20primary\x20headache\x20characterized\x20by\x20daily\x20attacks\x20of\x20short-duration\x20unilateral\x20headaches\x20lasting\x20<strong>8-10\x20weeks</strong>\x20a\x20year.\x20It\x20presents\x20as\x20severe,\x20brief\x20(15-180\x20minutes)\x20<strong>unilateral\x20retro-orbital\x20pain</strong>\x20with\x20autonomic\x20features,\x20such\x20as\x20unilateral\x20<strong>lacrimation</strong>,\x20<strong>nasal\x20congestion</strong>,\x20and\x20<strong>conjunctival</strong>\x20<strong>injection</strong>.\x20Patients\x20are\x20usually\x20perfectly\x20well\x20in\x20between\x20episodes.<br\x20/><br\x20/><strong>Verapamil</strong>\x20is\x20the\x20<strong>drug\x20of\x20choice</strong>\x20for\x20<strong>prophylaxis</strong>.\x20Other\x20drugs\x20used\x20are\x20prednisone,\x20topiramate,\x20lithium,\x20gabapentin,\x20melatonin,\x20and\x20greater\x20occipital\x20nerve\x20injection\x20with\x20lidocaine\x20and\x20glucocorticoids.</p>','kIhvR','explanation_video','msJHQ','SzJLF','exception','NJQNx','LadnM','A\x2060-year-old\x20male\x20patient\x20with\x20critical\x20mitral\x20stenosis\x20presented\x20with\x20atrial\x20fibrillation.\x20He\x20has\x20a\x20history\x20of\x20multiple\x20episodes\x20of\x20transient\x20ischemic\x20attacks.\x20Which\x20of\x20the\x20following\x20are\x20true\x20regarding\x20the\x20prevention\x20of\x20stroke\x20in\x20this\x20patient?','modeModal','flex','pgRtr','AFB\x20staining\x20of\x20sputum','mLVla','nav-btn-current','GBS','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','Biopsy\x20to\x20show\x20granuloma','In\x20a\x20PHC,\x20which\x20of\x20the\x20following\x20initial\x20screening\x20tests\x20are\x20used\x20to\x20diagnose\x20diabetes?','UUDME','Treatment\x20of\x20choice\x20for\x20an\x20acute\x20attack\x20of\x20cluster\x20headache\x20is\x20:','solution','A\x2045-year-old\x20male\x20patient\x20presented\x20with\x20a\x20history\x20of\x20bilateral\x20lower\x20limb\x20weakness\x20which\x20progressed\x20to\x20his\x20upper\x20limbs\x20in\x20a\x20year.\x20On\x20examination,\x20he\x20had\x20weakness\x20in\x20both\x20lower\x20limbs\x20and\x20wasting\x20in\x20the\x20left\x20upper\x20limb.\x20Babinski\x20sign\x20was\x20positive\x20and\x20the\x20deep\x20tendon\x20reflexes\x20were\x20absent.\x20He\x20has\x20no\x20sensory\x20loss\x20or\x20any\x20autonomic\x20dysfunction.\x20What\x20is\x20the\x20likely\x20diagnosis?','sMTfz','UTLWA','forEach','ywGBf','IXgWu','Ocrelizumab','DLzFl','Progressive\x20multifocal\x20leukoencephalopathy\x20shows\x20triphasic\x20and\x20slow\x20waves\x20on\x20EEG','Doing\x20EEG\x20is\x20mandatory\x20for\x20diagnosis\x20of\x20seizures','MBqMr','Which\x20of\x20the\x20following\x20drugs\x20is\x20preferred\x20in\x20the\x20management\x20of\x20primary\x20progressive\x20multiple\x20sclerosis\x20?','fpFVx','solutionImages','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','FxuDG','PXcFC','NZRbL','Metastatic\x20breast\x20cancer','kkNRx','MqlAZ','answered','WQWao','IjcwS','rHTuW','XuXaw','gnSYF','yDIyy','timed_study','markReviewText','<p>Statements\x20<strong>2\x20and\x203</strong>\x20are\x20correct.</p>\x0a<p><strong>Novel\x20Oral\x20Anticoagulants\x20(NOACs)</strong>\x20also\x20known\x20as\x20<strong>direct\x20oral\x20anticoagulants</strong>&nbsp;are\x20a\x20new\x20class\x20of\x20anticoagulants\x20that\x20include\x20oral\x20thrombin\x20inhibitor\x20(dabigatran)\x20and\x20oral\x20factor\x20Xa\x20inhibitors\x20like\x20rivaroxaban,\x20apixaban,\x20and\x20edoxaban.\x20They\x20are\x20easier\x20to\x20use,\x20achieve\x20reliable\x20anticoagulation,\x20and\x20do\x20not\x20require\x20dosage\x20adjustment\x20based\x20on\x20blood\x20tests.\x20They\x20have\x20a<strong>\x20lower\x20risk\x20of\x20intracranial\x20hemorrhage</strong>&nbsp;compared\x20to\x20warfarin\x20and\x20are\x20used\x20as\x20alternatives\x20to\x20warfarin\x20for\x20patients\x20who\x20have\x20atrial\x20fibrillation.</p>\x0a<p>Anticoagulation\x20with\x20<strong>warfarin</strong>\x20or\x20<strong>NOACs</strong>\x20should\x20be\x20given\x20in\x20patients\x20with\x20<strong>ischemic\x20stroke\x20due\x20to\x20atrial\x20fibrillation</strong>.\x20In\x20patients\x20with\x20small\x20or\x20moderate-sized\x20infarcts\x20and\x20no\x20intracranial\x20bleeding,\x20<strong>warfarin</strong>\x20can\x20be\x20started\x20soon\x20<strong>(after\x2024\x20hours</strong>)\x20after\x20admission.\x20The\x20risks\x20of\x20transformation\x20to\x20hemorrhagic\x20stroke\x20are\x20minimal.\x20<strong>NOACs</strong>\x20should\x20be\x20started\x20<strong>after\x2048\x20hours</strong>\x20as\x20they\x20have\x20a\x20more\x20rapid\x20anticoagulant\x20effect.</p>\x0a<p>Statement\x203:\x20NOACs\x20are\x20<strong>contraindicated</strong>\x20in\x20patients\x20with<strong>\x20prosthetic\x20mechanical\x20heart\x20valves</strong>\x20due\x20to\x20a\x20lack\x20of\x20sufficient\x20evidence.</p>\x0a<p>Statement\x201:\x20NOACs\x20are\x20<strong>not\x20used</strong>\x20in\x20the\x20treatment\x20of\x20<strong>moderate\x20to\x20severe\x20mitral\x20stenosis</strong>\x20(MS)\x20due\x20to\x20limited\x20clinical\x20evidence\x20supporting\x20their\x20efficacy\x20and\x20safety\x20in\x20MS.&nbsp;<strong>Warfarin</strong>\x20is\x20the\x20recommended\x20anticoagulant\x20for\x20patients\x20with\x20<strong>MS</strong>\x20and\x20<strong>mechanical\x20prosthetic\x20valves.</strong></p>\x0a<p>Statement\x204:\x20<strong>Beta-blockers</strong>\x20and\x20<strong>calcium\x20channel\x20blockers</strong>\x20are\x20the\x20<strong>first\x20line\x20drugs</strong>\x20used\x20to\x20acheive\x20rate\x20control\x20in\x20atrial\x20fibrillation.&nbsp;</p>\x0a<p>&nbsp;</p>','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','width','1,\x20\x202,\x204','hxoMy','trace','Alemtuzumab','pMorK','EnABa','nJOYq','gpmWb','1,\x202,\x203\x20and\x204\x20correct','WXCDo','questions','HLIox','attachMedia','PilMk','wnjxg','12iWhKhH','veyUm','textContent','WXuvX','QEiec'];_0x5131=function(){return _0x5dff1a;};return _0x5131();}function showInlineFeedback(_0x28fc0c){const _0x220d0d=_0xf5d6bd,_0x184228={'IXgWu':_0x220d0d(0x1ba),'sjlhn':function(_0x2e685c,_0x346188){return _0x2e685c===_0x346188;},'hdcDf':_0x220d0d(0x280),'WCVJS':function(_0x243bed,_0x49089d){return _0x243bed!==_0x49089d;},'BCJWT':_0x220d0d(0x33f),'fSNKf':_0x220d0d(0x3bc),'CRSZX':_0x220d0d(0x338)};if(currentMode!==_0x184228[_0x220d0d(0x2ec)]&&_0x184228[_0x220d0d(0x198)](currentMode,_0x184228[_0x220d0d(0x3aa)]))return;const _0x299fa1=document['getElementById'](_0x184228[_0x220d0d(0x228)]),_0x32142b=_0x299fa1[_0x220d0d(0xfa)](_0x220d0d(0x2bd)),_0x24deea=questionsData[currentQuestionIndex],_0x286186=_0x24deea['correct_choice_id'];let _0x47d2a0=_0x24deea[_0x220d0d(0x17b)]['findIndex'](_0x470a73=>_0x470a73['id']===_0x286186);_0x299fa1[_0x220d0d(0x139)][_0x220d0d(0x3b3)](_0x184228[_0x220d0d(0x2ef)]),_0x32142b[_0x220d0d(0x326)]((_0x5e77da,_0x46f03f)=>{const _0x1748ab=_0x220d0d;_0x5e77da[_0x1748ab(0x139)][_0x1748ab(0x39e)](_0x184228[_0x1748ab(0x328)]);if(_0x184228['sjlhn'](_0x46f03f,_0x47d2a0))_0x5e77da[_0x1748ab(0x139)][_0x1748ab(0x3b3)]('correct');else{if(_0x184228[_0x1748ab(0x23a)](_0x46f03f,selectedOption)&&!_0x28fc0c)_0x5e77da[_0x1748ab(0x139)][_0x1748ab(0x3b3)]('incorrect');}}),setTimeout(showSolution,0x5dc);}function showSolution(){const _0x33b9ce=_0xf5d6bd,_0x119c7e={'WCQZR':_0x33b9ce(0x280),'ILDQZ':function(_0x42cb9,_0x4f34a4){return _0x42cb9===_0x4f34a4;},'NGrjQ':_0x33b9ce(0x25f),'UObJr':_0x33b9ce(0x156),'oYyfB':'totalAttempted','faAZa':function(_0x466b5b,_0x519aa6){return _0x466b5b>_0x519aa6;},'uZUav':function(_0x50ee7c,_0x340d03){return _0x50ee7c*_0x340d03;},'Cubda':function(_0x5a8673,_0x4ba844){return _0x5a8673/_0x4ba844;},'LadnM':function(_0x4b388a,_0x59d29c){return _0x4b388a+_0x59d29c;},'qUsiK':function(_0x10cf2d,_0x6ccdae){return _0x10cf2d/_0x6ccdae;},'AMMAs':_0x33b9ce(0x18f),'FuMxW':function(_0x733da9,_0x4d10f6){return _0x733da9+_0x4d10f6;},'FQneT':_0x33b9ce(0x248),'TzWkG':function(_0x5267bd,_0x3b4d57){return _0x5267bd!==_0x3b4d57;},'KiEqj':function(_0x46fa7c,_0x3999e1){return _0x46fa7c!==_0x3999e1;},'WXCDo':_0x33b9ce(0x2ad),'MFTyg':_0x33b9ce(0x26a),'kNupE':function(_0x108e16,_0xff5c4){return _0x108e16===_0xff5c4;},'yItXG':'OzlEc','CrEqh':'kxHYn','idzzV':_0x33b9ce(0x3c2),'ehMlc':function(_0x9fdd36,_0x55c3be){return _0x9fdd36!==_0x55c3be;},'kisgr':_0x33b9ce(0x2ca),'ONVOZ':_0x33b9ce(0x254),'QpVKC':_0x33b9ce(0x27c),'QOBAS':_0x33b9ce(0x247),'twJVw':_0x33b9ce(0x330),'DODkq':function(_0x8dfd3a,_0x575b18){return _0x8dfd3a!==_0x575b18;},'MqlAZ':_0x33b9ce(0x2b0),'HjGNP':_0x33b9ce(0x2e9)};if(_0x119c7e[_0x33b9ce(0x21f)](currentMode,_0x119c7e[_0x33b9ce(0x1ca)])&&_0x119c7e[_0x33b9ce(0x2ee)](currentMode,_0x33b9ce(0x33f)))return;const _0x163cd7=questionsData[currentQuestionIndex];document['getElementById'](_0x119c7e[_0x33b9ce(0x34d)])[_0x33b9ce(0x266)]=_0x163cd7[_0x33b9ce(0x322)]||_0x33b9ce(0x39b);const _0x47a669=document[_0x33b9ce(0x38e)](_0x119c7e['MFTyg']),_0x208a0c=document['getElementById'](_0x33b9ce(0x18b)),_0xf8680a=_0x163cd7[_0x33b9ce(0x30f)];if(_0xf8680a){if(_0x119c7e[_0x33b9ce(0x27a)](_0x119c7e[_0x33b9ce(0x2db)],_0x119c7e['CrEqh'])){if(_0x5706c4===_0x119c7e[_0x33b9ce(0x1ca)]||_0x119c7e[_0x33b9ce(0x3a0)](_0x4b3946,_0x33b9ce(0x33f))){_0x4ddb44[_0x33b9ce(0x38e)](_0x119c7e[_0x33b9ce(0x15b)])[_0x33b9ce(0x355)]=_0xe2ad70[_0x33b9ce(0x370)],_0x40513d[_0x33b9ce(0x38e)](_0x119c7e[_0x33b9ce(0x1f1)])[_0x33b9ce(0x355)]=_0x21fd92[_0x33b9ce(0x217)],_0x2d78af['getElementById'](_0x119c7e[_0x33b9ce(0x1d9)])[_0x33b9ce(0x355)]=_0x52d995[_0x33b9ce(0x2ab)];const _0x4882d7=_0x119c7e[_0x33b9ce(0x274)](_0x46d2f5['totalAttempted'],0x0)?_0x289095[_0x33b9ce(0x2c4)](_0x119c7e[_0x33b9ce(0x275)](_0x119c7e['Cubda'](_0x187a48['correctAnswers'],_0x197f60[_0x33b9ce(0x2ab)]),0x64)):0x0;_0x306dd9[_0x33b9ce(0x38e)](_0x33b9ce(0x2a1))[_0x33b9ce(0x355)]=_0x119c7e[_0x33b9ce(0x314)](_0x4882d7,'%'),_0x3f6e8f[_0x33b9ce(0x2df)]=_0x4b5cf2[_0x33b9ce(0x187)]((_0x2f1563,_0x311c64)=>_0x2f1563+_0x311c64[_0x33b9ce(0x18f)],0x0);const _0x3bfb08=_0x331db7['floor'](_0x119c7e[_0x33b9ce(0x1a9)](_0x14ec80['totalTime'],0x3e8)),_0x2f9536=_0x51c5d0[_0x33b9ce(0x222)](_0x119c7e[_0x33b9ce(0x2f8)](_0x3bfb08,0x3c)),_0xa4f1a=_0x3bfb08%0x3c;_0x1f2399[_0x33b9ce(0x38e)](_0x119c7e[_0x33b9ce(0x23f)])[_0x33b9ce(0x355)]=_0x119c7e[_0x33b9ce(0x314)](_0x119c7e[_0x33b9ce(0x37d)](_0x2f9536,':'),_0xa4f1a['toString']()['padStart'](0x2,'0'));}}else{_0x47a669[_0x33b9ce(0x139)][_0x33b9ce(0x39e)]('hidden');if(_0xf8680a['includes'](_0x119c7e[_0x33b9ce(0x180)]))setupVideo(_0x208a0c,_0xf8680a);else _0x208a0c[_0x33b9ce(0x2a4)]=_0xf8680a;}}else _0x119c7e['ehMlc'](_0x119c7e[_0x33b9ce(0x223)],_0x119c7e[_0x33b9ce(0x223)])?_0x36f11a[_0x33b9ce(0x15e)]['includes'](_0x22cc96[_0x33b9ce(0x101)]()[_0x33b9ce(0x1d1)](/ /g,'-'))&&(_0x433d6b[_0x33b9ce(0x151)]<_0x1c40c8['length']&&(_0x12cdb4[_0x23af31[_0x33b9ce(0x151)]]['bookmarked']=!![])):_0x47a669['classList']['add'](_0x119c7e[_0x33b9ce(0x1e6)]);const _0x38c91c=document[_0x33b9ce(0x38e)](_0x119c7e[_0x33b9ce(0x375)]);_0x38c91c['innerHTML']='';_0x163cd7[_0x33b9ce(0x267)]&&(_0x38c91c[_0x33b9ce(0x266)]+=_0x33b9ce(0x2da)+_0x163cd7[_0x33b9ce(0x267)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');if(_0x163cd7[_0x33b9ce(0x282)]){if(_0x119c7e[_0x33b9ce(0x2ee)](_0x33b9ce(0x247),_0x119c7e[_0x33b9ce(0x221)])){const _0x28b72c=_0x175156[_0x33b9ce(0x299)]['prototype']['bind'](_0x55301b),_0x5b67dd=_0x3f0fc4[_0x313fbe],_0x330664=_0xbf40ae[_0x5b67dd]||_0x28b72c;_0x28b72c['__proto__']=_0x44a82b[_0x33b9ce(0x237)](_0x46ea2f),_0x28b72c['toString']=_0x330664[_0x33b9ce(0x121)][_0x33b9ce(0x237)](_0x330664),_0x35067d[_0x5b67dd]=_0x28b72c;}else _0x38c91c[_0x33b9ce(0x266)]+=_0x33b9ce(0x209)+_0x163cd7['explanation_audio_hin']+_0x33b9ce(0x1fe);}const _0x4abd84=document[_0x33b9ce(0x38e)](_0x119c7e['twJVw']);_0x4abd84[_0x33b9ce(0x266)]='',_0x163cd7[_0x33b9ce(0x28f)]&&(_0x119c7e[_0x33b9ce(0x2ae)](_0x33b9ce(0x38f),_0x119c7e[_0x33b9ce(0x337)])?_0x163cd7[_0x33b9ce(0x28f)][_0x33b9ce(0x326)](_0x332df5=>{const _0x38ef86=_0x33b9ce;if(_0x332df5)_0x4abd84['innerHTML']+=_0x38ef86(0x177)+_0x332df5+_0x38ef86(0x161);}):(_0x286f48=_0x33b9ce(0x265),_0x1dbf78=_0x119c7e[_0x33b9ce(0x1f5)])),document['getElementById'](_0x119c7e[_0x33b9ce(0x1e4)])[_0x33b9ce(0x139)][_0x33b9ce(0x39e)](_0x119c7e[_0x33b9ce(0x1e6)]);}function submitQuiz(){const _0x4c20e8=_0xf5d6bd,_0x56974c={'LUzBn':function(_0x1a10fd,_0x2ea58b){return _0x1a10fd(_0x2ea58b);},'opWKd':_0x4c20e8(0x376),'Bgjtz':'custom_quiz.html','rMqHW':_0x4c20e8(0x2f5),'tXCrp':function(_0x5e65e1,_0x41877c){return _0x5e65e1===_0x41877c;},'AyfqX':_0x4c20e8(0x285),'GYmdd':_0x4c20e8(0x313),'OqDpD':function(_0x46dc2f,_0x5056dc){return _0x46dc2f!==_0x5056dc;},'jvzzJ':function(_0x5e262d,_0x44a1ec){return _0x5e262d===_0x44a1ec;},'BLBkW':_0x4c20e8(0x265),'OSULS':_0x4c20e8(0x19b),'DSKTt':function(_0x3c36f0,_0x5901da){return _0x3c36f0(_0x5901da);},'kkNRx':function(_0x254ae0,_0x97b785){return _0x254ae0-_0x97b785;},'fTocR':function(_0x4ec052,_0x59421e){return _0x4ec052+_0x59421e;},'lXoyI':_0x4c20e8(0x3a1),'TBnpF':function(_0x2d8c17,_0x364a09,_0x196028,_0x5a856a,_0x4a7887){return _0x2d8c17(_0x364a09,_0x196028,_0x5a856a,_0x4a7887);}};if(timer)_0x56974c[_0x4c20e8(0x3b1)](clearInterval,timer);if(!confirm(_0x4c20e8(0x143)))return;isQuizCompleted=!![];let _0x4ff235=0x0,_0x3873f5=0x0;const _0x3cf93d=_0x56974c[_0x4c20e8(0x336)](Date['now'](),quizStartTime);questionsData[_0x4c20e8(0x326)]((_0x1244ab,_0x469021)=>{const _0x5ae390=_0x4c20e8;if(_0x56974c['tXCrp'](_0x56974c[_0x5ae390(0x1b2)],_0x56974c[_0x5ae390(0xff)]))_0x56974c['LUzBn'](_0xc5c3d5,_0x56974c[_0x5ae390(0x279)])&&(_0x28cf8e['location'][_0x5ae390(0x2d8)]['endsWith'](_0x56974c['Bgjtz'])&&_0xa960df[_0x5ae390(0x277)](_0x56974c[_0x5ae390(0x181)]),_0x2b250e[_0x5ae390(0x386)]());else{const _0x4cb410=questionStates[_0x469021];_0x56974c[_0x5ae390(0x3c1)](_0x4cb410['selectedAnswer'],null)&&(_0x56974c[_0x5ae390(0x289)](_0x1244ab[_0x5ae390(0x17b)][_0x4cb410[_0x5ae390(0x2cb)]]['id'],_0x1244ab['correct_choice_id'])?(_0x4ff235++,_0x4cb410['status']=_0x56974c['BLBkW']):(_0x3873f5++,_0x4cb410[_0x5ae390(0x137)]=_0x56974c['OSULS']));}});const _0x2766d9=JSON[_0x4c20e8(0x2d2)](localStorage[_0x4c20e8(0x136)]('quizPerformanceData'))||[];_0x2766d9[_0x4c20e8(0x29d)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x4c20e8(0x1b1)](),'totalTime':_0x3cf93d,'stats':{'correct':_0x4ff235,'incorrect':_0x3873f5,'notAttempted':_0x56974c['kkNRx'](questionsData[_0x4c20e8(0x236)],_0x56974c[_0x4c20e8(0x359)](_0x4ff235,_0x3873f5))}}),localStorage['setItem'](_0x56974c[_0x4c20e8(0x225)],JSON[_0x4c20e8(0x246)](_0x2766d9)),_0x56974c[_0x4c20e8(0x16d)](showPerformanceAnalysis,_0x4ff235,_0x3873f5,_0x56974c[_0x4c20e8(0x336)](questionsData[_0x4c20e8(0x236)],_0x56974c[_0x4c20e8(0x359)](_0x4ff235,_0x3873f5)),_0x3cf93d);}function showPerformanceAnalysis(_0x32039b,_0x5c64e9,_0x30da26,_0x56dcbe){const _0x33ff9f=_0xf5d6bd,_0x198434={'sWgcx':_0x33ff9f(0x1b6),'EnABa':function(_0x3738e8,_0x1d54bd){return _0x3738e8>_0x1d54bd;},'VqbnK':function(_0x40e0e4,_0x2e2024){return _0x40e0e4/_0x2e2024;},'nCkcC':function(_0x5d1608,_0x416fc2){return _0x5d1608+_0x416fc2;},'sMdmR':function(_0x4b96ed,_0x32f694){return _0x4b96ed*_0x32f694;},'oNdQl':function(_0x196754,_0x4a35b8){return _0x196754*_0x4a35b8;},'sCBVp':'scoreCircle','ASUSE':function(_0x2bf138,_0x3303c2){return _0x2bf138-_0x3303c2;},'JxtaI':function(_0x352048,_0x413ae7){return _0x352048/_0x413ae7;},'WQWao':'accuracyScore','qzWTy':_0x33ff9f(0x35e),'KvNbo':_0x33ff9f(0x28b),'KpNzn':_0x33ff9f(0x28d),'OsIxN':_0x33ff9f(0x13c),'mLVla':function(_0x333e2b,_0x266edb){return _0x333e2b%_0x266edb;},'LgBbR':_0x33ff9f(0x243),'frnyp':function(_0x3e9aae,_0x2d2a42){return _0x3e9aae/_0x2d2a42;},'gpmWb':_0x33ff9f(0x3c3)},_0x45b782=document[_0x33ff9f(0x38e)](_0x198434[_0x33ff9f(0x18c)]),_0x1115db=_0x198434[_0x33ff9f(0x349)](_0x32039b+_0x5c64e9,0x0)?Math[_0x33ff9f(0x2c4)](_0x198434[_0x33ff9f(0x381)](_0x32039b,_0x198434['nCkcC'](_0x32039b,_0x5c64e9))*0x64):0x0,_0x2c69b4=_0x198434['sMdmR'](_0x198434[_0x33ff9f(0x301)](0x2,Math['PI']),0x41),_0x33fdf1=document['getElementById'](_0x198434[_0x33ff9f(0x398)]);_0x33fdf1[_0x33ff9f(0x189)][_0x33ff9f(0xfc)]=_0x2c69b4+'\x20'+_0x2c69b4,_0x33fdf1[_0x33ff9f(0x189)][_0x33ff9f(0x1ef)]=_0x198434[_0x33ff9f(0x1a8)](_0x2c69b4,_0x198434[_0x33ff9f(0x29c)](_0x1115db,0x64)*_0x2c69b4),document['getElementById'](_0x198434[_0x33ff9f(0x339)])[_0x33ff9f(0x355)]=_0x1115db+'%',document['getElementById'](_0x198434[_0x33ff9f(0x2a6)])['textContent']=questionsData[_0x33ff9f(0x236)],document[_0x33ff9f(0x38e)](_0x198434[_0x33ff9f(0x1eb)])['textContent']=_0x32039b,document['getElementById'](_0x198434[_0x33ff9f(0x35f)])[_0x33ff9f(0x355)]=_0x5c64e9,document[_0x33ff9f(0x38e)](_0x198434[_0x33ff9f(0x1e7)])[_0x33ff9f(0x355)]=_0x30da26;const _0xcfb03e=Math[_0x33ff9f(0x222)](_0x198434['VqbnK'](_0x56dcbe,0xea60)),_0xa74e6e=Math[_0x33ff9f(0x222)](_0x198434[_0x33ff9f(0x31a)](_0x56dcbe,0xea60)/0x3e8);document[_0x33ff9f(0x38e)](_0x198434[_0x33ff9f(0x10b)])[_0x33ff9f(0x355)]=_0xcfb03e+':'+_0xa74e6e[_0x33ff9f(0x121)]()[_0x33ff9f(0x1bf)](0x2,'0');const _0x56e4eb=_0x198434['VqbnK'](_0x56dcbe,questionsData[_0x33ff9f(0x236)]),_0x17d794=Math[_0x33ff9f(0x222)](_0x56e4eb/0xea60),_0x2c7fb0=Math[_0x33ff9f(0x222)](_0x198434[_0x33ff9f(0x226)](_0x56e4eb%0xea60,0x3e8));document['getElementById'](_0x198434[_0x33ff9f(0x34b)])[_0x33ff9f(0x355)]=_0x17d794+':'+_0x2c7fb0[_0x33ff9f(0x121)]()[_0x33ff9f(0x1bf)](0x2,'0'),_0x45b782['classList'][_0x33ff9f(0x39e)](_0x33ff9f(0x254));}function closePerformanceModal(){const _0x980d4e=_0xf5d6bd,_0x100442={'msJHQ':_0x980d4e(0x254)};document['getElementById'](_0x980d4e(0x1b6))[_0x980d4e(0x139)][_0x980d4e(0x3b3)](_0x100442[_0x980d4e(0x310)]);}function reviewQuestions(){const _0x13e292=_0xf5d6bd,_0x5b7944={'VlmlV':function(_0x1aea23,_0x5558dd){return _0x1aea23-_0x5558dd;},'HLIox':_0x13e292(0x3ab),'dSkwa':_0x13e292(0x2f7),'Mxskd':function(_0x586cfb,_0x3f387c){return _0x586cfb===_0x3f387c;},'ajUfB':_0x13e292(0x27b),'SFRxf':_0x13e292(0x2e1),'vhILK':function(_0xaf2eff,_0x31507d){return _0xaf2eff!==_0x31507d;},'ouLWT':'correct','MTkZk':'Correct','PuXMD':_0x13e292(0x19b),'DtdKf':'Incorrect','NRfGy':'div','HCByh':function(_0x5a4945,_0x36451e){return _0x5a4945+_0x36451e;},'fpFVx':_0x13e292(0x2fc),'uoemb':_0x13e292(0x1d4),'SOEci':_0x13e292(0x3be),'wiqcY':_0x13e292(0x254),'veQof':_0x13e292(0x3a2)};document[_0x13e292(0x38e)](_0x5b7944[_0x13e292(0x39c)])[_0x13e292(0x139)]['remove'](_0x5b7944[_0x13e292(0x10d)]);const _0x311a73=document[_0x13e292(0x38e)](_0x5b7944[_0x13e292(0x17a)]);_0x311a73[_0x13e292(0x266)]='',questionsData[_0x13e292(0x326)]((_0x1a6992,_0x4d1b46)=>{const _0x30a285=_0x13e292,_0xd02d46={'OZKei':function(_0x3ca3af,_0x15140f){const _0x1261b0=_0x2d0e;return _0x5b7944[_0x1261b0(0x260)](_0x3ca3af,_0x15140f);},'GwnUu':_0x5b7944[_0x30a285(0x34f)],'sFwJv':_0x5b7944['dSkwa'],'ohRaA':function(_0x44d3d5,_0xa76d54){const _0x310961=_0x30a285;return _0x5b7944[_0x310961(0x2e0)](_0x44d3d5,_0xa76d54);},'RpIvz':_0x5b7944[_0x30a285(0x22f)],'RGyfk':_0x30a285(0x2f0),'zkSHr':function(_0x4f1a2e,_0x53f7cd){return _0x4f1a2e+_0x53f7cd;}},_0x3f9304=questionStates[_0x4d1b46],_0x18c6d0=_0x1a6992[_0x30a285(0x2e7)];let _0x39332a=_0x30a285(0x2fe),_0x17503b=_0x5b7944[_0x30a285(0x116)];if(_0x5b7944[_0x30a285(0x262)](_0x3f9304[_0x30a285(0x2cb)],null)){const _0x12b8e6=_0x1a6992['choices'][_0x3f9304[_0x30a285(0x2cb)]];_0x12b8e6['id']===_0x18c6d0?(_0x39332a=_0x5b7944[_0x30a285(0x133)],_0x17503b=_0x5b7944[_0x30a285(0x179)]):(_0x39332a=_0x5b7944['PuXMD'],_0x17503b=_0x5b7944[_0x30a285(0x273)]);}const _0x3c5138=document[_0x30a285(0x11e)](_0x5b7944[_0x30a285(0x3b5)]);_0x3c5138[_0x30a285(0x2c9)]='review-question\x20'+_0x39332a;let _0x48dd3a=(_0x1a6992[_0x30a285(0x17b)]||[])[_0x30a285(0x115)]((_0x3e511e,_0x4bedf9)=>{const _0x1824a3=_0x30a285;if(_0xd02d46[_0x1824a3(0x218)]!==_0xd02d46['sFwJv']){const _0x2649e5=_0xd02d46[_0x1824a3(0x1a1)](_0x3f9304[_0x1824a3(0x2cb)],_0x4bedf9),_0x3f54dd=_0xd02d46[_0x1824a3(0x1a1)](_0x3e511e['id'],_0x18c6d0);let _0x1c46e8='border-gray-600';if(_0x3f54dd)_0x1c46e8=_0xd02d46[_0x1824a3(0x13b)];else{if(_0x2649e5)_0x1c46e8=_0xd02d46[_0x1824a3(0x2ac)];}return'<div\x20class=\x22p-3\x20rounded-lg\x20border\x20'+_0x1c46e8+_0x1824a3(0x342)+String['fromCharCode'](_0xd02d46[_0x1824a3(0x13e)](0x41,_0x4bedf9))+'</span><span>'+_0x3e511e[_0x1824a3(0x380)]+'</span></div>';}else _0x47a319[_0x3e9a85]['timeSpent']+=_0xd02d46[_0x1824a3(0x272)](_0x19a512[_0x1824a3(0x1b1)](),_0x3271b5);})[_0x30a285(0x3b0)]('');const _0x26a9fd=_0x1a6992[_0x30a285(0x30f)]?_0x30a285(0x100)+_0x4d1b46+_0x30a285(0x2c3)+_0x1a6992[_0x30a285(0x30f)]+_0x30a285(0x2bf):'';let _0x55c1bd='';if(_0x1a6992[_0x30a285(0x267)])_0x55c1bd+=_0x30a285(0x1d7)+_0x1a6992[_0x30a285(0x267)]+_0x30a285(0x1fe);if(_0x1a6992[_0x30a285(0x282)])_0x55c1bd+=_0x30a285(0x249)+_0x1a6992[_0x30a285(0x282)]+_0x30a285(0x1fe);let _0x25fbc1=(_0x1a6992['explanation_images']||[])[_0x30a285(0x115)](_0x1f52ef=>_0x1f52ef?_0x30a285(0x177)+_0x1f52ef+_0x30a285(0x161):'')[_0x30a285(0x3b0)]('');_0x3c5138[_0x30a285(0x266)]=_0x30a285(0x2c1)+_0x5b7944[_0x30a285(0x155)](_0x4d1b46,0x1)+_0x30a285(0x12c)+(_0x5b7944[_0x30a285(0x2e0)](_0x39332a,_0x5b7944[_0x30a285(0x133)])?_0x5b7944[_0x30a285(0x32f)]:_0x5b7944[_0x30a285(0x2e0)](_0x39332a,_0x5b7944['PuXMD'])?_0x5b7944[_0x30a285(0x129)]:_0x30a285(0x378))+_0x30a285(0x258)+_0x17503b+_0x30a285(0x21b)+_0x1a6992[_0x30a285(0x380)]+_0x30a285(0x298)+_0x48dd3a+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>'+(_0x1a6992[_0x30a285(0x322)]||_0x30a285(0x3a8))+_0x30a285(0x36d)+_0x26a9fd+_0x30a285(0xf8)+_0x55c1bd+_0x30a285(0xf8)+_0x25fbc1+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x311a73[_0x30a285(0x214)](_0x3c5138);}),initializeReviewVideos();}function initializeReviewVideos(){const _0x279716=_0xf5d6bd,_0x3bc9c8={'EuYsV':'nav-btn-bookmarked','SzJLF':'.m3u8','ycAbp':_0x279716(0x1d5),'UdihZ':_0x279716(0x36a),'toiDa':function(_0x2699fd,_0x57e35b,_0x5399c4){return _0x2699fd(_0x57e35b,_0x5399c4);},'nvMRW':_0x279716(0x2ff)};document[_0x279716(0xfa)](_0x3bc9c8['nvMRW'])[_0x279716(0x326)](_0x4b3a90=>{const _0x134438=_0x279716,_0x5b2b15=_0x4b3a90['dataset'][_0x134438(0x2a4)];if(_0x5b2b15&&_0x5b2b15[_0x134438(0x24d)](_0x3bc9c8[_0x134438(0x311)]))_0x3bc9c8[_0x134438(0x149)]===_0x3bc9c8[_0x134438(0x293)]?_0x4c9176=_0x3bc9c8[_0x134438(0x288)]:_0x3bc9c8['toiDa'](setupVideo,_0x4b3a90,_0x5b2b15);else _0x5b2b15&&(_0x4b3a90[_0x134438(0x2a4)]=_0x5b2b15);});}function retakeQuiz(){const _0x305f28=_0xf5d6bd,_0x494f9a={'eYqSH':'custom_quiz.html','PilMk':_0x305f28(0x2f5)};confirm(_0x305f28(0x376))&&(window[_0x305f28(0x12b)][_0x305f28(0x2d8)][_0x305f28(0x362)](_0x494f9a[_0x305f28(0x21e)])&&localStorage['removeItem'](_0x494f9a[_0x305f28(0x351)]),location[_0x305f28(0x386)]());}function loadBookmarkedQuestions(){const _0x3f9454=_0xf5d6bd,_0x5c08d8={'HmlJK':'selected','DNChm':function(_0x1be414,_0x3308ee){return _0x1be414+_0x3308ee;},'QCRLp':_0x3f9454(0x2e8),'VVpAN':function(_0x523248,_0x55a89d){return _0x523248!==_0x55a89d;},'ffQmF':_0x3f9454(0x35c),'ysoSZ':function(_0x274276,_0x5ca76f){return _0x274276<_0x5ca76f;},'VtFoc':function(_0x43dbe6,_0x40f254){return _0x43dbe6===_0x40f254;},'nJOYq':'mOgwb','Erykt':_0x3f9454(0x256),'dNpoC':'bookmarkedQuestions'},_0x3d8dd2=JSON[_0x3f9454(0x2d2)](localStorage[_0x3f9454(0x136)](_0x5c08d8['dNpoC']))||[];_0x3d8dd2[_0x3f9454(0x326)](_0xec099=>{const _0xb5160f=_0x3f9454,_0x3e80a5={'ZHpbi':function(_0x467948){return _0x467948();},'ClsEo':_0x5c08d8[_0xb5160f(0x3c6)],'isrpa':function(_0x3c21cf,_0x244431){const _0xe41eb9=_0xb5160f;return _0x5c08d8[_0xe41eb9(0x287)](_0x3c21cf,_0x244431);},'djBoe':_0x5c08d8[_0xb5160f(0x14c)]};if(_0xec099[_0xb5160f(0x15e)][_0xb5160f(0x24d)](quizName['toLowerCase']()[_0xb5160f(0x1d1)](/ /g,'-'))){if(_0x5c08d8[_0xb5160f(0x208)](_0x5c08d8['ffQmF'],_0xb5160f(0x35c)))_0x3e80a5['ZHpbi'](_0x2708ba);else{if(_0x5c08d8['ysoSZ'](_0xec099['questionIndex'],questionsData[_0xb5160f(0x236)])){if(_0x5c08d8[_0xb5160f(0x36e)](_0x5c08d8[_0xb5160f(0x34a)],_0x5c08d8['Erykt'])){const _0x29d75c=_0x4f2d73[_0xb5160f(0x1ad)](0x41+_0x63fde2),_0x10b39e=_0x1bdc2f===_0x2051ba,_0x51ae53=_0x2b93d['createElement']('div');_0x51ae53['innerHTML']=_0xb5160f(0x296)+(_0x10b39e?_0x3e80a5[_0xb5160f(0x1e2)]:'')+'\x22\x20data-option-index=\x22'+_0x58fc7e+_0xb5160f(0x202)+_0x29d75c+_0xb5160f(0x16a)+(_0x58912d[_0xb5160f(0x380)]||_0x3e80a5[_0xb5160f(0x2de)](_0x3e80a5[_0xb5160f(0x1ed)],_0x5c03b5+0x1))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x2cca9e[_0xb5160f(0x214)](_0x51ae53);}else questionStates[_0xec099[_0xb5160f(0x151)]][_0xb5160f(0x17e)]=!![];}}}});}function toggleBookmark(){const _0x2a6bc7=_0xf5d6bd,_0x582bce={'iTvxM':'bookmarkedQuestions','HbOXA':function(_0x2b5cc9){return _0x2b5cc9();}},_0x22845e=!questionStates[currentQuestionIndex]['bookmarked'];questionStates[currentQuestionIndex][_0x2a6bc7(0x17e)]=_0x22845e;let _0x3c1d4f=JSON['parse'](localStorage[_0x2a6bc7(0x136)](_0x582bce[_0x2a6bc7(0x182)]))||[];if(_0x22845e){const _0x187ea7={'quizName':quizName,'quizFile':window[_0x2a6bc7(0x12b)][_0x2a6bc7(0x2d8)][_0x2a6bc7(0x3bb)]('/')[_0x2a6bc7(0x24f)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x2a6bc7(0x1b1)]()};_0x3c1d4f['push'](_0x187ea7);}else _0x3c1d4f=_0x3c1d4f[_0x2a6bc7(0x304)](_0x15c560=>!(_0x15c560[_0x2a6bc7(0x15e)][_0x2a6bc7(0x24d)](quizName[_0x2a6bc7(0x101)]()['replace'](/ /g,'-'))&&_0x15c560[_0x2a6bc7(0x151)]===currentQuestionIndex));localStorage[_0x2a6bc7(0x14f)](_0x582bce[_0x2a6bc7(0x182)],JSON[_0x2a6bc7(0x246)](_0x3c1d4f)),_0x582bce[_0x2a6bc7(0x22e)](updateBookmarkButton),_0x582bce[_0x2a6bc7(0x22e)](updateQuestionNav);}function updateBookmarkButton(){const _0x4440c0=_0xf5d6bd,_0x21a7ea={'tCbQL':_0x4440c0(0x1d6),'TBvOK':_0x4440c0(0x204),'cXKua':_0x4440c0(0x24a)},_0x3ffa79=document['getElementById'](_0x21a7ea['tCbQL']),_0x2760a1=document['getElementById'](_0x4440c0(0x14a)),_0x1a69f8=questionStates[currentQuestionIndex][_0x4440c0(0x17e)];_0x3ffa79[_0x4440c0(0x2c9)]=_0x1a69f8?_0x4440c0(0x331):_0x21a7ea[_0x4440c0(0x203)],_0x2760a1[_0x4440c0(0x355)]=_0x1a69f8?_0x4440c0(0x295):_0x21a7ea[_0x4440c0(0x144)];}function toggleMarkForReview(){const _0x5e179b=_0xf5d6bd,_0x2c77ba={'acMQW':function(_0x27310f){return _0x27310f();}};questionStates[currentQuestionIndex][_0x5e179b(0x245)]=!questionStates[currentQuestionIndex][_0x5e179b(0x245)],updateMarkReviewButton(),_0x2c77ba['acMQW'](updateQuestionNav);}function updateMarkReviewButton(){const _0x56a542=_0xf5d6bd,_0x580487={'DLzFl':_0x56a542(0x10a),'baXGC':_0x56a542(0x340),'WKCaZ':_0x56a542(0x30b),'rVukw':_0x56a542(0x31d),'xwmQX':_0x56a542(0x1dc)},_0x4a1a4b=document[_0x56a542(0x38e)](_0x580487[_0x56a542(0x32a)]),_0x2fd7f7=document['getElementById'](_0x580487[_0x56a542(0x39f)]),_0x202ba3=questionStates[currentQuestionIndex]['markedForReview'];_0x4a1a4b[_0x56a542(0x2c9)]=_0x202ba3?_0x580487[_0x56a542(0x1c3)]:_0x580487['rVukw'],_0x2fd7f7[_0x56a542(0x355)]=_0x202ba3?'Marked':_0x580487[_0x56a542(0x211)];}function previousQuestion(){const _0xd49c5c=_0xf5d6bd,_0x4d08f5={'sDQFA':function(_0x569a00,_0x5aa457){return _0x569a00>_0x5aa457;},'Cfzsf':function(_0x3f29a4,_0x244ceb){return _0x3f29a4-_0x244ceb;},'QIfAe':function(_0x9e4d1b){return _0x9e4d1b();}};_0x4d08f5[_0xd49c5c(0x105)](currentQuestionIndex,0x0)&&(questionStartTime&&(questionStates[currentQuestionIndex][_0xd49c5c(0x18f)]+=_0x4d08f5['Cfzsf'](Date[_0xd49c5c(0x1b1)](),questionStartTime)),currentQuestionIndex--,_0x4d08f5[_0xd49c5c(0x114)](displayQuestion));}function nextQuestion(){const _0x18a4cd=_0xf5d6bd,_0x8b5ef9={'WKAzK':_0x18a4cd(0x10a),'kmRVj':_0x18a4cd(0x340),'fasAz':'gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','cicYu':_0x18a4cd(0x23b),'MRxpy':_0x18a4cd(0x1dc),'dvsne':_0x18a4cd(0x3c2),'sOVuq':'video[data-src]','FmfBr':function(_0x27d9bc,_0x28b372){return _0x27d9bc===_0x28b372;},'UUDME':_0x18a4cd(0x1d3),'adAWD':_0x18a4cd(0x1be),'dFJqz':function(_0x87dc69,_0x164a16){return _0x87dc69-_0x164a16;},'KGBcn':function(_0x45beed,_0x4be377){return _0x45beed<_0x4be377;},'SEAqi':function(_0x596527,_0x16faf5){return _0x596527!==_0x16faf5;},'ChlDd':_0x18a4cd(0x32d),'RFxfT':_0x18a4cd(0xfd),'Kobuz':'wTOVD','HqWHj':function(_0x313c19,_0x17c9f9){return _0x313c19===_0x17c9f9;},'lrnuk':'test','aEIkG':function(_0x49957b){return _0x49957b();},'GkMzg':function(_0x912eea,_0x427016){return _0x912eea(_0x427016);},'etOky':_0x18a4cd(0x1b4),'GcLXb':'clYjV','tIHAS':function(_0x551fb1){return _0x551fb1();}};if(questionStartTime){if(_0x8b5ef9[_0x18a4cd(0x216)](_0x8b5ef9[_0x18a4cd(0x320)],_0x8b5ef9['adAWD'])){const _0x55dc9f=_0x24ea1c['getElementById'](_0x8b5ef9[_0x18a4cd(0x2b2)]),_0x12eb72=_0x434c5b['getElementById'](_0x8b5ef9['kmRVj']),_0x413bd0=_0x5effa1[_0x478c26][_0x18a4cd(0x245)];_0x55dc9f[_0x18a4cd(0x2c9)]=_0x413bd0?_0x8b5ef9[_0x18a4cd(0x165)]:_0x18a4cd(0x31d),_0x12eb72['textContent']=_0x413bd0?_0x8b5ef9[_0x18a4cd(0x148)]:_0x8b5ef9['MRxpy'];}else questionStates[currentQuestionIndex][_0x18a4cd(0x18f)]+=_0x8b5ef9['dFJqz'](Date['now'](),questionStartTime);}if(_0x8b5ef9[_0x18a4cd(0x119)](currentQuestionIndex,questionsData[_0x18a4cd(0x236)]-0x1))_0x8b5ef9[_0x18a4cd(0x35d)](_0x8b5ef9[_0x18a4cd(0x26f)],_0x8b5ef9[_0x18a4cd(0x309)])?(currentQuestionIndex++,displayQuestion()):_0x5e7124['querySelectorAll'](_0x8b5ef9[_0x18a4cd(0x141)])[_0x18a4cd(0x326)](_0x126ac4=>{const _0x586881=_0x18a4cd,_0x250133=_0x126ac4[_0x586881(0x371)][_0x586881(0x2a4)];if(_0x250133&&_0x250133['includes'](_0x8b5ef9['dvsne']))_0x46fa73(_0x126ac4,_0x250133);else _0x250133&&(_0x126ac4[_0x586881(0x2a4)]=_0x250133);});else{if(_0x8b5ef9[_0x18a4cd(0x216)](_0x18a4cd(0x220),_0x8b5ef9[_0x18a4cd(0xf9)]))_0x15638c[_0x5ea831[_0x18a4cd(0x151)]]['bookmarked']=!![];else{if(_0x8b5ef9['HqWHj'](currentMode,_0x8b5ef9['lrnuk'])||_0x8b5ef9['FmfBr'](currentMode,_0x18a4cd(0x3a9)))confirm('You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?')&&_0x8b5ef9[_0x18a4cd(0x185)](submitQuiz);else{if(_0x8b5ef9[_0x18a4cd(0x1f9)](confirm,_0x8b5ef9[_0x18a4cd(0x35a)])){if(_0x8b5ef9[_0x18a4cd(0x242)]!==_0x8b5ef9['GcLXb']){const _0x2239a2={'quizName':_0x557f43,'quizFile':_0x2a6288['location']['pathname'][_0x18a4cd(0x3bb)]('/')[_0x18a4cd(0x24f)](),'questionIndex':_0x515e53,'question':_0x2a1d09[_0x4da1db],'hierarchy':_0x43204e,'timestamp':_0x1f8009[_0x18a4cd(0x1b1)]()};_0x3025f0[_0x18a4cd(0x29d)](_0x2239a2);}else currentQuestionIndex=0x0,_0x8b5ef9[_0x18a4cd(0x201)](displayQuestion);}}}}}function startTimer(){const _0x3f809d=_0xf5d6bd,_0x3f9cce={'GGRwI':'hidden','RcFVq':_0x3f809d(0x110),'cthEl':function(_0x1c6778,_0x4252cb){return _0x1c6778<_0x4252cb;},'YwVjq':function(_0x11b91a,_0x381943){return _0x11b91a+_0x381943;},'xrWSM':_0x3f809d(0x172),'LafAF':function(_0x4f2016){return _0x4f2016();},'yJnfQ':_0x3f809d(0x2bd),'gnSYF':function(_0x131db0,_0x13a914){return _0x131db0(_0x13a914);},'ReLUw':_0x3f809d(0x2f4),'zbCIH':function(_0x1c3788,_0x40e639){return _0x1c3788(_0x40e639);},'zNpqe':function(_0x18c83a){return _0x18c83a();},'jTVnw':function(_0x2624b2,_0x400513){return _0x2624b2<=_0x400513;},'pMJzc':function(_0x2ee53a,_0x242ab3){return _0x2ee53a===_0x242ab3;},'mZYOa':_0x3f809d(0x166),'zQjLP':_0x3f809d(0x3a9),'AqKHs':function(_0x11b299,_0x44f598){return _0x11b299===_0x44f598;},'xrLGs':_0x3f809d(0x366),'UYCJI':'BdCZS','GOTHW':_0x3f809d(0x1c5),'RVmDL':_0x3f809d(0xfe),'JQHhW':function(_0x582a0e){return _0x582a0e();},'kkRie':function(_0x2749a9,_0x275ac9){return _0x2749a9(_0x275ac9);},'KKMpN':function(_0x44d79f){return _0x44d79f();},'JpDRn':function(_0x154bf7,_0x23c1bd,_0x323ce3){return _0x154bf7(_0x23c1bd,_0x323ce3);}};if(timer)_0x3f9cce[_0x3f809d(0x176)](clearInterval,timer);timeRemaining=0x78,_0x3f9cce[_0x3f809d(0x1e9)](updateTimerDisplay),timer=_0x3f9cce[_0x3f809d(0x2cd)](setInterval,()=>{const _0x4a498e=_0x3f809d;timeRemaining--,_0x3f9cce['zNpqe'](updateTimerDisplay);if(_0x3f9cce[_0x4a498e(0x379)](timeRemaining,0x0)){if(_0x3f9cce[_0x4a498e(0x1fb)](_0x3f9cce[_0x4a498e(0x360)],_0x3f9cce[_0x4a498e(0x360)])){clearInterval(timer);if(currentMode===_0x3f9cce[_0x4a498e(0x16e)])_0x3f9cce['AqKHs'](_0x3f9cce[_0x4a498e(0x219)],_0x3f9cce[_0x4a498e(0x192)])?_0x59d8b9[_0x4a498e(0x139)][_0x4a498e(0x3b3)](_0x3f9cce[_0x4a498e(0x184)]):submitQuiz();else{if(_0x3f9cce[_0x4a498e(0x1fb)](_0x3f9cce[_0x4a498e(0x186)],_0x3f9cce['RVmDL'])){const _0x372464=_0x45770f[_0x4a498e(0x38e)](_0x3f9cce[_0x4a498e(0x19c)]);_0x372464['innerHTML']='';for(let _0x5f0788=0x0;_0x3f9cce['cthEl'](_0x5f0788,_0x1797d6[_0x4a498e(0x236)]);_0x5f0788++){const _0x3b95c3=_0x4c40bb[_0x4a498e(0x11e)](_0x4a498e(0x1e1));_0x3b95c3[_0x4a498e(0x355)]=_0x3f9cce[_0x4a498e(0x2d3)](_0x5f0788,0x1),_0x3b95c3[_0x4a498e(0x2c9)]=_0x3f9cce[_0x4a498e(0x160)],_0x3b95c3[_0x4a498e(0x3a3)]=()=>_0x3a0bcb(_0x5f0788),_0x3b95c3['id']=_0x4a498e(0x140)+_0x5f0788,_0x372464[_0x4a498e(0x214)](_0x3b95c3);}_0x3f9cce[_0x4a498e(0x1f8)](_0x50a996);}else _0x3f9cce[_0x4a498e(0x20d)](nextQuestion);}}else{const _0x1a4623=_0x438cf7['target'][_0x4a498e(0x383)](_0x3f9cce[_0x4a498e(0x3a4)]);if(_0x1a4623){const _0x5d1c8b=_0x3f9cce[_0x4a498e(0x33d)](_0x47fee7,_0x1a4623['getAttribute'](_0x3f9cce['ReLUw']));_0x3f9cce['zbCIH'](_0x2ed56d,_0x5d1c8b);}}}},0x3e8);}function updateTimerDisplay(){const _0x5288b3=_0xf5d6bd,_0x5163bc={'xuTOA':function(_0x33c88d,_0x23b332){return _0x33c88d/_0x23b332;},'XvvKy':function(_0x50b32c,_0x14ba80){return _0x50b32c%_0x14ba80;},'qfMtm':_0x5288b3(0x17f),'GcCAR':function(_0x49d6d0,_0x262fdd){return _0x49d6d0+_0x262fdd;}},_0x3a4816=Math['floor'](_0x5163bc[_0x5288b3(0x26e)](timeRemaining,0x3c)),_0x1e4598=_0x5163bc['XvvKy'](timeRemaining,0x3c);document[_0x5288b3(0x38e)](_0x5163bc['qfMtm'])['textContent']=_0x5163bc['GcCAR'](_0x3a4816+':',_0x1e4598['toString']()[_0x5288b3(0x1bf)](0x2,'0'));}function toggleSidebar(){const _0x1e163a=_0xf5d6bd,_0x45d998={'DfFbP':'quizSidebar','UTLWA':_0x1e163a(0x2f9)};document[_0x1e163a(0x38e)](_0x45d998['DfFbP'])['classList']['toggle'](_0x45d998[_0x1e163a(0x325)]);}document['addEventListener'](_0xf5d6bd(0x1c0),()=>{const _0x2af2f6=_0xf5d6bd,_0x3cfb57={'kDheU':_0x2af2f6(0x316),'fQuwp':_0x2af2f6(0x317),'gREQu':function(_0x380470){return _0x380470();}};!window[_0x2af2f6(0x12b)][_0x2af2f6(0x2d8)][_0x2af2f6(0x362)](_0x2af2f6(0x300))?document['getElementById'](_0x3cfb57['kDheU'])[_0x2af2f6(0x189)][_0x2af2f6(0x162)]=_0x3cfb57[_0x2af2f6(0x111)]:_0x3cfb57[_0x2af2f6(0x388)](initializeQuiz);}),document[_0xf5d6bd(0x390)](_0xf5d6bd(0x257),function(_0x50fc46){const _0x334c81=_0xf5d6bd,_0x36ec5d={'bifJM':_0x334c81(0x31b),'jassV':function(_0x3a1069,_0x56d860){return _0x3a1069(_0x56d860);},'XAHLA':function(_0x70af84,_0x4fdf0f){return _0x70af84+_0x4fdf0f;},'nAJTO':_0x334c81(0x1cc),'cTJts':function(_0x5cddb4,_0x5a1c90){return _0x5cddb4!==_0x5a1c90;},'MOjKp':_0x334c81(0x316),'WNfTE':'none','MlKZY':'performanceModal','BXELQ':_0x334c81(0x254),'UMewf':function(_0x53082e,_0x1045fa){return _0x53082e<=_0x1045fa;},'EJDRg':function(_0x5c97ec,_0x4b6e56){return _0x5c97ec===_0x4b6e56;},'XKHSa':_0x334c81(0x1fa),'GGBcn':_0x334c81(0x152),'Rupgo':function(_0x51b6cd,_0x38a37e){return _0x51b6cd-_0x38a37e;},'CeEGY':function(_0x17c264,_0x220a01){return _0x17c264<_0x220a01;},'rVekJ':_0x334c81(0x26b),'CkeEn':_0x334c81(0x1ea),'SLyHo':function(_0x45b5ee){return _0x45b5ee();},'EQojE':_0x334c81(0x17d),'IjkjJ':_0x334c81(0x280),'abyTj':_0x334c81(0x33f),'VpeOP':function(_0x305724){return _0x305724();},'qFckt':_0x334c81(0x1f3),'gmceR':_0x334c81(0x3a9),'iotXN':'fgUjx','lLkGo':function(_0x420178,_0x5c9240){return _0x420178===_0x5c9240;},'FxuDG':function(_0x379adf,_0x4a7626){return _0x379adf!==_0x4a7626;},'NXhoV':_0x334c81(0x11c),'zpuDu':_0x334c81(0x345)};if(_0x36ec5d[_0x334c81(0x1c4)](document[_0x334c81(0x38e)](_0x36ec5d[_0x334c81(0x1f6)])[_0x334c81(0x189)][_0x334c81(0x162)],_0x36ec5d[_0x334c81(0x1ac)]))return;if(document['getElementById'](_0x36ec5d['MlKZY'])[_0x334c81(0x139)]['contains'](_0x36ec5d[_0x334c81(0x2d5)])===![])return;if(_0x50fc46[_0x334c81(0x2d4)]>='1'&&_0x36ec5d['UMewf'](_0x50fc46['key'],'4')){if(_0x36ec5d[_0x334c81(0x132)](_0x36ec5d['XKHSa'],_0x36ec5d[_0x334c81(0x1fd)]))_0x3dbc70();else{const _0x10ec76=_0x36ec5d[_0x334c81(0x224)](_0x36ec5d['jassV'](parseInt,_0x50fc46[_0x334c81(0x2d4)]),0x1),_0x2fba11=document['querySelectorAll'](_0x334c81(0x2bd));if(_0x36ec5d['CeEGY'](_0x10ec76,_0x2fba11[_0x334c81(0x236)]))_0x36ec5d['jassV'](selectOption,_0x10ec76);}}else{if(_0x36ec5d[_0x334c81(0x132)](_0x50fc46[_0x334c81(0x2d4)],_0x36ec5d[_0x334c81(0x28c)]))_0x36ec5d['cTJts'](_0x334c81(0x354),_0x36ec5d[_0x334c81(0x1a5)])?_0x36ec5d['SLyHo'](previousQuestion):_0x3c2b10=_0x36ec5d['bifJM'];else{if(_0x36ec5d[_0x334c81(0x132)](_0x50fc46[_0x334c81(0x2d4)],_0x36ec5d[_0x334c81(0x197)])||_0x50fc46[_0x334c81(0x2d4)]==='\x20')_0x50fc46[_0x334c81(0x29b)](),_0x36ec5d[_0x334c81(0x1c9)](nextQuestion);else{if(_0x36ec5d[_0x334c81(0x132)](_0x50fc46['key'][_0x334c81(0x101)](),'b')&&(currentMode===_0x36ec5d[_0x334c81(0x175)]||currentMode===_0x36ec5d[_0x334c81(0x1dd)]))_0x36ec5d[_0x334c81(0x120)](toggleBookmark);else{if(_0x50fc46[_0x334c81(0x2d4)][_0x334c81(0x101)]()==='m'&&(currentMode===_0x36ec5d[_0x334c81(0x2c8)]||_0x36ec5d['EJDRg'](currentMode,_0x36ec5d[_0x334c81(0x29f)]))){if(_0x36ec5d[_0x334c81(0x2a3)]!==_0x334c81(0x153))_0x36ec5d[_0x334c81(0x120)](toggleMarkForReview);else{if(_0x499bfb)_0x3fe5d1+=_0x334c81(0x30a)+_0x70bef3+_0x334c81(0x28e);}}else _0x50fc46[_0x334c81(0x2d4)][_0x334c81(0x101)]()==='s'&&(_0x36ec5d['lLkGo'](currentMode,_0x36ec5d[_0x334c81(0x2c8)])||_0x36ec5d[_0x334c81(0x132)](currentMode,_0x36ec5d['gmceR']))&&(_0x36ec5d[_0x334c81(0x332)](_0x36ec5d['NXhoV'],_0x36ec5d[_0x334c81(0x1a2)])?_0x36ec5d[_0x334c81(0x1c9)](submitQuiz):_0x3a0d64=LYQAfD['jassV'](_0x3d196b,LYQAfD['XAHLA'](LYQAfD[_0x334c81(0x128)]('return\x20(function()\x20',LYQAfD[_0x334c81(0x19d)]),');'))());}}}}});</script>

</body></html>